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Abstract(
"
" "
"Cytotoxic" T" Lymphocyte"Associate"Antigen" 4" (CTLA64)" is" an" important" negative" regulator" of" T" cell"
activation.""The"protein"is"expressed"in"activated"T"cells"and"can"also"be"found"in"regulatory"T"cells."
The"mechanism"of"action"of"this"protein"remains"controversial;"it"has"typically"been"associated"with"a"
cell"intrinsic"negative"signal"however,"there"is"increasing"evidence"that"CTLA64"may"act"as"an"effector"
molecule.""Surprisingly,"we"find"that"blocking"CTLA64"in"a"model"of"T"cell"activation"driven"by"ligand6
expressing"transfectants"has"no"effect"on"either"proliferation"or"cytokine"production,"suggesting"that"
CTLA64"does"not" inhibit" in" this" setting." In" contrast," blocking"CTLA64" in" a"dendritic" cell" based"assay"
enhances"proliferation"and"cytokine"production,"only"when"the"amount"of"co6stimulation"is"limiting."
In" these" experiments" CTLA64" function" correlates" with" decreased" expression" of" B7" ligands" on"
dendritic"cells"consistent"with"the"removal"of"ligands"by"CTLA64."Furthermore,"the"addition"of"CTLA64"
transfected" Jurkat" cells" acts" to" suppress" T" cell" responses" consistent" with" a" role" for" CTLA64" as" an"
effector" of" suppression." Overall" our" data" do" not" support" a" role" for" CTLA64" in" delivering" a" ligand6
dependent"cell6intrinsic"negative"signal"and"instead"suggest"a"role"for"CTLA64"as"an"effector"molecule"
which"inhibits"co6stimulation"by"APC.""""
""
"
"
"
"
"
ii"
"
"
Acknowledgements(
(
"
Firstly,"and"most"importantly"I’d"like"to"thank"Dave"Sansom"for"offering"a"stimulating"
and" challenging" project." " I" am" also" grateful" for" his" support" and" guidance" throughout" and"
especially" for"his"patience"with"my"slow"going"write6up." "Thank"you." "A"Big"thank"you"also"
goes"to"Omar"Qureshi"for"his"technical"advice"and"assistance"over"the"years,"it"is"very"much"
appreciated"and"I"definitely"owe"you"lunch."""I"am"also"very"much"grateful"for"the"help"and"
expertise" offered" by" Steve" Young" with" reference" to" the" BIAcore" experiments." " A" special"
mention"also"goes" to" the" rest"of" the"members"of" the"Sansom" lab"with"whom" I"worked"at"
various"stages"of"my"project,"namely"Yong,"Claire,"Louisa,"Saty"and"Zoe."""I"would"also"like"to"
acknowledge" those"people" I"had" lunch"with"every"day" (particularly"Emily"Schmidt," I"didn’t"
forget!)" and" those" that" could"be" found" in" the"pub"on" a" Friday" evening," thanks" for" all" the"
laughs"and"good"times"and"for"making"my"time"in"Birmingham"enjoyable.""""
"
"
"
"
"
"
"
"
"
"
iii"
"
"
Table(of(Contents((
(
1.(Introduction( 1(
1.1""The"Immune"Response( 2"
1.2""T"cell"Development"and"the"T"cell"Receptor( 4"
1.3""T"cell"Activation( 7"
1.4""Co6stimulation" 10"
1.4.1""CD28" 10"
1.4.2""Inducible"COStimulator"(ICOS)" 11"
1.4.3""Programmed"Death"1"(PD61)" 12"
1.5""Immunological"Tolerance" 13"
1.5.1""Central"Tolerance" 13"
1.5.2""Peripheral"Tolerance" 15"
1.5.2.1""Regulatory"T6cells"(Tregs)"and"peripheral"tolerance" 15"
1.5.2.2""Clonal"Deletion"in"the"Periphery" 16"
1.5.2.3""Anergy" 17"
1.5.2.4""Tolerogenic"Dendritic"Cells" 17"
1.6""Regulatory"T6cells"(Tregs)" 19"
1.6.1""Treg"Development" 19"
1.6.2""Mechanisms"of"Treg"Mediated"Suppression" 21"
1.6.2.1""Cytotoxic"T"Lymphocyte"Antigen"4"(CTLA64)" 21"
1.6.2.2""IL62" 22"
1.6.2.3""Transforming"Growth"Factor6β"(TGF6β)" 22"
iv"
"
"
1.6.2.4""IL610" 23"
1.6.2.5""Other"factors"mediating"Treg"suppression" 24"
1.7"Cytotoxic"T"Lymphocyte"Associated"Antigen64"(CTLA64)" ( 25"
1.7.1""Biochemical"Interactions" 26"
1.7.2""Mechanisms"of"Action" 27"
"""""""""""""1.7.2.1""Sequestration"of"Ligand( 28"
"""""""""""""1.7.2.2""Signalling( 28"
"""""""""""""1.7.2.3""Cell"Extrinsic"Mechanisms"of"CTLA64"Function"""""""""( 31"
""""""""""""""""""""""""""1.7.2.4""CTLA64"and"Regulatory"T"cells" 32"
""""""""""""""""""""""""""1.7.2.5""Indoleamine"2,36dioxygenase"(IDO)" 33"
1.8""Immune"Mediated"Disease" 34"
1.8.1""Autoimmunity" 34"
1.8.2""CTLA64"and"Immune"Mediated"Disease" 36"
1.9""CTLA64"as"a"Therapeutic"Target" 37"
1.10""Project"Aims" 39"
" (
2.((Materials(and(Methods( 41(
2.1""Antibodies" 42"
2.2""Flow"Cytometry"Antibodies" 43"
2.3""Western"Blotting"Antibodies" 44"
2.4""Maintenance"of"Cell"Lines" 45"
2.5""Generation"of"CHO"Cell"Transfectants" 46"
v"
"
" "
2.6""Generation"of"CTLA64"Expressing"Jurkats" 46"
2.7""Freezing"of"Cell"Lines" 47"
2.8""Conjugation"of"Anti6CTLA64"Antibody"to"HRP" 47"
2.9"Enzyme"Linked"ImmunoSorbent"Assay"(ELISA)" 48"
2.10""Surface"Plasmon"Resonance" 49"
2.11""Antibody"Binding"to"CTLA64"Expressing"CHO"Cells" 50"
2.12""Ability"of"Antibodies"to"Block"CTLA64"Ligand"Binding" 51"
2.13""Isolation"of"PBMC" 52"
2.14""Isolation"of"T"cells" 52"
2.15""Isolation"of"Monocytes" 53"
2.16""Isolation"of"Regulatory"T"cells" 54"
2.17""Differentiation"of"Dendritic"cells" 54"
2.18""Gluteraldehyde"Fixing"of"CHO"Cells" 55"
2.19""T"cell"Proliferation"Assays" 55"
2.20""Re6Stimulation"Experiments" 56"
2.21""Staining"of"Cells"for"Flow"Cytometry" 57"
2.22""Cytokine"Staining"of"T"cells" 58"
2.23""FoxP3"Staining"of"T"Cells" 58"
2.24""Isolation"of"Protein" 59"
2.25""Protein"Quantification"by"Bradford"Assay" 59"
2.26""Western"Blot"Analysis" 60"
2.27""Statistical"Analysis" 61"
vi"
"
3.((Characterisation(of(anti?CTLA?4(Antibodies( 62(
3.1""Introduction" 63"
3.2""Results" 64"
3.3""Discussion" 87"
" (
4.((Assessing(CTLA?4(Function" 93(
4.1""Introduction" 94"
4.2""Results" 95"
""""""""""4.2.1""Activating"T"cells"with"CHO"cells"Expressing"CTLA64"Ligands" 95"
""""""""""4.2.2""Does"Blocking"CTLA64"Affect"Proliferation"in"a"Dendritic"Cell"Assay" 111"
4.3""Discussion" 122"
" (
5.((CTLA?4(Acts(as(an(Extrinsic(Regulator(of(T(cell(Activation( 127(
5.1""Introduction" 128"
5.2""Results" 129"
5.2.1""Can"CTLA64"Expressing"Cells"Regulate"the"Proliferation"of"a""""""""""""""""
Responder"""Population?"
129"
""""""""""5.2.2""Determining"CTLA64"Effector"Function" 138"
5.3""Discussion" 151"
" (
6.((Final(Discussion( 156(
6.1""Final"Discussion" 157"
" (
vii"
"
7.((References( 168(
"
"
"
"
List(of(Figures(
"
Figure"1.2.1:""T"cell"Development"in"the"Thymus" 6"
Figure"1.3.1:""The"Immunological"Synapse" 8"
Figure"1.4.2.1:""CTLA64"Signalling"Pathways" 30"
Figure'3.2.1:''Anti6CTLA64"antibodies'bind'to'the'extracellular'domain'of'CTLA6
4"Ig"in"an"ELISA"
65"
Figure"3.2.2:""Kinetics"of"Tremelimumab"Binding"to"CTLA64"Ig" 68"
Figure"3.2.3:""Kinetics"of"BNI3"Binding"to"CTLA64"Ig" 69"
Figure"3.2.4:""Kinetics"of"10A8"Binding"to"CTLA64"Ig" 70"
Figure"3.2.5:""Kinetics"of"11G1"Binding"to"CTLA64"Ig" 71"
Figure"3.2.6:""Kinetics"of"26B"Whole"Binding"to"CTLA64"Ig" 72"
Figure"3.2.7:""Kinetics"of"26B"ScFv"Binding"to"CTLA64"Ig" 73"
Figure"3.2.8:""Kinetics"of"11D4"Whole"Antibody"Binding"to"CTLA64"Ig" 74"
Figure"3.2.9:""Kinetics"of"11D4"F(ab)2"Binding"to"CTLA64"Ig" 75"
Figure"3.2.10:""Phenotype"of"CHO6CTLA64"Cells" 77"
Figure"3.2.11:""Antibodies"Binding"to"Full"Length"CTLA64"Expressed"in"CHO"Cells" 79"
Figure'3.2.12:''Titration'of'CTLA64"Ig"to"achieve"sub"maximal"staining"of"CHO"
cell$tranfectants.$$"
81"
viii"
"
Figure'3.2.13:''Tremelimumab'blocks'CTLA64"binding"to"ligands"expressed"on"
CHO$cells"
83"
Figure'3.2.14:''Anti6CTLA64"antibodies"blocking"CTLA64"binding"to"its"ligands"
with%differing%efficiencies"
84"
Figure'3.2.15:''Does'KD!Value&Predict&Blocking&Capability&of&Antibody" 86"
Figure"3.3.1:""Crystal"Structure"of"CTLA64"Ligand"Binding"Domain" 91"
Figure"4.2.1:""Phenotype"of"CHO"Cells" 96"
Figure'4.2.2:''Purity'of'T6cells%isolated%from%PBMCs" 97"
Figure"4.2.3:""CHO"Cells"Expressing"CD80"or"CD86"can"Provide"T"Cell"Co6
stimulation"
99"
Figure'4.2.4:''Blocking'CTLA64"has"no"effect"on"the"proliferation"of"T6cells%co6
stimulated*with*CHO*cell*transfectants"
101"
Figure"4.2.5:""CD256"T"Cells"co6stimulated"with"CHO"cell"Transfectants"Express"
CTLA64"
102"
Figure'4.2.6:''Titrating'the'number'of'co6stimulatory+CHO+cells+does+not+reveal+
a"negative"signal"
105"
Figure'4.2.7:''Blocking'CTLA64"does"not"enhance"IL62"production"in"a"CHO"cell"
transfectant)driven)assay)of)T6cell$proliferation"
106"
Figure'4.2.8:##Blocking#CTLA64"has"differential"effects"on"the"production"of"
cytokines"
107"
Figure'4.2.9:''Blocking'CTLA64"upon"re6stimulation*of*T6cell$blasts$with$CHO$cell$
transfectants)does)not)affect)T6cell$proliferation."
109"
Figure'4.2.10:''Anti6CD28%and%CTLA64!Ig#are#able#to#modulate#T6cell$ 110"
ix"
"
proliferation+where+anti6CTLA64"cannot."""
Figure"4.2.11:""Phenotype"of"Dendritic"Cells"" 112"
Figure"4.2.12:""T"Cell"Responses"are"Dependent"on"co6stimulation" 113"
Figure"4.2.13:""Blocking"CTLA64"in"a"DC"Based"Assay"Enhances"Proliferation"
when"Co6stimulation"is"Limiting"
115"
Figure"4.2.14:""Proliferating"Cells"Express"CTLA64"" 116"
Figure"4.2.15:""Blocking"CTLA64"Enhances"IL62"Production"Where"the"Number"
of"DCs"Used"to"Provide"co6stimulation"is"Limited"
117"
Figure'4.2.16:'!Blocking)CTLA64"has"differential"effects"on"T6cell$cytokine$
production"
118"
Figure'4.2.17:''Blocking'CTLA64"enhances"the"proliferation"of"T6cell$blasts$co6
stimulated*with*DCs"
120"
Figure"4.2.18:""Does"Addition"of"a"CD28"Agonist"Overcome"the"Effect"of"
Blocking"CTLA64"
121"
Figure"5.2.1.1:""Purity"of"Tregs"Isolated"by"CD25"Positive"Selection" 131"
Figure'5.2.1.2:''Negative'selection'of'regulatory'T6cells%by%a%combination%of%
CD49d&and&CD127&negative&selection&improves&the&yield&of&Tregs.&&"
132"
Figure'5.2.1.3:'Addition'of'Treg'cells'enhances'proliferation'of'responder'CD25
6
!
T6cells.&&"
134"
Figure'5.2.1.4:''Jurkat'cell'lines'express'CTLA64.##" 135"
Figure"5.2.1.5:""CTLA64"Expressing"Jurkats"can"Suppress"Responder"Cell"
Proliferation"
137"
Figure"5.2.2.1:""Enhanced"Proliferation"after"CTLA64"Blockade"is"not"a"Result"of" 140"
x"
"
IDO"
Figure"5.2.2.2:""Effect"of"Blocking"CTLA64"Does"Not"Correlate"with"the"Effect"of"
16MT"Inhibition"
141"
Figure"5.2.2.3:""Jurkats"can"Acquire"CD86"GFP"from"CHO"Cells" 143"
Figure'5.2.2.4:''Blocking!CTLA64"results"in"the"down"regulation"of"CD80"and"
CD86%on%DCs."
145"
Figure"5.2.2.5:""Acquired"CD86"is"Degraded"in"the"Jurkat" 147"
Figure"5.2.2.6:""CD86"is"Degraded"after"Acquisition" 148"
Figure"5.2.2.7:""CTLA64"is"also"Degraded"after"Acquiring"CD86" 150"
Figure&6.1:&&Summary&Diagram&of&CTLA64"Mediated"Suppression.!!" 161"
" "
"
"
"
"
"
List"of"Tables"
"
"
Table"1:""Antibodies"Details" 42"
Table"2:""Details"of"Antibodies"Used"in"Flow"Cytometry"Analysis" 43"
Table"3:""Details"of"Antibodies"Used"in"Western"Blot"Analysis" 44"
"
!!
!
!
Chapter!1:!
Introduction!
!
!
!
!
!
!
!
! 2!
1.1 The!Immune!Response!
!
! The! immune! system!has! evolved! to! protect! the! host! from! the! array! of! pathogens!
encountered! over! its! lifetime.! ! The! system! requires! tight! regulation! to! ensure! that! the!
correct! level! of! response! is! achieved.! ! Too!hesitant! a! response! can! result! in! the!organism!
succumbing!to!infection;!conversely,!too!vigorous!a!response!can!result!in!reactivity!to!self<
antigens,!which!may!result!in!autoimmunity.!There!are!two!broad!types!of!immunity:!!innate!
and! adaptive.! ! The! innate! response! provides! the! first! line! of! defence! against! invading!
pathogens!comprising!a!broad!range!of!mechanisms!designed!to!generate!a!rapid!response!
against! infection.! ! Such! mechanisms! include! physical! barriers! like! the! skin! which! stop!
antigens!getting!into!the!body,!proteins!such!as!the!complement!system!which!mediate!the!
killing!of!pathogens,!innate!immune!cells!such!as!neutrophils!and!biologically!active!enzymes!
that!cause!the!destruction!of!infected!cells![1].!!!
!
!
Unlike! innate! immunity,! the! adaptive! response! is! antigen! specific! generating! highly!
adapted!responses!to!specific!antigens,!which!result!in!memory.!!Two!types!of!adaptive!cells!
exist,! T! cells! and! B! cells.! Whilst! B! cells! are! responsible! for! antibody! production,! T! cells!
recognise! antigens! expressed! in! a! cellular! context.! T! cell! antigens! are! presented! on! the!
surface!of! cells! by!molecules! known!as!major! histocompatibility! complexes! (MHC).! ! There!
are!two!classes!of!MHC;!I!and!II!and!they!differ!in!the!type!of!cells!that!they!present!antigens!
on.!!MHC!I!molecules!present!short!peptides!of!both!self!and!non<self!antigen!on!the!surface!
on!most!cell!types!in!the!body.!!Conversely,!MHC!II!molecules!are!used!by!antigen!presenting!
cells! (APCs)! and! they! display! peptides! that! have! been! processed! within! the! cell! after!
ingestion! by! the! APC.! ! The! different! classes! of!MHC!molecules! activate! different! types! of!
! 3!
immune! cells.! ! For! example,! MHC! I! cells! trigger! a! response! from! CD8+! T<cells,! which! are!
involved! in! the! cytotoxic! killing! of! cells! infected! by! intracellular! pathogens.! ! On! the! other!
hand,!MHC!II!molecules!cause!CD4+!T<cells!to!activate.!!The!CD4+!T<cells!are!known!as!helper!
cells! and! they!are! involved! in! the! regulation!of!both! cell!mediated!and!humoral! immunity!
[2].! !Historically,! there!were! two!major! types!of!helper!T<cells!known!as!Th1!and!Th2!cells!
[3],! however! these! subsets! have! since! been! expanded! to! include! other! cell! types! such! as!
Th17!cells.!!Different!helper!T<cell!subsets!produce!different!cytokines!upon!activation!with!
differing! effector! functions.! ! For! example,! Th1! cells! produce! IL<2! and! interferon! γ! (IFNγ),!
which! stimulate! macrophage! antigen! presentation! and! the! proliferation! of! CD8+! T<cells!
hence!up<regulating!the!response!against!intracellular!pathogens![3].!!Th2!cells,!on!the!other!
hand,!produce!IL<4,!5,!6!and!10,!which!drive!B!cells!to!produce!antibodies![3].! ! In!contrast,!
Th17!cells!have!been!shown!to!produce!IL<17!and!play!a!role!in!the!defence!against!a!range!
of!extracellular!pathogens!by!producing!a!very!strong!inflammatory!response.!!Indeed,!it!has!
been! suggested! that! these! cells! are! required! to! clear! infection! where! the! Th1! or! Th2!
response!has!been!inefficient![4].!!!
!
!
An! important! feature! of! the! adaptive! immune! response! is! the! generation! of! immune!
memory.! ! This! allows! the! immune! system! to! act! promptly! upon! detection! of! previously!
encountered! antigens! without! causing! serious! disease.! ! Memory! T<cells! are! thought! to!
differentiate!into!either!central!memory!cells!that!circulate!in!secondary!lymphoid!organs,!or!
effector!memory!cells!that!patrol!peripheral!tissues![5].!!Memory!cells!survive!after!antigen!
clearance;! there! is! some! evidence! to! suggest! that! development! of!memory! cells! requires!
strong! antigen! driven! signals! during! the! primary! response! [6].! ! ! Subsequent! survival! is!
thought!not!to!be!dependent!on!MHC!engagement![7,!8],!instead!it!appears!that!IL<7!and!IL<
! 4!
15! engagement! are! required! for! maintenance! of! the! CD4! memory! population! [9<11].!!
Despite!their!potential!for!survival,!the!numbers!of!CD4!memory!cells!are!thought!to!decline!
over!time!with!the!population!having!a!half!life!of!around!10!years![12],!however,!it!has!been!
shown!that!numbers!can!be!maintained!with!persistent!viral!antigen!stimulation[13].!!!!
!
1.2 T8cell!development!and!the!T8cell!Receptor!
!
! T<cells!are!produced!in!bone!marrow!but!migrate!to!the!thymus!where!they!undergo!
the! maturation! process! (figure! 1.2.1).! ! A! number! of! critical! processes! take! place! in! the!
thymus,!including!the!rearrangement!of!genes!encoding!the!T!cell!receptor!and!critically,!the!
selection! of! T! cells! expressing! TCRs! of! appropriate! and! “tolerable”! specificities.! The! T<cell!
progenitors! enter! the! thymus! at! the! cortico<medullary! junction! [14]! and! become! double!
negative! 1! cells! (DN1)!which! lack! expression!of! both!CD4!and!CD8.! ! ! The!double!negative!
cells!pass!through!a!further!3!stages!as!DN!cells!as!they!migrate!from!the!cortico<medullary!
junction! to! the! subcapsular! zone.! ! It! is! during! this! phase! of! development! that! the! genes!
encoding! the! T<cell! receptor! (TCR)! undergo! rearrangement! in! a! process! known! as! V(D)J!
recombination.!!This!allows!the!formation!of!a!broad!repertoire!of!antigen!specific!receptors!
[3]! enabling! the! T<cell! to! recognise! and! hence!mount! responses! against! the! pathogens! it!
encounters.! There!are!2types!of! T<cell! receptor! (TCR);! the!most! commonα:β! receptor!and!
the!rarer!γ:δ!receptor![15].!!In!each!case!the!extracellular!part!of!the!receptor!is!formed!by!
both! an!α! chain! and! β! chain! or! a! γ! and! δ! chain! which! are! covalently! linked! together! by!
disulphide!bonds![15].! ! In!the!cell!the!TCR!forms!an!association!with!the!CD3!complex;! it! is!
this!complex!that! is!required!for!signalling!after!TCR!engagement![16].! ! !After!formation!of!
the!TCR,!the!DN!cells!develop!into!cells!that!are!both!CD4+!and!CD8+;!these!cells!are!termed!
double!positive!cells!(DP).!!!
! 5!
! !In!the!cortex,!the!DP!cells!are!exposed!to!MHC!and!antigens.!!If!the!T<cells!respond!
too!strongly!to!these!self!antigens!or!if!they!don’t!respond!at!all,!the!cells!undergo!a!process!
of!deletion!known!as!negative!selection!which!helps!remove!self!reactive!T<cells![17].!!Those!
cells!that!respond!moderately!are!positively!selected.!!These!cells!become!single!CD4!or!CD8!
cells!and!migrate!to!the!medulla![18].!!The!medulla!contains!medullary!thymic!epithelial!cells!
(mTEC),!which!express!a!diverse!range!of!tissue!specific!antigens![19,!20].!!The!single!positive!
cells!are!exposed!to!these!antigens!and!are!thought!to!undergo!a!further!process!of!negative!
selection! [17].! !The!mature!single!positive! thymocytes!are! then!exported! from!the!thymus!
enabling!them!to!enter!the!circulation.!!Ultimately,!these!processes!result! in!a!peripheral!T!
cell!repertoire,!which!is!both!capable!of!responding!to!a!vast!array!of!foreign!antigens!whilst!
at!the!same!time!limited!in!its!capacity!to!respond!to!self!antigens!under!normal!conditions.!
!
!
!
!
!
!
!
!
!
!
! 6!
!
!
!
!
!
! 7!
1.3 T8cell!Activation!
!
The!effective!response!of!T!cells!to!a!foreign!antigen!first!requires!the!activation!and!
expansion! of! relatively! rare! antigen<specific! T! cells.! T<cell! activation! begins! with! antigen!
recognition! by! the! T<cell! receptor! in! the! context! of! MHC! molecules! on! the! APC.! ! The!
alpha/beta!T<cell!receptor!itself!is!unable!to!signal!and!associates!with!CD3!complex!which!is!
responsible!for!delivering!T<cell!receptor!signalling.!
!
Upon!antigen! recognition! the!T<cell! and! the!APC! form!an! interaction! known!as! an!
immunological!synapse!(IS)![21],!figure!1.3.1.!!The!structure!of!the!IS!allows!organisation!of!
the!T<cell!signalling!equipment!to!aid!activation.!!The!IS!can!be!organised!into!three!distinct!
structural! regions! known! as! supramolecular! activation! clusters! (SMAC)! [22].! ! The! central!
SMAC! (cSMAC)! contains! the! TCR! and! co<stimulatory!molecules! [22],! whilst! the! peripheral!
SMAC! (pSMAC)! contains! adhesion!molecules! such! as! LFA<1! [22,! 23]! and! the! distal! SMAC!
(dSMAC)!contains!proteins!such!as!CD45![24].! !Upon!T<cell! interaction!with!DCs,!multifocal!
synapses!have!been!shown!to! form![25,!26].! It! is! thought! that!TCR!engages!with!signalling!
molecules! in!the!dSMAC!before!migrating!through!the!pSMAC,!towards!the!cSMAC![27<30]!
making!the!synapse!a!structure!that!enables!organisation!of!the!T<cells!signalling!equipment!
to!aid!activation.!
!
!
!
!
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A! number! of!molecules! are! associated!with! T<cell! receptor! signalling.! ! One! of! the!
first!stages!of!signalling!involves!the!phosphorylation!of!the!immunoreceptor!tyrosine!based!
activation!motif! (ITAM)!of!the!CD3!and!TCR!ζ!chain!by! lck!and!fyn![31<33].! !Most!evidence!
points! to! lck! being! the!major!molecule! responsible! for! ITAM! phosphorylation,! specifically!
due!to!the!findings!that!lck!knockout!cells!have!significantly!reduced!ITAM!phosphorylation!
and!that!this!can!be!recovered!by!inducing!expression!of!lck![34<37].!!ITAM!phosphorylation!
results!in!recruitment!of!ZAP<70!to!the!TCR!ζ!chain,!which!enables!lck!mediated!activation!of!
ZAP<70![38,!39].!!!!
!
Activation! of! ZAP<70! leads! to! recruitment! of! two! adapter! proteins;! linker! for! the!
activation! of! T<cells! (LAT)! and! src! homology! 2! (SH2)! domain! containing! leukocyte!
phosphorylation! of! 76kDa! (SLP<76)! [40,! 41].! ! LAT! binds! to! the! PLCγ1! subunit! of!
phosphoinositide!3<kinase! (PI3K)!which! results! in! the!breakdown!of! the!molecule! into! two!
components,!diaglycerol!(DAG)!and!tris!phosphate!(IP3).!!DAG!results!in!the!activation!of!PKC!
and!IP3!initiates!the!release!of!Ca2+.!!In!addition!to!this,!LAT!has!been!shown!to!activate!the!
Ras<MAPK!pathway!by!binding!to!Grb2,!which!leads!to!recruitment!of!son!of!sevenless!(Sos)!
[42].! ! Finally,! LAT! can!also!activate!NFAT! function! through! recruitment!of! SLP<76,!which! is!
mediated! by! LAT! binding! to! Gads! [43<45].! ! ! Activation! of! these! pathways! results! in!
differentiation!of!effector!T<cells!and!drives!their!proliferation.!
!
!
!
!
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1.4 Co8stimulation!
!
Despite! its! critical! role! in! generating! antigen! specificity,! TCR/CD3! signalling! alone!
appears!to!be! insufficient!and!can!result! in!the!T<cell!becoming!anergic!or!being!destroyed!
[3].! ! Therefore,! in! order! to! generate! a! highly! effective! response! additional! co<stimulatory!
signal!are!required.!!!
!
1.4.1 CD28!
!
One!of!the!most!important!co<stimulatory!molecules!identified!to!date!is!CD28.!!The!
importance!of!this!protein!in!T<cell!activation!is!most!notably!shown!by!the!fact!that!CD28!</<!
mice!fail!to!mount!sufficient!immune!responses!when!challenged!with!antigen![46].! !These!
mice! suffer! from!decreased! IL<2! production,! highly! impaired! ability! for! IgG! class! switching!
and! limited! T<cell! function.! ! This! highlights! the! importance! of! CD28! in! T<cell! –! B<cell!
collaboration! and! its! essential! role! in! the! induction! of! an! effective,! high! affinity,! class!
switched!antibody!response![46].! !CD28!binds!to!one!of!2!ligands,!CD80!or!CD86,!found!on!
the!surface!of!APCs!where!ligation!of!CD28!induces!signalling!pathways!within!the!T<cell!that!
result!in!full!T<cell!activation,!survival,!proliferation!and!cytokine!production.!!Co<stimulation!
through!CD28!is!important!for!cytokine!production!and!it!has!been!shown!that!signalling!via!
CD28!has!been!shown!to!be!required!for!the!induction!of!IL<2![47,!48].!!!Further!studies!have!
suggested!that!the!CD28!signalling!pathway!plays!a!critical!role!increasing!enhancer!activity!
of!the!IL<2!gene,!as!well!as!stabilising!of!the!cytokine’s!mRNA![49,!50].!!In!addition!to!its!role!
in! inducing! cytokine! production,! CD28! has! been! shown! to! enhance! cell! survival.! ! Studies!
have!shown!that!CD28!can!up<regulate!Bcl<xL!and!that!this!is!decrease!the!susceptibility!of!T<
cells!to!apoptosis![51<56].!!!
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!
The! cytoplasmic! tail! of! CD28! contains! a! YMNM! motif! that! is! known! to! mediate!
binding! of! the! signalling!molecules! of! PI3K! and!Grb2! upon! phosphorylation! following! TCR!
activation![57<60].!!Engagement!of!PI3K!results!in!the!production!of!the!phosphatidylinositol!
(3,4)<bisphosphate! (PIP2)! and! phosphatidylinositol<(3,4,5)<trisphosphate! (PIP3)! lipids! ! [61]!
which!enable!the!recruitment!proteins!containing!a!pleckstrin!homology! (PH)!domain!such!
as! phosphoinositide<dependent! protein! kinase! 1! (PDK1)! [62,! 63].! ! Recruitment! of! PDK1!
results!in!the!phosphorylation!and!subsequent!activation!of!protein!kinase!B!(PKB)![64,!65].!!
Activation! of! PKB! enables! the! phosphorylation! of! BAD,! which! releases! Bcl<2! and! Bcl<XL!
enabling! them! to!exert! their! anti<apoptotic! functions!hence!promoting!T<cell! survival! [66].!!
CD28! can! also! signal! by! the! recruitment! of! Grb2! to! the! asparagine! residue! of! the! YMNM!
motif![67,!68].!!Grb2!is!then!thought!to!recruit!Sos!and!vav![67,!69,!70],!which!results!in!the!
downstream!activation!of!JNK![71].!!!Whilst!the!exact!role!of!CD28!signals!compared!to!the!
role! of! TCR! signals! is! not! well! understood,! it! is! clear! that! combined! signals! from! both!
partners!are!required!to!generate!an!effective!T!cell!response.!
!
1.4.2 ICOS!
!
ICOS! (Inducible!COStimulator)! is!a!co<stimulatory!molecule!whose!expression! is!up!
regulated!upon!T<cell!activation![72].!!Signalling!by!this!molecule!is!initiated!upon!binding!its!
ligand,! ICOS<L,! which! can! be! found! on! B<cells,! DCs! and!macrophages! [73,! 74].! ! Similar! to!
CD28,! ICOS!signals!through!the!recruitment!of!PI3K!to! its!SH2!domain,!which!results! in!the!
downstream!activation!of!JNK,!p38!and!ERK![75<77].!!Further,!ICOS!has!been!shown!to!signal!
through! the! Akt! pathway! leading! to! the! suggestion! that! the! protein! is! required! for! cell!
survival![75,!77<79].!!!!
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!
ICOS! signalling! is! also! thought! to! be! important! for! the!production!of! a! number! of!
cytokines,! including! IL<4,! IL<10,! INF<γ,! TNF<α! and! IL<5! [72,!74,!76,!80{Dong,!2001!#591,!81,!
82],!this!pathway!is!therefore!thought!to!be!required!for!optimal!Th1!and!Th2!cell!responses!
and!more!recently!T!follicular!helper!responses.!!On!top!of!this,!there!is!evidence!to!suggest!
that! the!protein!may!have!a! role! to!play! in!survival!and!maintenance!of!Regulatory!T<cells!
(Tregs)![81,!83<85].!!!
!
1.4.3 Programmed!Death!1!(PD81)!
!
PD<1!is!a!negative!regulator!of!immune!responses!that!is!up!regulated!on!both!T!and!
B<cells!upon!their!activation![86<90].!!The!protein!has!two!ligands;!PD<L1!and!PD<L2![88,!91<
93].!PD<L1!can!be!found!on!DCs,!macrophages,!T<cells!and!B<cells![88,!94,!95],!whereas!PD<L2!
expression!is!limited!to!DCs!and!macrophages![88,!92,!93,!96,!97].!!!
!
The!tail!of!PD<1!contains!an!ITIM!motif!immediately!followed!by!an!immunoreceptor!
tyrosine<based! switch! motif! (ITSM)! motif! [98]! and! it! is! this! region! that! is! thought! to! be!
important! for! PD<1! function! [99].! ! It! is! thought! that! PD<1! could! function! through! the!
recruitment!of!SHP<1!and!SHP<2!to!the!ITSM!resulting!in!decreased!Akt!function,!possibly!as!
a! result!of! inhibition!of!PI3K!activity! [93,!99<102].! !Other!evidence!points! to! the!possibility!
that!PD<1!is!thought!to!function!through!deactivation!of!the!AP<1!transcription!factor![103<
105].!!!
!
!
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1.5 Immunological!Tolerance!
!
Immunological!tolerance!is!the!term!used!to!describe!the!fact!that!the!immune!system!
does! not! generally! mount! a! response! against! self<antigens.! There! are! two! categories! of!
immune! tolerance,! peripheral! and! central! and! both! play! an! important! role! in! protecting!
against!the!development!of!autoimmunity.!!!
!
1.5.1 Central!Tolerance!
!
Central! tolerance! occurs! during! T! lymphocyte! development! in! the! thymus.! ! As! stated!
previously,! during! development! T<cells! undergo! two! stages! of! selection.! ! Firstly,! positive!
selection,!where!only!cells!that!react!to!antigens!expressed!on!the!thymic!cortical!epithelium!
survive.! !The!second!stage! is!negative!selection!where!cells! that! react! too!strongly! to!self<
antigens! expressed! on! DCs! and! other! epithelial! cells! in! the! medulla! are! removed.! ! ! This!
second! is! stage! is! essential! for! limiting! the! number! of! self<reactive! T<cells! that! enter! the!
periphery!thus!reducing!the!occurrences!of!autoimmune!disease.! !This! is!evidenced!by!the!
finding!that!inhibition!of!the!negative!selection!step!by!the!removal!of!the!capacity!for!DCs!
and!medullary! epithelial! cells! to!present! antigens! to! the! T<cells! increases! the! incidence!of!
pathogenic,!self<reactive!T<!cells!entering!the!periphery![106,!107].!!!
!
A!key!feature!of!negative!selection!is!that!self<antigens!from!various!tissues!around!the!
body!can!be!expressed!in!the!thymus,!particularly!in!the!medullary!epithelial!cells![19].!!The!
transcription!factor!Autoimmune!Regulator!(Aire)!was!found!to!be!expressed!in!the!medulla!
and! is! thought! to! be! responsible! for! tissue! specific! antigens! being! expressed! within! the!
thymus!and!is!thus!important!in!preventing!autoimmunity![108,!109].!!Consistent!with!this!is!
the! finding! that! autoimmune! polyendocrinopathy! candidiasis! ectodermal! dystrophy!
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(APECED)! was! associated! with! a! defect! in! Aire! [110].! ! Subsequent! studies! using! Aire!
knockout! mice! showed! that! these! animals! developed! autoimmunity! and! that! this! was!
specifically! associated! the! absence! of! Aire! [111,! 112]! adding! further! weight! to! the!
importance!of!the!protein!in!negative!selection.!Exactly!how!Aire!regulates!gene!expression!
remains! open! to! question! although! there! is! some! evidence! to! suggest! that! Aire! binding!
directly!to!target!DNA!sequences!in!order!to!drive!expression!of!self!antigens![113].!!!
!
Negative!selection!of!T<cells!requires!the!presentation!of!self<antigens!either!on!mTECs!
or!DCs![114,!115].!!The!mTEC!cells!are!able!to!present!antigens!to!T<cells!directly![116<118],!
however,! these! cells! have! been! shown! to! inefficiently! process! and!present! antigens! using!
the!classical!MHC!II!pathway![117].!!Instead,!it!is!thought!that!mature!mTECs!attach!antigen!
to!MHC<II!by!a!process!known!as!macroautophagy!where!portions!of!the!cell!cytoplasm!are!
enclosed! in! a! membranous! structure! and! are! targeted! towards! lysosomes! where! the!
contents! are! broken! down! into! smaller! fragments! [119].! ! ! ! These! fragments! can! then! be!
loaded!onto!MHC<II!molecules!and!presented!to!T<cells.!!This!process!of!MHC<II!loading!has!
been! shown! to! be! important! for! central! tolerance! as! blocking! of! this!mechanism! inhibits!
positive!selection!and!leads!to!the!development!of!autoimmunity![120].!!!
!
Self<antigens!are!also!presented!by!DCs!in!the!thymus.!!There!is!evidence!to!suggest!that!
the! thymic!DC!population!are!made!up!of! cells! that!are!derived! in! thymus!as!well! as! cells!
that!migrate! there! from! the!periphery! [121<123].! ! The!migrating!DCs!are! thought! to!bring!
peripheral!antigens!with!them!to!assist!in!the!negative!selection!of!self!reactive!T<cells![124,!
125].!!More!generally,!there!is!evidence!to!suggest!that!DCs!are!able!to!acquire!self<antigens!
from!mTEC!cells! [118,!126<128]!although!the!mechanism!by!which!transfer!occurs!remains!
elusive.! !The!fact!that!there!is!a!naturally!high!turnover!of!mTEC!cells!and!that!the!DCs!are!
able!to!present!antigens!from!intracellular!compartments!has!led!to!the!suggestion!that!the!
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DCs! acquire! antigen! through! the! uptake! of! apoptotic! cells! [118,! 129,! 130].! ! Alternatively!
there! is! also! evidence! to! suggest! that! the! DCs! may! acquire! antigens! through! removal! of!
proteins!from!the!surface!of!the!mTECs![127,!128,!131,!132].!!!
!
!
1.5.2 Peripheral!Tolerance!
!
Despite!there!being!several!mechanisms!in!place!to!delete!overtly!self!reactive!T<cells,!it!
is! clear! that! this! process! is! incomplete! [133<138].! Indeed! it! seems! implausible! that! T! cells!
reactive!to!all!self<antigens!could!be!deleted!whilst!retaining!a!sufficiently!broad!repertoire.!
For! this! reason,! it! is! necessary! to! have! other! mechanisms! in! place! that! will! control! self!
reactive!T<cells!in!the!periphery.!!A!number!of!mechanisms!exist!to!control!the!expansion!of!
self<reactive!T<cells!in!the!periphery!including!clonal!deletion,!anergy,!regulatory!T<cells!and!
tolerogenic!DCs.!
!
!
1.5.2.1 Regulatory!T8cells!(Tregs)!and!peripheral!tolerance!
!
Another! critical! control! point! for! self<reactive! T! cells! is! the! generation! of! Tregs.!
These! cells! are! generally! identified! as! a! subset! of! T<cells! that! constitutively! express! CD25!
[139].! Depletion! of! Treg! cells! in! mice! results! in! development! of! autoimmune! disorders,!
highlighting!a!requirement!for!these!cells! in!tolerance![140,!141].! !Additionally,! it!has!been!
shown! that! stimulation! of! peripheral! blood! samples! delpletied! of! Treg! cells! revealed! the!
presence!of! responder! T<cell! populations! that! had! reactivity! to! a! number! of! self<antigens.!!
Subsequent!re<introduction!of!Tregs!to!these!cultures!was!sufficient!for!suppression!of!these!
self<reactive!cells![142<145].!!! Further,! it! is!possible! to! induce! tissue!specific!autoimmune!
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conditions! by! injecting! self! antigens! into! mice! [146].! ! In! experiments! where! Tregs! were!
depleted! prior! to! introduction! of! self<antigen,! it! was! found! that! this! exacerbated! the!
resulting!autoimmunity![147,!148].!!Taken!together,!these!data!highlight!the!importance!of!
Tregs!in!the!maintenance!of!peripheral!tolerance.!
!
!
1.5.2.2 Clonal!Deletion!in!the!Periphery!
!
It!has!been!shown!that!clonal!deletion!of!self<reactive!T<cells!s!not!restricted!to!the!
thymus!and!that!this!process!can!also!occur!in!the!periphery.!!T<cell!survival!in!the!periphery!
is! dependent! on! the! recognition! of! MHC! molecules! in! the! absence! of! antigen.! ! This! is!
evidenced! by! the! finding! that! naïve! T<cells! transferred! into! MHC! deficient! mice! have!
significantly! shortened! lifespans! [149].! ! One! of! the! pathways! thought! to! be! important! in!
tolerance! is! the! Fas/FasL! pathway! which! causes! cell! to! undergo! apoptosis! in! a! process!
known!as!activation! induced!cell!death![150].! !Both!TCR!signalling!and!Il<2!are!required!for!
the! induction! of! FasL! expression! on! T<cell! [150].! ! The! importance! of! this! pathway! of! cell!
death! in!maintaining! tolerance! is! indicated! from! findings! that! Fas! or! FasL! knockout!mice!
develop!autoimmune!disorders![151<153].!!!!
!
Other! studies! have! indicated! a! role! for! passive! cell! death! in! controlling! tolerance.!!
Passive!cell!death!occurs!in!the!absence!of!growth!factors!that!are!required!for!T<cell!survival!
and!proliferation! [154].! ! This! is! indicated!by! the! finding! that!mice!deficient! in! Bim,! a! pro<
apoptotic! factor,! are! resistant! to! cell! death! under! conditions! where! cytokines! are! absent!
[155].!!Further,!Bim!knockout!mice!developed!autoimmunity,!consistent!with!a!role!for!this!
pathway!in!tolerance![155].!!This!pathway!is!thought!to!be!important!for!the!removal!of!T<
cells!after!clearance!of!infection![156,!157]!
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1.5.2.3 Anergy!
!
One!suggested!mechanism!for!preventing!the!activation!of!self!reactive!T<cells!is!known!
as!anergy![158].!!When!T<cells!encounter!an!antigen!that!results!in!signalling!through!the!T<
cell!receptor!without!subsequent!co<stimulation,!they!enter!a!state!of!hypo!responsiveness!
[159].!!The!requirement!for!co<stimulation!appears!to!relate!to!the!need!for!IL<2!production!
in! order! to! drive! the! T<cell! through! the! cell! cycle! [160,! 161].! ! Once! these! cells! become!
anergic,!it!is!thought!that!they!are!able!to!suppress!other!effector!cells!using!cytokines!such!
as!IL<10!and!TGF<β![162<165].!!!
!
Anergised! cells!have!been! shown! to!have!a!distinct! gene!expression!profile! [166<168].!!
Specifically,! it!has!been!shown!that!anergic!cells!have!up<regulated!expression!of!ubiquitin!
E3!ligases,!diaglycerol!kinase!α!(DKGα),!caspase!3!and!Ikaros![168<170].!!The!genetic!profile!
induced! during! anergy! thought! to! be! driven! by! nuclear! factor! of! activated! T<cells! (NFAT)!
signalling!as! inhibition!of! this!pathway!by!cyclosporine!A! inhibited!expression!of! the!genes!
associated!with!anergy! [168].! !This!altered!genetic!profile!of!T<cells! is! thought! to!suppress!
TCR!signalling,!therefore!suppressing!T<cell!proliferation![171<173].!
!
1.5.2.4 Tolerogenic!Dendritic!Cells!
!
DCs!are! thought! to!play!a!critical! role! in!peripheral! tolerance!as! removal!of!DCs! in!
mice!results! in! the!activation!of!T<cells! leading!to! fatal!autoimmunity! [174].! ! Initial! reports!
suggested!that! immature!DCs!are!capable!of! inducing!tolerance![175<178]!whereas!mature!
DCs!stimulate!immunogenic!responses![179<182],!an!effect!thought!to!arise!as!a!result!of!the!
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immature! DCs! delivering! TCR! stimulation! with! inadequate! co<stimulatory! signals! [183].!!
Subsequent! studies! have! shown! that! mature! DCs! can! also! have! a! regulatory! phenotype.!!
Specifically,!it!has!been!shown!that!DCs!matured!with!tumour!necrosis!factor<α!(TNF<α)!had!
a! regulatory! phenotype! and! protected! mice! from! the! development! of! experimental!
autoimmune!encephalomyelitis!(EAE)![184].! !Additionally,!mature!DCs!have!been!shown!to!
be! capable! of! presenting! self<antigens! in! draining! lymph! nodes,! a! process! thought! to! be!
important! for!peripheral! tolerance! [185,!186].! !Tolerogenic!DCs!are!thought!to! function!by!
up<regulating! the! inhibitory! receptors! PD<1! and! CTLA<4! on! T<cells! as! well! as! through! the!
induction!of!Tregs![187,!188].!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
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1.6 Regulatory!T8cells!
!
These!cells!are!generally!identified!as!a!subset!of!T<cells!that!constitutively!express!CD25!
[139].!!Furthermore,!these!cells!can!be!distinguished!from!activated!T<cells!by!expression!of!
the!transcription!factor!forkhead!box!protein!3!(Foxp3).!In!humans!however,!while!Treg!do!
express! FoxP3,! a! subset! of! activated! T<cells! have! also! been! shown! to! be! capable! of! up<
regulating!this!transcription!factor![189].!!However,!this!expression!of!FoxP3!in!activated!T<
cells! appears! to! be! transient! and! occurs! at! lower! levels! than! is! found! in! Treg! [190].!!!!
Nonethless,!in!both!humans!and!mice!FoxP3!is!absolutely!required!for!the!development!and!
maintenance!of!Treg![191,!192]!and!accordingly,!scurfy!mice,!which!have!a!mutation! if!the!
FoxP3! gene! develop! lymphoproliferative! and! autoimmune! disease! [193].! ! ! In! humans,! a!
similar! mutation! in! the! FoxP3! gene! results! a! condition! known! as! immune! dysregulation,!
polyendocrinopathy,! enterophathy! x<linked! (IPEX)! which! is! characterised! by! autoimmune!
endocrinopathy,! type! I! diabetes! and! thyroiditis! [194].! ! This! profound! autoimmune!
phenotype!is!testimony!to!the!fact!that!our!T!cell!repertoire!is!in!fact!highly!self<reactive!and!
that!control!of!these!cells!is!critical!to!prevent!autoimmunity.!
!
!
1.6.1 Treg!Development!
!
The! majority! of! Regulatory! T<cells! develop! in! the! thymus,! known! as! natural! Tregs,!
however,!there!is!also!a!subset!of!Tregs!that!are!induced!in!the!periphery.!!Natural!Treg!cell!
development! is! thought!to!begin!with! induction!of!FoxP3!expression! in! the!medulla!of! the!
thymus! [195].! ! There! is! evidence! to! suggest! that! TCRs! recognising! self! antigen! with! a!
medium! avidity! [116,! 196<201]! and! subsequent! co<stimulation! is! required! to! induce! the!
development!of!Treg![202,!203].!!Under!these!conditions,!TCR!signalling!results!in!activation!
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of! the!NF<κB! pathway,!which! is! in! turn! responsible! for! the! induction! of! FoxP3! expression!
[204<206].! !The!cytokines!present! in!the!thymus!have!also!been!observed!to!play!a!role,! in!
particular,!IL<2!has!been!shown!to!be!crucial,!further,!Treg!generation!via!IL<2!is!thought!to!
be! mediated! via! JAK! 1/3! and! signal! transducer! and! activator! of! transcription! 5! (STAT! 5)!
signalling![207<210].!!!!Once!a!cell!becomes!a!Treg,!it!leaves!the!thymus!where!it!suppresses!
activation! of! effector! T<cells! against! self<antigens! and! is! thus! a!major! player! in!mediating!
peripheral!tolerance.!!!
!
As!well!as!natural!Treg,!it!is!also!possible!for!effector!T<cells!to!be!converted!into!Tregs!in!
the! periphery;! these! cells! are! known! as! induced! Tregs! (iTreg).! ! Induction! of! Treg! occurs!
through! a! combination! of! TCR,! IL2! and! TGF<β! signalling! [211<213],! although! the! exact!
mechanism!and!balance!of!signals!required!for!iTreg!induction!remains!elusive.!!!
!
There!are!two!subsets!of!iTregs:!type!1!regulatory!cells!(Tr1)!and!Th3!cells.!!The!Tr1!cells!
are!a!subset!of!regulatory!cell!that!secrete!high!levels!of!IL<10!and!TGF<β!but!that!lack!FoxP3!
expression![162].!!!These!Tr1!cells!are!thought!to!arise!in!the!presence!of!IL<27!secreted!from!
tolerogenic!DCs![214<217].!!Secretion!of!IL<27!is!thought!to!activate!the!transcription!factor!
Maf!and!the!arylhydrocarbon!receptor!(Ahr)![218,!219].!!
!
The!second!subset!of!induced!Tregs!are!the!Th3!cells!and!these!are!thought!to!arise!from!
a! combination! of! IL<2! and! TGF<β! signalling! in! the! periphery! [211<213].! ! The! signalling!
pathways! induced! by! these!molecules! are! thought! to! target! transcription! factors,! such! as!
STAT5,!NFAT!and!CREB/ATF,! to! the!FoxP3!promoter!as!well! as! inducing!Smad!signalling! to!
stimulate!the!expression!of!FoxP3![206,!220<222].!!There!is!evidence!to!suggest!that!T<cells!
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lose!the!capacity!for!becoming!Tregs!2<3!days!post!stimulation!and!that!memory!T<cells!are!
unable!to!be!converted!to! iTreg!cells![212].! !Additionally,! it!appears!that! low!doses!of!high!
affinity!ligands!were!necessary!for!generation!of!Tregs![223,!224].!!!Taken!together,!this!data!
implies!that!a!very!specific!set!of!environmental!conditions!are!required!for!the!generation!
of!Th3!cells.!
!
1.6.2!! Mechanisms!of!Treg!Mediated!Suppression!
!
There! is! a! growing! body! of! evidence! to! suggest! that! Tregs! use! various! means! of!
suppressing! the! action! of! effector! T<cells! depending! on! specific! microevironmental!
conditions.!!Some!of!the!major!mechanisms!are!suggested!below.!
!
1.6.2.1 Cytotoxic!T!Lymphocyte!Antigen!4!(CTLA84)!
!
CTLA<4! is!an! important!negative!regulator!of!T<cell!activation!with!a!role!to!play! in!
the!suppression!of! immune!responses!by!Tregs! [225].! !This! is! indicated!by!the! finding!that!
Tregs! express! constiutively! high! levels! of! CTLA<4! in! both! humans! and! mice! [226<229].!!
Further,!blocking!CTLA<4!results!in!mice!results!in!the!development!of!autoimmunity,!whilst!
CTLA<4</<! mice! die! at! an! early! each! form! severe! immunoproliferative! disorders! [227,! 229,!
230].!!CTLA<4!is!thought!function!in!Tregs!by!a!number!of!mechanisms,!including!modulation!
of! co<stimulatory! ligands! on! DCs! [230].! ! A! further! possible! mechanism! is! through! the!
induction! of! Indoleamine! 2,3<dioxygenase! (IDO)! expression! in! the! DC,! which! results! in!
depletion!of!tryptophan!and!subsequent!inhibition!of!responder!T<cell!proliferation![231].!
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1.6.2.2 IL82!
!
IL<2! is! a! cytokine! that! induces! cell!proliferation!and! survival! [232,!233].! !Mice! that!
lack! IL<2! receptor!or! the!ability! to!produce! Il<2! suffer! lympoprolfierative!disease! [234<236]!
suggesting!a!role!for!this!cytokine!in!prevention!of!autoimmunity.!!Indeed,!it!has!been!shown!
that!Tregs!can!inhibit!IL<2!production![237,!238]!and!that!the!lack!of!IL<2!results!in!apoptosis!
of!responder!T<cells![239].!!The!down!regulation!of!IL<2!by!Treg!is!thought!to!occur!indirectly,!
possibly!as!a!result!of!Treg!mediated!modulation!of!APC!resulting!in!reduced!co<stimulation!
and! hence! impaired! IL<2! production! [230].! ! An! alternative! suggestion! is! that! since! Tregs!
require!IL<2!for!their!survival![240,!241],!their!presence!results!in!localised!depletion!of!IL<2!
leading!to!apoptosis!of!the!effector!T<cells.!!!!
!
!
1.6.2.3 Transforming!Growth!Factor8β!(TGF8β)!
!
TGF<β! is! a!member!of! the!TGF<β! superfamily!with! three! subsets! (TGF<β!1,2!and!3)!
being! found! in!mammalian! tissues! [242].! ! ! TGF<β! is! thought! to! inhibit! the! proliferation! of!
cells!and!drives!cellular!differentiation;!it!has!also!been!identified!as!an!important!inducer!of!
Treg! cells! [243,! 244].! ! Tregs! have! been! shown! to! produce! high! levels! of! both! soluble! and!
membrane!bound!TGF<β!and!mice!whose!cells!are!unable!to!produce!the!molecule!succumb!
to! autoimmune! disorders! suggesting! a! role! for! the!molecule! in! immunosuppression! [245<
249].! !TGF<β! is! thought! to!down<regulate! IL<2!production!by!T<cells! thus! inhibiting!effector!
cell! expansion;! this! is! supported!by! the! finding! that!proliferation! can!be!partially! restored!
through!the!addition!of!exogenous!IL<2![250,!251].!!In!addition!to!modulation!of!IL<2,!TGF<β!
is!also!thought!to!control!proliferation!via!various!cell!cycle!regulators!such!as!c<myc,!cdk4,!
Cyclin!D2!and!E![252<255].!!
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!
!The!effects!of!TGF<β!are!thought!not! to!be!universal!as! the!molecule!seems!to!be!
able! to! inhibit! naive! T<cells!more!effectively! than! it! can! activated!T<cells! [256].! ! In! fact,! in!
activated!T<cells,!it!has!been!shown!that!TGF<β!drives!T<cell!proliferation!and!protects!these!
cells!from!apoptosis!suggesting!that!TGF<β’s!function!is!dependent!on!specific!environmental!
factors![257,!258].!!Regulatory!T<cells!may!therefore!be!able!to!utilise!TGF<β!to!prevent!the!
initial!activation!of!autoreactive!T<cells!in!the!periphery.!
!
1.6.2.4 IL810!
!
IL<10! is! thought!to!be!particularly! important! for!maintaining! intestinal! tolerance!as!
IL<10!knockout!mice!develop!intestinal! inflammation,!a!condition!that! is!overcome!through!
the! addition! of! Treg! or! IL<10! [259].! ! ! ! Further,! there! is! evidence! to! suggest! that! IL<10! is!
specifically! required! for! Treg! mediated! control! of! intestinal! inflammation! [260].! ! The!
cytokine!is!thought!to!impair!the!secretion!of!pro<inflammatory!molecules!such!as!TNF<α,!IL<
6! and! GM<CSF! form! monocytes! and! macrophages,! whilst! simultaneously! promoting! the!
secretion! of! anti<inflammatory!molecules! like! IL<1! and! IL<12! [261<264].! ! Additionally,! IL<10!
downregulates! surface! expression! of!MHC<II,! CD86! and! the! adhesion!molecule! CD54! thus!
impairing!T<cell!responses![265<267].!!As!well!as!modulating!APCs,!IL<10!can!exert!its!effect!
directly!on!T<cells!by! inhibiting! the!production!of! IL<2,! IFN<γ,! IL<4!and! IL<5! [268,!269].! ! The!
major!effects!of!IL<10!are!thought!to!be!mediated!through!the!activation!of!STAT!3!following!
engagement!of!the!IL<10!receptor![270<272].!
!
!
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1.6.2.5 Other!factors!mediating!Treg!suppression!
!
There!has!been!some!evidence!to!suggest!that!Tregs!can!mediate!suppression! in!a!
contact! dependent!manner! [229,! 238],! one!possible!mechanism! for! this! could! be! through!
the!action!of!granzyme,!which!results!in!the!targeted!apoptosis!of!responder!cells![273,!274].!!!
This! method! of! control! is! supported! by! the! finding! that! granzyme! deficient! Tregs! have!
reduced! capacity! for! suppression! [274].! ! In! addition! to! granzyme,! both!Galectin! 1! and! 10!
have!been!implicated!in!Treg!function![275,!276].!!!!These!molecules!are!members!of!the!β<
galactosides! and! could! play! a! role! in! cell! cycle! arrest! and! inhibition! of! pro<inflammatory!
cytokines.!!!
!
Another!possible!mechanism!is!through!the!action!of!IL<35,!a!relatively!new!cytokine!
that! has! been! shown! to! be! capable! of! suppressing! effector! T<cells.! ! Certainly,! it! has! been!
shown! that! Tregs! lacking! functional! IL<35! are! unable! to! inhibit! effector! cell! proliferation!
[277].! ! The! cytokine! is! made! of! and! IL<12α! and! EBI3! chain! giving! the!molecule! structural!
similarity!to!IL<12!and!IL<27![277],!however,!the!specifics!of!the!biology!of!how!the!cytokine!
exerts!its!regulatory!function!remain!largely!unknown.!!!!!!
!
!
!
!
!
!
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1.7 Cytotoxic!T!Lymphocyte!Associated!Antigen84!(CTLA84)!
!
! CTLA<4!(also!known!as!CD152)!is!an!important!negative!regulator!of!T<cell!activation.!!
This! is!most! strikingly! illustrated!by! the! fact! that!CTLA<4!knockout!mice!die!at!a!very!early!
age!(3<4!weeks)!from!severe!lymphoproliferative!disorders![278,!279].!!Further!to!this,!it!has!
been!shown!that!blocking!CTLA<4!with!F(ab)s!causes! increased!T<cell!activation![280].! !This!
negative! regulatory! role! for! CTLA<4! has! been! shown! to! require! TCR! stimulation! and! co<
stimulation! via! CD28! [281,! 282]! although! its! exact! mechanisms! of! action! remain!
controversial.!!!
!
CTLA<4!is!a!type!I!transmembrane!glycoprotein!consisting!of!an!Ig<V!like!extracellular!
domain!and!a!short!36!amino!acid!(aa)!cytoplasmic!domain![283].!!It!exists!as!a!homodimeric!
molecule,! the! dimer! is! produced! by! the! formation! of! disulphide! linkages! between! the!
cysteine!molecules! at!position!122! [284].! ! Further! to! this,! glycosylation!of! the!asparginine!
residues!at!positions!78!and!110!act! to! cement!dimerisation! [285,!286].! ! The!extracellular!
portion! contains! a! MYPPPY! sequence! that! is! required! for! the! binding! of! the! two! CTLA<4!
ligands!CD80!and!CD86!(also!known!as!B7<1!and!B7<2!respectively;![287]).!!This!same!binding!
site!is!conserved!in!the!co<stimulatory!molecule!CD28.!!For!the!most!part!CTLA<4!expression!
is! initiated! upon! activation! of! T<cells! at! which! point,! CTLA<4! is! re<localised! towards! the!
immunological! synapse! where! it! associates! with! lipid! rafts! [288].! ! However,! a! small!
proportion!of!cells!ubiquitously!express!the!molecule.! !These!cells!are!known!as!regulatory!
T<cells! and! are! required! to! inhibit! the! activation! of! other! immune! cells.! ! Only! a! small!
proportion! of! CTLA<4! is! expressed! on! the! cell! surface! at! any! given! time,! the! majority! of!
molecules! are! found! in! intracellular! vesicles! [289,! 290].! ! The! pool! of! CTLA<4! expressed!
internally! is!exported! to! the! surface!before!being! returned! to! the!endocytic! vesicles.! ! This!
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trafficking!has!been!shown!to!involve!a!region!of!the!tail!known!as!the!Y201VKM!motif.!!This!
region! allows! an! association!with! the!AP50! subunit! of! the! clathrin! adaptor!molecule!AP<2!
[291,!292],!a!molecule! that!mediates!CTLA<4! internalisation.! !This!process! is! thought! to!be!
controlled! by! phosphorylation! since! mutation! of! this! Y201! residue! prevents! the! AP<2!
interaction!and!results!in!increased!surface!levels!of!CTLA<4![293,!294].!!!
!
!
1.7.1!Biochemical!Interactions!
!
Although!CD28!and!CTLA<4!bind!to!the!same!ligands,!they!do!so!with!very!different!
kinetics.! ! CTLA<4! is! capable! of! binding! to! both! CD80! and! CD86! with! greater! avidity! and!
affinity.!!CTLA<4!binds!to!CD86!with!a!dissociation!constant!(Kd)!of!2.6µM,!and!to!CD80!with!
a!Kd!of!0.2µM![295].!!!Binding!for!these!ligands!with!CD28!is!considerably!lower!with!Kds!of!
4µM!and!20µM!for!CD80!and!CD86!respectively![295].! ! ! In!part,!some!of!the!differences!in!
the!ligand!interactions!may!arise!from!the!fact!that!CD80!exists!as!a!dimer,!whereas!CD86!is!
a!monomer![295,!296].!!!A!dimeric!CD80!has!been!shown!to!be!capable!binding!two!CTLA<4!
or! CD28!molecules! at! one! time! [297]!which! is! thought! to! lead! to! the! formation! of! lattice!
style! arrangements! on! the! surface! of! the! T<cell! [295].! ! ! ! In! contrast,! CD86! can! only! bind!
molecule!can!only!bind!one!molecule!of!CD28!or!CTLA<4!at!a!time![296,!298].!!!
!
!
!
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The!fact!that,!comparatively!speaking,!CD86!binds!CD28!more!effectively!than!CD80!
does! led! to! the! suggestion! that!CD86! is! the!more!potent! co<stimulatory! ligand!of! the! two!
[298].!!Conversely,!CTLA<4’s!enhanced!binding!to!CD80!points!to!the!possibility!of!this!being!
the! major! inhibitory! receptor! [298].! ! ! Certainly,! there! have! been! several! studies!
demonstrating! that! blocking! CD86! results! in! impaired! immune! responses,! whilst! blocking!
CD80!has!an!enhancing!effect![54,!55].!!Furthermore,!nonobese!diabetic!(NOD)!mice!treated!
with!blocking!CD80!antibodies!developed!disease!more!rapidly!than!controls,!whereas!those!
treated! with! blocking! CD86! were! protected! [299].! ! An! additional! difference! between! the!
molecules!is!that!CD28!has!a!monovalent!binding!profile,!whereas!CTLA<4!is!bivalent![298].!!!
This!is!thought!to!enable!CTLA<4!to!from!more!stable!interactions!with!its!ligands,!compared!
to!CD28![298].!!!Exactly!what!role!these!binding!differences!play!in!these!receptors!function!
remains!elusive!at!this!time.!
!
!
1.7.2 Mechanisms!of!action!
!
The! mechanisms! by! which! CTLA<4! acts! to! suppress! T<cell! responses! remain!
controversial!and!multiple!mechanisms!of!CTLA<4!mediated!inhibition!have!been!suggested;!
these! include! direct! negative! signalling! by! the! cytoplasmic! domain! of! the! molecule,!
sequestration! of! the! ligands! CD80! and! CD86! away! from! CD28! [300]! and! the! control! of!
proliferation!by!regulatory!T<cells.!!Further!to!this,!there!is!evidence!to!suggest!that!CTLA<4!
binding!to!its!ligands!causes!back!signalling!into!the!APC!resulting!in!tryptophan!catabolism.!!
These!mechanisms!are!discussed!in!more!detail!below.!
!
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1.7.2.1!Sequestration!of!Ligands!
!
! The! finding! that! CTLA<4! and! the! co<stimulatory! molecule! CD28! bind! to! the! same!
ligands! on! DCs! led! to! the! suggestion! that! this! had! functional! significance.! ! Although! they!
bind! to! the! same! ligands,! it!has!been! shown! that!CTLA<4!does! so!with!greater!avidity!and!
affinity! than! CD28! [300<302].! ! ! It! was! thought! that! CTLA<4! could! therefore! sequester! the!
ligands! away! from! CD28! hence! restricting! the! positive! signal! normally! initiated! by! this!
molecule![283],!such!a!model!is!only!functional!if!the!B7!ligands!are!limiting.!!This!model!is!
supported! by! the! fact! that! after! T<cell! activation,! CTLA<4! expression! is! induced! and! the!
molecules! transported!to! the! immunological! synapse! (IS)! [303].! !However,! this!mechanism!
may!not!be!sufficient!for!down!regulation!of!T<cell!responses!since! it!has!been!shown!that!
transgenic!mice! expressing! “tailless”! CTLA<4! still! suffer! from! lymphoproliferative! disorders!
[304].!
!
!
1.7.2.2!Signalling!
!
! The!second!suggested!mechanism!of!CTLA<4!action!is!that!it!negatively!signals!via!its!
cytoplasmic! tail! (Figure! 1.4.1).! ! The! exact! signalling!methods! employed! by! CTLA<4! remain!
unclear! although! it! has! been! shown! that! CTLA<4! acts! to! reduce! production! of! IL<2! and! its!
receptor,!as!well!as!causing!cell!cycle!arrest![280,!305].!!It!has!been!shown!that!the!Y201VKM!
motif! of! CTLA<4’s! tail! can! interact!with! the! SH2! domain<containing! tyrosine! phophatase<2!
(SHP<2)! [291,! 306].! ! This! interaction!occurs!when! the! Y201! becomes!phosphorylated! and! is!
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thought!to!inhibit!T<cell!responses!by!dephosphorylating!TCR!ζ!and!linker!for!activation!of!T<
cells! (LAT,! [306<309])! hence! down<regulating! positive! signalling! pathways.! ! However! this!
mechanism! remains! controversial! as! it! has! been! shown! that!mutating! the! Y201! and! hence!
inhibiting!phosphorylation!does!not!diminish!suppression![310].!!!
!
CTLA<4! has! also! been! shown! to! interact! with! PI3K! however! the! importance! of!
PI3K:CTLA<4! interactions! in! down! regulating! the! immune! responses! remains! contentious!
since! inhibition!of!PI3K! !has! little!effect!on!CTLA<4!function! ! [16].! !PI3K! is!also!recruited!by!
CD28![311],!when!PI3K!is!bound!to!CD28,!Akt!becomes!activated![283].!!This!gave!rise!to!the!
hypothesis!that!CTLA<4!binding!to!PI3K!prevents!its!interaction!with!CD28,!down<regulating!
signalling!involved!in!driving!T<cell!activation![283].!!More!recently,!it!has!been!reported!that!
CTLA<4!may!regulate!anergy!via!PI3K!signalling![312].!!!
!
! It!has!been!also!been!reported!that!CTLA<4!may!be!able!to!signal!by!binding!to!the!
serine/threonine! phosphatase! PP2A! [313,! 314].! ! This!molecule! is! thought! to! interact!with!
the!tail!of!CTLA<4!preventing!CTLA<4’s!inhibitory!function![313].!!Upon!T<cell!activation!PP2A!
becomes!phosphorylated!causing!it!to!dissociate!from!CTLA<4!freeing!this!molecule!to!inhibit!
T<cell! inactivation![283].! !This!model!is!supported!by!the!finding!that!mutation!of!the!PP2A!
binding! site! increased! CTLA<4’s! inhibitory! capacity! [313].! ! Overall,! exactly! how! PP2A!
regulates!CTLA<4!activity!remains!unknown![283].!!In!general,!whilst!much!has!been!written!
about!the!inhibitory!signals!emanating!from!CTLA<4,!there!is!still!considerable!uncertainty!in!
the!field!as!to!the!exact!nature!and!indeed!the!functional!importance!of!such!signals.!
!
!
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1.7.2.3!Cell!Extrinsic!Mechanisms!of!CTLA84!Function!
!
A! number! of! recent! studies! have! suggested! that! CTLA<4! is! able! to! function! by!
extrinsically! regulating! the! proliferation! of! responder! cells.! ! One! of! the! first! studies!
demonstrating!this!was!the!finding!that!reconstituting!RAG<2!deficient!mice!with!a!mixture!
of!wild! type!and!CTLA<4</<!bone!marrow!rescued! these!animals! from!disease! [315].! ! It!was!
subsequently!shown!that!virus!specific!responses!were!equivalent!in!CTLA<4!knockout!T<cells!
when! compared! to! wild! type! cells! in! bone! marrow! chimeras! [316].! ! Other! data! have!
suggested!that!expression!of!CTLA<4!within!a!population!of!T<cells! is!enough!to!confer! the!
ability!of!these!cells!to!act!as!suppressors![317].!!Taken!together,!these!data!would!suggest!
that!the!presence!of!CTLA<4!expressing!cells!is!enough!to!regulate!the!proliferation!of!non<
expressing!cells.!!There!are!a!number!of!other!studies!that!show!extrinsic!function![230,!318,!
319]! and! recent! studies! by! the! Walker! and! Allison! labs! has! established! that! even!
conventional!T!cells!can!utilise!CTLA<4!cell<extrinsically!to!regulate!immune!responses!in!vivo!
[320,!321].!
!
!
!
!
!
!
!
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1.7.2.4!CTLA84!and!Treg!
!
! One!possible!way!that!CTLA<4!could!regulate!proliferation!of!a!responder!population!
is! through! the! action! of! regulatory! T<cells! (Treg).! ! Tregs! are! a! subset! of! cells! that!
constitutively!express!CTLA<4.!!!!
!
The!role!of!CTLA<4!on!Treg!was!initially!controversial!as!it!was!reported!that!CTLA<4!
knockout! mice! contain! FoxP3! expressing! cells! and! that! these! cells! are! able! to! suppress!
immune! responses! [322].! However,! increasing! evidence! for! a! role! of! CTLA<4! in! Treg!
suppression! arises! from! the! finding! that! blocking! CTLA<4! in! Tregs!with! antibodies! inhibits!
suppression! [227,! 237,! 322<326].! ! In! addition,! a! number!of! studies! using!CTLA<4! knockout!
regulatory! T<cells! have!now! shown!a! clear! requirement! for!CTLA<4! for! Treg! function! [230,!
318,!319,!327].!!Although!the!exact!role!played!in!Treg!suppression!is!still!unknown,!a!recent!
study! using! CTLA<4! conditional! knockout! T<cells! showed! CTLA<4! dependent!modulation! of!
the!dendritic!cell![230].!!Also,!recent!work!from!our!own!laboratory!showed!that!CTLA<4!was!
able! to! remove! CD80! and! CD86! from! the! surface! of! cells! [328]! suggesting! a! possible!
explanation!of!how!CTLA<4!could!exert!its!inhibitory!function.!
!
!
!
!
!
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1.7.2.5!Indoleamine!2,38dioxygenase!(IDO)!
!
! Another! proposed! extrinsic!mechanism! is! that! CTLA<4!may! be! able! to! back! signal!
through!CD80!and!CD86!after!ligand!binding.!!The!CTLA<4:B7!interaction!has!been!shown!to!
increase! the! concentration! of! IDO,! an! enzyme! involved! in! the! breakdown! of! tryptophan,!
present! in! the! APC! [231].! ! Tryptophan! is! essential! for! T<cell! proliferation! [329]! therefore!
increased! IDO! expression!would! reduce! the! capacity! of! T<cells! to! proliferate.! ! This! idea! is!
supported! in! pregnancy! when! inhibition! of! IDO! leads! to! abortion! of! allogeneic! embryos!
[330].!!The!gene!encoding!IDO!is!thought!to!be!induced!by!IFN<γ![331]!indicating!a!possible!
role! for! IDO! during! inflammation.! ! However,! the! importance! of! IDO! to! CTLA<4! responses!
remains! subject! to!debate.! !Certainly,!CTLA<4! Ig!has!been! found!up<regulate!expression!of!
IDO! in! a! specific! subset! of! DCs! known! as! plasmacytoid! DCs! [332],! suggesting! that! this!
mechanism!may!be!functional!under!a!specific!set!of!conditions.!!However,!signalling!via!IDO!
is!unlikely! to! fully! explain!CTLA<4! function!due! to! the! fact! that! IDO!knockout!mice! remain!
healthy![333].!!!
!
!
!
!
!
!
!
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1.8 Immune!Mediated!Disease!
!
Although! the! immune! system! is! designed! to! protect! the! body! from! invading!
pathogens! whilst! maintaining! tolerance! to! self<antigens,! sometimes! the! mechanisms! in!
place! to! control! the! immune! system! are! overcome.! ! In! situations! like! this,! the! immune!
system! can! cause! disease.! ! Two! of! the! major! immune! mediated! diseases! types! are!
autoimmunity!and!allergies.!
!
!
1.8.1 Autoimmunity!
!
Tight! regulation! of! the! immune! system! exists! in! order! to! ensure! that! a! robust!
response! is!mounted! against! foreign! antigens! that! would! otherwise! cause! disease,! whilst!
simultaneously!ensuring!that!self<antigens!are!tolerated.!!However,!some!autoreactive!cells!
escape!this!regulation!and!cause!autoimmune!disease.! !The!onset!of!autoimmune!diseases!
are! thought! to! be! triggered! by! a! combination! of! genetic! and! environmental! factors.! ! It! is!
thought!that!the!most!likely!environmental!factor!that!triggers!autoimmunity!is!infection.!
!
One!theory!of!how!infection!causes!autoimmune!disease!is!through!a!process!known!as!
molecular!mimicry.!!This!is!a!process!whereby!viral!or!bacterial!proteins!that!have!structural!
similarities! to! self<antigens! trigger! immune! responses! that! persist! after! clearance! of! the!
infection! [334].! ! ! Indeed,! there! is!mounting! evidence! that! TCRs! are! able! to! cross! react! to!
peptide! sequences! with! similar! charge! distributions! and! structures! [335<337].! ! Further,! a!
number!of!animal!models!that!develop!autoimmune!disease!from!molecular!mimicry!exist,!
examples! include! herpes! simplex! virus! infection! leading! to! blindness,! streptococcus!
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pyogenes!antigens!are!thought!to!give!rise!to!rheumatoid!myocarditis!and!infection!with!H<
2Kb! restricted! antigens! resulting! in! autoimmune! diabetes! [338<343].! ! A! second! theory! of!
how! infection! causes! autoimmune! disease! is! through! bystander! activation! of! autoreacive!
cells.! ! It! is! thought! that!during! the!course!of!an! inflammatory! response,!APCs!pick!up!and!
present! self<antigens! that! are! released! from! localised! tissue! destruction! during! infection,!
and!this!results!in!activation!of!self<reactive!T<cells![344].!!Despite!this,!the!role!of!infectious!
agents! in! the! development! of! autoimmune! disease! remains! difficult! to! prove! conclusively!
and!continues!to!be!subject!to!further!investigation.!!!
!
Many! autoimmune! diseases! are! thought! to! have! a! genetic! susceptibility! coupled!with!
environmental! triggers.! ! Twin! studies! looking! at! coeliac! disease! (CD)! have! shown! strong!
genetic!links!with!a!concordance!rate!of!up!to!83%![345,!346].!!However,!this!contrasts!with!
much!lower!rates!of!concordance!in!other!diseases!such!as!RA.!In!general!it!is!thought!that!
multiple!genetic!loci!are!responsible!for!the!genetic!component!of!autoimmunity,!however,!
the! genes! expressing! MHC! on! chromosome! 6p21! are! thought! to! be! a! major! factor! in!
development!and!disease.!!Further!studies!have!also!identified!possible!associations!with!IL<
2!and!IL<21!genes![347<349].!! !There!are,!however,!many!other!autoimmune!diseases,!such!
as! rheumatoid!arthritis! (RA),! that!appear! to!have! less!of!a!genetic! link! [350<353].! !Despite!
this,!numerous!genes!have!been!implicated! in!RA!suggesting!that!genetics! is!a!factor![354<
360].! !Taken!together,!this!data!suggest!that!numerous!factors!can!contribute!to!the!onset!
of!autoimmune!disease.!
!
!
!
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1.8.2 CTLA84!and!Immune!mediated!disease!
!
Regulatory! T<cells! have! been! shown! to! have! a! pivotal! role! in! the! maintenance! of!
immune!tolerance!in!the!periphery!and!therefore!in!the!prevention!of!autoimmune!disease.!!
With!CTLA<4!suggested!to!be!critical!for!Treg!function,!it!is!not!surprising!that!defects!in!the!
gene! expressing! CTLA<4! are! implicated! in! a! number! of! autoimmune! conditions! including!
Graves’!disease![361],!Type!1!Diabetes![362,!363]!and!rheumatoid!arthritis![364,!365].!!!
!
Three!polymorphisms!have!been!identified!within!the!locus!encoded!the!CTLA<4!gene.!!It!
has! been! shown! that! there! can! be! a! dinucleotide! repeat! in! exon! 3! [366].! ! There! has! also!
been!shown!to!be!a!G49A!insertion!in!exon!1,!which!leads!to!the!inclusion!of!alanine!instead!
of!threonine!at!this! location![363].! !There! is!a!general! lack!of!clarity!pertaining!to!how!this!
mutation!affects!the!function!of!CTLA<4.!!Some!studies!have!suggested!that!this!mutation!is!
reduces!CTLA<4!expression!due!to!inefficient!mRNA!leading!to!increased!T<cell!proliferation!
in! these! individuals! [367<369].! ! Subsequent! in# vitro! studies! of! this! polymorphism! have!
suggested! that! it! leads! to! decreased! surface! expression! of! the! protein! due! to! abnormal!
glycosylation!patterns! [370].! ! In!other!studies,!CTLA<4!appears! to!bind!more!strongly! to! its!
co<stimulatory!molecules!resulting!in!improved!down!regulation!of!immune!responses![371].!!
A!third!reported!polymorphism!is!a!C<318T!substitution!in!the!promoter!region![372]!which!
has!been!shown!to!increase!expression!of!the!protein![373]!possibly!due!to!the!fact!that!this!
mutation! introduces! a! lymphoid! enhancer! factor<1! site! to! the! promoter! [367].! ! There! is!
evidence! to! suggest! that! the! increased! expression! of! CTLA<4! plays! a! role! in! suppressing!
autoimmunity![374,!375].!!!
!
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1.9 CTLA84!as!a!therapeutic!target!
!
CTLA<4’s! role! in! controlling! peripheral! tolerance! to!has! led! to! it! being! a! target! for!
autoimmune!therapy.!!Abatacept!is!an!immunoglobulin!molecule!fused!to!the!extra<cellular!
domain!of!CTLA<4!and!is!thought!to!function!by!inhibiting!T<cell!activation![376].!!Abatacept!
is! licensed! for!use! in! the! treatment!of! rheumatoid!arthritis! (RA)!where!TNF<α! therapy!has!
failed![377],!and!in!the!EU,!must!be!used!as!a!combination!therapy!with!methotrexate![378].!!
More! recently,! Abatacept! has! also! been! approved! for! the! treatment! of! juvenile! arthritis!
[379].! ! The! treatment! has! been! shown! to! successfully! reduce! the! symptoms! of! RA! in! a!
number!of!patient!groups![378].!!!Overall,!therapy!with!abatapcept!resulted!in!very!few!side!
effects!when!used!as!a!treatment,!common!adverse!reactions!when!they!did!occur!included!
headache,!respiratory!infection!and!nausea![378].!!!!!
!
It! has! been! suggested! that! the! immune! system! plays! a! role! in! inhibiting! tumour!
progression! although! certain! aspects! of! this! idea! have! remained! controversial! [380].! ! ! In!
particular!the!theory!of!immunosurveillance!has!been!subjected!to!much!criticism!over!the!
years.! ! This! model! suggested! that! transformed! cells! present! tumour<associated! antigens!
(TAAs)! and! that! these!molecules! alert! the! immune! system! to! the!presence!of! the! tumour!
[380].!!Evidence!for!involvement!of!the!immune!system!in!tumour!management!arose!from!
the! observation! that! some! tumours! contain! infiltrating! lymphocytes! [380].! ! For! example,!
patients! suffering! from! melanoma! had! a! better! prognosis! if! lymphocyte! infiltration! was!
detected![381].!!This!was!subsequently!found!to!be!true!of!a!number!of!other!tumour!types!
including!ovarian![382],!breast! [383]!and!colorectal!cancers! [384,!385].! !However,! tumours!
that! contained! regulatory! T<cells! (Tregs)! actually! worsened! the! prognosis! of! that! patient!
[386].!!This!led!to!the!targeting!of!CTLA<4!in!cancer!immunotherapy.!!!
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!
There!are!currently!two!human!anti<CTLA<4!monoclonal!antibodies! in!clinical!trials;!
these! are! ipilimumab! (Bristol<Myers! Squibb)! and! tremelimumab! (Pfizer).! ! These! studies!
initially! involved! patients! with! metastatic! melanoma! [387]! however,! they! have! been!
extended! to! include! patients! with! ovarian,! breast,! prostate! and! renal! cancers! [387,! 388].!!
Both!treatments!have!been!used!in!clinical!trials!alone!as!well!as!in!combination!with!other!
therapies![389].! !Such!trials!showed!evidence!that!administration!of!anti<CTLA<4!antibodies!
resulted!in!some!anti<tumour!responses,!however,!one!of!the!negative!sides!of!this!type!of!
therapy! is! the!common!occurrence!of! immune!related!adverse!events! (irAEs).! !These! irAEs!
include!dermatitis,!colitis,!uveitis,!hepatitis!and!hypophystitis![387].!!The!presence!irAEs!have!
been!shown!to!indicate!to!a!certain!extent!that!the!anit<tumour!treatments!are!having!some!
effect![387]!however,!better!treatments!would!cause!the!same!anti<tumour!effects!without!
resulting!in!adverse!reactions!in!the!patients.!!!!!!!!
!
!
!
!
!
!
!
!
!
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1.10 Project!Aims!
!
The!main!overall!aim!of!this!project!was!to!look!at!the!various!proposed!mechanisms!of!
CTLA<4!action! to! try!and!elucidate!exactly!how!this!protein!exerts! its!effects!as!a!negative!
regulator!of!T<cell! activation.! !One!of! the!most! commonly! sated!mechanisms!of!action! for!
CTLA<4! is! through! the!delivery! of! a! cell! intrinsic! negative! signal.! !Our! hypothesis!was! that!
CTLA<4!did!not!function!in!this!manner!due!to!the!lack!of!evidence!demonstrating!a!negative!
signal! when! stimulating! T<cells! with! natural! ligand.! ! Instead,! the! major! evidence! for! a!
negative! signal! came! from! antibody! cross! <inking! experiments.! ! We! therefore! wished! to!
design!experiments!to!test!the!role!of!CTLA<4!when!engaged!by!its!natural!ligands.!
!
An! additional! aim! was! to! study! the! role! of! CTLA<4! in! Tregs,! part! of! the! project! was!
therefore! to! isolate! a! highly! pure! population! of! Tregs! from! peripheral! blood! for! use! in!
functional! sutides.! ! In!doing!so,! it!was!hoped! that! the! function!of!CTLA<4! in!Treg!could!be!
compared! to! that!of! convention!T<cells! to!elucidate!possible!differences! in! the! function!of!
the!protein!in!these!cell!types.!!
!
A!further!aim!was!to!determine!whether!any!CTLA<4!expressing!cells!could!suppress!the!
proliferation! of! a! responder! population.! ! Based! on! the! finding! that! CTLA<4</<! mice! can! be!
rescued!from!disease!by!the!addition!of!wild! type!bone!marrow![315]! it!was!hypothesised!
that! the!presence!of!any!CTLA<4!expressing!cells! in!culture!would!be!capable!of! regulating!
the!proliferation!of!a!responder!population.!!
!
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!!Since!robust! tools!are!an!absolute!requirement! for!studying!CTLA<4! function,!another!
aim!of! this!project!was! to! carry!out!a!broad!characterisation!of!anti<CTLA<4!antibodies! for!
use!in!functional!studies.! !Specifically,! it!was!vital!to!ensure!that!the!antibodies!being!were!
capable!of!blocking!the!interactions!between!CTLA<4!and!its!ligands!as!this!would!form!the!
basis!of!the!key!experimental!approach.!
!
!
!
!
!
!
!
!
!
!
!
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!
!
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Chapter!2:!
Materials!and!Methods!
!
!
!
!
!
!
!
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2.1!Antibodies!
!
Details!of!the!antibodies!used!in!this!study!can!be!found!in!table!1.!
Antibody!Name! Target!
Species!
Raised!in! Isotype! Obtained!From!
BNI3! CTLA<4! Mouse! IgG2a! Pharmingen!
26B! CTLA<4! Mouse! IgG2! B.!Carreno!(Wyeth!Research)!
11D4! CTLA<4! Mouse! IgG1! R.!Peach!(Bristol!Myers!Squibb)!
11G1! CTLA<4! Mouse! IgG1! J.!Allison!(MSKCC)!
10A8! CTLA<4! Mouse! IgG1! R.!Peach!(Bristol!Myers!Squibb)!
Tremelimumab! CTLA<4! Human! IgG2! Pfizer!
Table!1:!Antibody!Details.!!!Name!of!the!antibody,!what!molecule!it!reacts!against,!
the!species!it!was!raised!in!and!where!the!antibodies!came!from!are!all!indicated!in!
the!table.!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
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2.2!Flow!Cytometry!Antibodies!
Target! Fluorophore! Clone! Species!Raised!in! Company!
CD3! PerCP! SK7! Mouse!IgG1! BD!
CD4! FITC! RPA<T4! Mouse!IgG1! BD!
CD11c! APC! B<Ly6! Mouse!IgG1! BD!
CD25! PE/APC! M<A251! Mouse!IgG1! BD!
CD49d! FITC! MZ18<24A9! Mouse!IgG2b! Miltenyi!Biotec!
CD80! PE! L307.4! Mouse!IgG1! BD!
CD86! PE! 2331!(FUN<1)! Mouse!IgG1! BD!
CD127! FITC! eBioRDR5! Mouse!IgG1! eBioscience!
CD127! PE! HIL<7R<M21! Mouse!IgG1! BD!
CTLA<4! PE/APC/PE<Cy5! BNI3! Mouse!IgG2a! BD!
FoxP3! PE/APC! PCH101! Rat!IgG2a! eBioscience!
IL<2! PE! MQ1<17H12! Rat!IgG2a! eBioscience!
IL<17! PE! ebio64CAP17! Mouse!IgG1! eBioscience!
IL<21! PE! ebio3A3<N2! Mouse!IgG1! eBioscience!
IFNγ! eFlour!450! 4S.B3! Mouse!IgG1! eBioscience!
Table! 2:! ! Details! of! Antibodies!Used! in! Flow!Cytometry!Analysis.! !Details! include!
target! protein,! fluorescent! labels,! clone! and! isotype! of! antibody,! species! the!
antibody! was! raised! in! and! the! company! the! antibody! was! obtained! from.! ! All!
antibodies!react!with!the!human!protein.!!!
!
!
!
!
!
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2.3!Western!Blotting!Antibodies!
!
Target! Clone! Dilution! Species!Raised!in! Company!
Actin! AC<40! 2500! Mouse! Sigma!
CD86! C<19! 1000! Goat! SantaCruz!
CTLA<4! C<19! 2500! Goat! SantaCruz!
anti<mouse!HRP! P0260! 2500! Rabbit! Dako!
anti<goat!HRP! P0449! 2500! Rabbit! Dako!
Table!3:!!Details!of!Antibodies!Used!in!Western!Blot!Analysis.!!Details!include!target!
protein,!clone!of!antibody,!species!the!antibody!was!raised!in!and!the!company!the!
antibody!was!obtained!from.!!!!!
!
!
!
!
!
!
!
!
!
!
!
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2.4!Maintenance!of!Cell!Lines!
!
All!cells!were!grown! in!a!5%!carbon!dioxide!environment!at!37°C.! !CHO!cell!
lines! were! maintained! in! Dulbecco’s! Modified! Eagles! Medium! (DMEM,! Gibco)!
supplemented!with!10%!foetal!calf!serum!(FCS),!1%!penicillin!and!streptomycin!and!
1%!L<glutamine.!!Cell!lines!were!expanded!by!removing!media!and!washing!cells!with!
5ml! phosphate!buffer! saline! (PBS,! pH!7.2),! 2ml! of! Trypsin! EDTA!was! added! to! the!
cells!which!were! then! incubated!until! all! of! the! cells!had!detached! from! the! flask.!
The!trypsin!was!neutralised!with!8ml!of!media!and!an!appropriate!volume!of!this!cell!
suspension!was!transferred!to!a!new!flask.!!The!flask!was!then!replenished!with!20ml!
of!fresh!media.!!!
!
T<cells! and! jurkat! cell! lines!were!maintained! in!RPMI! (Gibco)! supplemented!
with!10%!FCS,!1%!penicillin!and!streptomycin!and!1%!L<glutamine.!!Jurkat!cells!were!
maintained!by!removing!cells!from!the!flask!and!replenishing!with!fresh!media.!!!
!
!
!
!
!
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2.5!Generation!of!CHO!Cell!Transfectants!
!
CHO!cell!lines!expressing!CD80,!CD86!or!CTLA<4!were!generated!previously!in!
the! lab! by! electroporation! of! human! cDNAs! cloned! into! a! CMV!expression! vector.!!
Cells!that!were!positive!for!the!expression!of!the!plasmid!were!selected!using!G418!
(500μg/ml)!treatment!and!were!sorted!by!flow!cytometry.!!
!
!
2.6!Generation!of!CTLA84!expressing!jurkat!cells!
!
The! jurkat! cell! lines! were! generated! by! Y.Zheng! at! the! university! of!
Birmingham.!!To!do!this,!CTLA4!was!cloned!into!the!MP71!retrovirus!vector.!Pheonix<
A! packaging! cells! were! transfected! with! the! vector! using! FUGENE6! transfection!
reagent! (Roche!Molecular! Biochemical).! Superanatants! containing! retrovirus! were!
collected!after!48!hours.!!Non<tissue!culture!treated!6<well!plates!were!coated!with!
RetroNectin! (TaKaRa)! at! 30!mg/ml! and! blocked! by! 2%!BSA.! ! 1ml! of! the! harvested!
retrovirus!containing!supernatants!were!added!to!the!plates!and!centrifuged!at!1500!
rpm!at!room!temperature!for!15!minutes!before!the!addition!of!2x106!jurkat!cells.!!
Plates! were! centrifuged! for! a! further! 60minutes! at! 2000! rpm! at! 30°C.! ! After! 24!
hours,!the!media!was!replaced!with!fresh!RPMI!and!after!72!hours!cells!were!sorted!
by!staining!with!CTLA<4!PE!(BD)!on!the!MoFlow!cell!sorter.!!
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!
2.7!Freezing!of!Cell!Lines!
!
Cells!were!split!as!described!above.!!Then,!cells!were!washed!once!in!PBS!and!
resuspended!in!DMEM!containing!1%!L<Glut,!1%!Pen!Strep,!10%!FBS!and!10%!DMSO!
and! were! transferred! to! cryovials.! ! Cryovials! were! incubated! overnight! at! <80°C!
before!being!transferred!to!liquid!nitrogen.!
!
!
2.8!Conjugation!of!Anti8CTLA84!Antibody!to!HRP!
!
Tremelimumab!was! directly! conjugated! to! horseradish! peroxidise! (HRP)! for!
the! enzyme! linked! immunosorbent! assay! (ELISA).! ! Direct! conjugation! of! these!
proteins!was!carried!out!using!lighting!link!HRP!conjugation!kit!(Innova!Biosciences)!
as!per!manufacturer’s!instructions.!!!
!
!
!
!
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2.9!Enzyme8Linked!ImmunoSorbent!Assay!(ELISA)!
!
Plates! were! coated! using! 50µl! of! coating! buffer! (0.5M! Sodium! Carbonate,!
0.5M! Sodium! Hydrogen! Carbonate)! containing! CTLA<4! Ig! (R&D! Systems)! at! a!
concentration! of! 0.5μg/ml;! plates! were! then! incubated! overnight! at! 4°C.! ! After!
coating!each!plate!was!washed!four!times!in!PBS!containing!0.1%!Tween!(PBS<T)!and!
was!blocked!in!a!10%!bovine!serum!albumin!(BSA)!solution!for!1!hour!at!37°C.!!Each!
anti<CTLA<4! antibody! (listed! in! table! 1)! was! titrated! from! a! top! dose! of! either!
10μg/ml! or! 1μg/ml! in! a! series! of! 10! fold! dilutions.! ! The! blocking! solution! was!
removed! and! 100μl! of! each! titration! was! added! to! the! wells,! the! plates! were!
incubated! at! 37C! for! 1! hour.! ! Plates!were!washed! four! times! in! PBS<T! before! the!
addition! of! 100μl! of! a! goat! anti! mouse! HRP! secondary! antibody! (Dako),! diluted!
1:1000,!plates!were! incubated! for!one!hour! at! 37°C.! ! The!wells!were!washed! four!
times! in! PBS<T.! ! For! detection,! 100μl! of! TMB! substrate! (Biofx)!was! added! to! each!
well.! !After!five!minutes!the!reaction!was!stopped!by!the!addition!of!STOP!solution!
(Biofx)!and!the!plates!were!read!at!450nm.!!
!
!
!
!
!
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2.10!Surface!Plasmon!Resonance!
!
Binding!affinities!of!anti<CTLA<4!antibodies!was!determined!using!the!Biacore!
3000!system!(Biacore!AB).! !To!do!this,!CTLA<4! Ig!was! fixed!to! the!surface!of!a!CD5!
chip!by!means!of!the!amine!coupling!method!(Biacore,!GE!Healthcare).!!All!antibody!
samples! were! titrated! from! 100nM! in! a! two<fold! dilution! series! in! HBS<EP! Buffer!
(Biacore,!GE!Healthcare).!!To!block!non<specific!binding,!an!anti<human!IgG!antibody!
was! passed! over! the! surface! of! the! chip! for! 10! minutes.! ! Then,! the! dilutions! of!
antibodies!were!passed!over! the!chip!at!a! rate!of!10μl!per!minute! for!30!minutes,!
the! flow! was! then! stopped! and! the! off! rates! were! measured! for! a! further! 30!
minutes.! ! Between!each! antibody!dilution,! any!bound!material! still! on! the! surface!
was!removed!by!passing!a!solution!of!100mM!glycine!at!pH!2.2!over!the!surface!of!
the!chip.! !The!KD!values!were!calculated!by!plotting!the!response!units!on!a!graph!
and!carrying!out!a!non<linear!regression.!
!
!
!
!
!
!
!
! 50!
2.11!Antibody!binding!to!CTLA84!expressing!CHO!cells!
!
A!surface!stain!was!carried!out!where!cells!were!washed!in!PBS!before!adding!
the! appropriate! dilution! of! each! antibody.! ! Samples!were! incubated! on! ice! for! 30!
minutes! before! being! washed! with! PBS.! ! An! anti<mouse! 488! (Invitrogen)! or! anti<
human!IgG!FITC!(Sigma)!antibody!was!added!and!samples!incubated!for!a!further!30!
minutes.!!Cells!were!washed!once!in!PBS!and!remained!on!ice!until!flow!cytrometry!
was!conducted.!
!
!
!
!
!
!
!
!
!
!
!
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2.12!Ability!of!Antibodies!to!Block!CTLA84!ligand!binding!
!
Blocking!experiments!were! carried!out!by! incubating!0.1μg/ml!of!CTLA<4! Ig!
with!various!dilutions!of!each!antibody!on!ice!for!30!minutes.! !Then,!150,000!CHO<
CD80! or! CHO<CD86! cells! were! added! and! samples! were! incubated! on! ice! for! a!
further!30!minutes.!!The!cells!were!washed!once!in!PBS!and!centrifuged!at!1800rpm!
for! 5! min.! ! To! stain! for! the! presence! of! the! CTLA<4! Ig! a! 1:1000! dilution! of! FITC!
conjugated! Fc! specific! anti<human! IgG! (Sigma)!was! incubated!with! the! cells! for! 30!
minutes!on!ice.!!Samples!were!washed!and!resuspended!in!PBS!before!carrying!out!
flow! cytometry.! ! Alternatively,! in! the! case! of! tremelimumab,! the! CTLA<4! Ig! was!
directly!conjugated!to!an!Alexa!Fluor!488!dye!using!the!Zenon!Human!IgG!labelling!
kit!(Molecular!Probes)!as!per!manufacturer’s!instructions.!
!
!
!
!
!
!
!
!
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2.13!Isolation!of!PBMC!
!
Buffy! coats! were! obtained! from! the! national! blood! service! in! Birmingham!
(NBS).! ! The!blood!was!diluted!1:1! in! PBS!before! layering!25ml!onto!15ml!of! Ficol<
Paque! (GE!Healthcare)! and! centrifuged! at! 2200rpm! for! 25!minutes!without! brake.!!
The! serum! layer!was! removed! and! the! peripheral! blood!mononuclear! cell! (PBMC)!
layer!containing!lymphocytes!was!transferred!to!a!fresh!tube,!which!was!filled!with!
MACS!buffer!(PBS,!EDTA!and!0.5%!BSA)!and!centrifuged!at!1500rpm!for!10!minutes.!!
The! pellet!was! resuspended! and!washed! in!MACS! buffer! a! further! 3! times! before!
being!diluted!to!a!concentration!of!100x106!cells!per!ml.!!!
!
!
2.14!Isolation!of!T8cells!
!
T<cells!were!isolated!from!PBMC!using!100μl!of!CD4+!T<cell!negative!selection!
cocktail! (EasySep,! Stemcell)!was!added! for!every!ml!of! cells,! this!was! incubated!at!
room!temperature!for!15!minutes.!!Then,!60μl!of!magnetic!colloid!beads!was!added!
per! ml! of! suspension! before! again! being! incubated! at! room! temperature! for! 15!
minutes.!!Samples!were!made!up!to!9ml!with!MACS!buffer!and!the!tube!was!put!in!
the! EasySep! magnet! for! 5! minutes.! ! The! supernatant! containing! CD4+! cells! were!
poured! into!a! fresh! tube.! ! This!process!was! carried!out!a! further! twice,! cells!were!
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counted! and! resuspended! 100x106! cells/ml.! ! Some! of! these! cells! were! kept! for!
phenotype!analysis,!the!remainder!were!subjected!to!a!CD25!selection!step.!!To!do!
this,!100μl!of!CD25!selection!cocktail!(Miltenyi)!per!1ml!of!cells!was!added.!!This!was!
incubated! on! ice! for! 30! minutes! before! being! washed! and! passed! through! the!
column!once.!!This!time,!CD25<!cells!pass!through!the!column!and!were!collected.!!!
!
!
2.15!Isolation!of!Monocytes!
!
A!similar!process!was!used!for!the!isolation!of!monocytes.!!This!time,!100µl!of!
human!monocyte!enrichment!cocktail!(EasySep,!Stemcell)!per!ml!of!cells!was!added!
and!incubated!on!ice!for!30!minutes.!!Then,!60µl!of!magnetic!beads!were!added!per!
ml! of! cells! and! samples!were! incubated!on! ice! for! a! further! 30!minutes.! ! Samples!
were! made! up! to! a! volume! of! 9ml! with!MACS! buffer! before! being! added! to! the!
Easysep!magnet.! ! Samples!were! incubated! for! 5!minutes! and! unbound! cells!were!
poured!into!a!fresh!tube.!!This!step!was!repeated!a!further!twice,!cells!were!counted!
and!resuspended!at!2x106/ml!in!fully!supplemented!RPMI.!!
!
!
!
!
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2.16!Isolation!of!Regulatory!T8cells!
!
Tregs! were! isolated! from! PBMCs! using! the! EasySep! CD4+CD127low! T<cell!
enrichment! kit! (Stemcell)! as!per!manufacturer’s! instructions.! ! To!purify! these! cells!
further,!the!CD4+CD127low!cells!were!resuspended!at!100x106cells/ml.!!Then!7.5μl!of!
CD49d!FITC!antibody!was!added!per!100x106!cells.! !Samples!were!incubated!on!ice!
for!30!minutes,!washed!once!in!MACS!buffer!before!adding!20μl!of!anit<FITC!beads!
(Miltenyi)!per!100x106!cells,!samples!were!incubated!on!ice!for!a!further!30!minutes.!!
Samples! were! washed! once! in! MACS! buffer! before! being! passed! through! two!
columns.!!The!collected!cells!were!counted!and!resuspended!at!2x106/ml!in!RPMI.!
!
!
2.17!Differentiation!of!Dendritic!Cells!
!
Monocytes!were!placed! into! a! 12!well! plate! at! a! density! of! 2x106! cells! per!
well! and!500U/ml! IL<4! (Peprotech)! and!800U/ml!GM<CSF! (Peprotech)!were! added.!!
Cells!were!cultured! for!2!days!before!addition!of!1ml!of!media!containing! IL<4!and!
GM<CSF;!cells!were!incubated!for!a!further!5!days.!!Half!of!the!DCs!were!matured!by!
adding!1μg/ml!LPS!(Sigma)!!!24!hours!before!the!cells!were!used!in!an!assay.!
! !
!
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2.18!Gluteraldehyde!Fixing!of!CHO!Cells!
!
Cells!were!washed!once!in!PBS!and!the!pellets!were!resuspended!in!0.025%!
gluteraldehyde! (Sigma)! and! incubated! at! room! temperature! for! two!minutes!with!
vigorous! agitation.! ! Cells! were! washed! three! times! in! fully! supplemented! RPMI!
before!finally!being!resuspended!at!2x106!!cells!per!ml.!
!
!
2.19!T8cell!Proliferation!Assays!
!
An! appropriate! number! of! CD25<! T<cells! were! washed! in! PBS! before! being!
incubated!for!10!minutes!in!2.5μm!carboxyfluorescein!succinimidyl!ester!(CFSE)!with!
periodic!gentle!agitation.!!Cells!were!washed!three!times!in!fully!supplemented!RPMI!
before! being! resuspended! in! RPMI! at! a! concentration! of! 2x106! cells! per!ml.! ! The!
appropriate!numbers!of! live!dendritic! cells!or! fixed!CHO!cells!were!added! to!wells!
containing!the!labelled!T<cells.!!All!DC!based!experiments!were!carried!out!using!live!
DCs,!whereas!all!CHO!experiments!made!use!of!fixed!cells.! !The!cultures!were!then!
stimulated!with!the!indicated!concentration!of!the!OKT3!clone!of!the!CD3!antibody!
and! were! allowed! to! grow! for! 5! days.! ! Each! sample! was! then! analysed! by! flow!
cytometry.! !CTLA<4!blocking!antibodies!were!added!at!a!concentration!of!40µg/ml,!
CTLA<4! Ig!and!blocking!CD28,!CD80!and!CD86!antibodies!were!all!used!at!10μg/ml!
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and!the!IDO!inhibitor!1<methyl!tryptophan!was!added!at!a!concentration!of!500µM.!!!
For!the! jurkat!suppression!assays,! jurkats!were!added!at!a!ratio!of!1! for!every!3!T<
cells.!
!
!
2.20!Re8stimulation!experiments!
!
CD25<!T<cells!were!stimulated!with!CD3/CD28!dynabeads!for!five!days.!!At!the!
point,!the!dynabeads!were!removed!from!samples!using!a!magnet!and!the!cells!were!
transferred!to!a! fresh!tube.! !Fresh! fully!supplemented!RPMI!media!was!added!and!
the! cells! incubated!overnight! at! 37°C.! ! The! cells!were! then!washed! three! times! in!
RPMI!and!resuspended!at!2x106cells/ml.!
!
!
!
!
!
!
!
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2.21!!Staining!of!Cells!for!Flow!Cytometry!
!
Surface! stains! were! carried! out! by! incubating! cells! with! the! indicated!
antibodies!on!ice!for!30!minutes!before!washing!three!times!in!PBS.!!Cells!were!kept!
on!ice!for!analysis!or!were!fixed!with!3%!PFA!prior!to!flow!cytometry!analysis.!!The!
CTLA<4!recycling!stains!were!carried!out!by!incubating!the!antibody!on!cells!at!37°C.!!
After! staining,! cells! were! washed! three! times! in! PBS.! ! ! Intracellular! staining! was!
carried!out!by!fixing!cells!in!3%!PFA!for!ten!minutes.!!Cells!were!washed!once!in!PBS!
and!once! in!PBS<Saponin! (5%!Saponin)! to!permeabilise! the! cells.! ! Antibodies!were!
diluted! in! PBS<Saponin! and! were! incubated! on! samples! for! 30! minutes! before!
washing!once!in!PBS<saponin!and!once!in!PBS.!!!
!
!
!
!
!
!
!
!
!
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2.22!Cytokine!Staining!of!T8cells!
!
CD4+CD25<!T<cells!were!stimulated!for!5!days!in!the!presence!of!CD3!and!co<
stimulation!as!described!above.! !On!day!five!cells!were!re<stimulated!with!50ng/ml!
PMA,! 1μM! ionomycin! and! 5μg/ml! brefeldin! A! (Sigma)! for! four! hours.! ! Cells! were!
washed!once! in!PBS!and!were!then!fixed!for!10!minutes! in!3%!PFA.! !Samples!were!
washed! once! in! PBS<Saponin! before! being! incubated! with! an! anti<IL<2! antibody.!!
Alongside!this,!cells!were!also!stained!for!the!presence!of!a!CTLA<4!antibody!at!room!
temperature!for!30!minutes.!!Samples!were!washed!once!more!in!PBS<Saponin!and!
were!analysed!by!flow!cytometry.!
!
!
2.23!FoxP3!Staining!of!T8cells!
!
FoxP3!stains!were!carried!out!using!the!staining!kit! from!eBioscience!as!per!
protocol.! ! Briefly,! T<cells! were! washed! three! times! in! PBS! and! 0.5ml! of! Fix/Perm!
buffer!was!added.! !The!cells!were! incubated!overnight!at!4°C!before!being!washed!
once! in! permeablisation! buffer.! ! FoxP3! antibody! was! added! and! samples! were!
incubated!for!one!hour!at!4°C!before!being!washed!once!more! in!permeabilisation!
buffer!followed!by!a!further!two!washes!in!PBS.!!!
!
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!
2.24!Isolation!of!Protein!
!
Samples!were!washed!twice! in!cold!PBS!before!adding!1mlμl!of!RIPA!buffer!
(ThermoScientific)!per!5x106!cells.! ! !Samples!were! incubated!on! ice! for!15!minutes!
and!were!centrifuged!at!15,000rpm!for!30!minutes.!!Supernatants!were!transferred!
to!fresh!tubes!and!stored!at!<20°C.!
!
!
!
2.25!Protein!Quantification!by!Bradford!Assay!
!
The!protein! in!each!sample!was!quantified!using!Bradford! reagent! (Biorad),!
which!was!diluted!1:5! in!distilled!water.! !Bovine!serum!albumin! (BSA)!was!used! to!
create! a! standard! curve.! ! One! millilitre! of! Bradford! reagent! was! added! to! each!
sample!tube!and!the!OD!was!read!at!595nm.!!The!OD!value!of!each!of!the!standards!
was! plotted! on! a! graph! and! this!was! used! to! calculate! the! amount! of! antibody! in!
each!sample.!
!
!
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!
2.26!Western!Blot!Analysis!
!
A! total! quantity! of! 10μg! of! protein! was! diluted! in! protein! loading! buffer!
(50mM! Tris<HCl! pH! 6.8,! 2%! SDS,! 10%! Glycerol,! 1%! β<Mercaptoethanol,! 12.5mM!
EDTA! and! 0.02%! Bromophenol! Blue).! ! Samples! were! incubated! at! 95°C! for! five!
minutes! to!denature! the!protein.! !Samples!were! loaded!onto!a!10%!SDS<PAGE!Gel!
composed!of!a!layer!of!stacking!gel!(125mM!Tris<HCl!pH6.8,!0.1%!SDS)!and!a!layer!of!
resolving!gel!(375mM!Tris<HCl!pH8.8!and!0.1%!SDS)!along!with!10μl!of! ladder.! !The!
gel!was! filled!with!a! running!buffer! (25mM!Tris!pH!8.3,! 250mM!Glycine,!0.1%!SDS!
with!the!pH!adjusted!to!8.3)!and!samples!were!resolved!at!100!Volts!until! the!dye!
front! reached! the! bottom!of! the! gel.! ! The! stacking! gel!was! removed! and! samples!
were! transferred! onto! nitrocellulose!membrane! (Amersham!Hybond<P!membrane,!
GE!Lifesciences)! that!had!been!pre<soaked! in!methanol! for!5!seconds!before!being!
soaked! in! transfer! buffer! (25mM! Tris,! 192mM! Glycine! and! 10%!Methanol)! for! at!
least! five!minutes.! ! Samples! were! transferred! at! 10! volts! for! 90!minutes! and! the!
membrane! was! blocked! overnight! in! 10%! blocking! buffer! (PBS<Tween! with! milk).!!
One!ten!minute!followed!by!three!five!minute!washes!were!carried!out!using!wash!
buffer!(PBS<Tween)!before!addition!of!the!primary!antibody.!!The!primary!antibody!
was!incubated!on!the!sample!for!one!hour,!samples!were!washed!again!as!described!
above! and! the! secondary! antibody!was! incubated! on! the!membrane! for! a! further!
hour.! ! The!membrane!was!washed!again!and! then! incubated!with!ECL! (Amersham!
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ECL! Prime,! GE! Healthcare)! for! one!minute! and!membrane!was! developed! for! the!
appropriate!time.!!!
!
2.27!Statistical!Analysis!
All!statistics!were!performed!in!Prism!version!5.0.!!Details!of!specific!tests!are!
described!in!figure!legends.!
!
!
!
!
!
!
!
!
!
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!
!
Chapter!3:!
Characterisation!of!anti8CTLA84!antibodies!
!
!
!
!
!
!
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3.1!Introduction!
!
Antibodies! targeting!CTLA<4!are!a!useful! tool! in! studying! the! function.! ! In! the!past!
many!groups!have!used!this!means!of!studying!the!role!of!CTLA<4,!but!with!varying!
results.!!Some!groups!found!that!blocking!protein!function!with!anti<CTLA<4!resulted!
in!inhibition!of!CTLA<4!mediated!suppression![1<7]!whereas;!other!groups!observed!
that! the! use! of! antibodies! had! no! effect! on! CTLA<4! function! [8<10].! ! Such!
discrepancies!may!be!explained!by!incomplete!assessment!of!the!capabilities!of!the!
antibodies!used! in!each!study.! ! It!was!therefore! important!to!understand!what!the!
antibodies!were! capable!of.! !Our! laboratory!had!a!panel!of! anti<CTLA<4!antibodies!
about! which! very! little! was! known! other! than! claimed! specificity! for! the! protein.!!
Moreover! in! the! situation! where! antibodies! to! CTLA<4! do! not! reveal! functional!
effects! it! is! important! to!be!confident!of! the!characterisation!of! the!antibody.! !We!
therefore!conducted!a!full!characterisation!of!these!antibodies!in!order!to!facilitate!
interpretation!of!the!functional!outcomes!in!future!experiments.!!!
!
!
!
!
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3.2!Results!!!
!
The!first!stage!in!the!characterisation!process!was!to!confirm!that!each!of!the!
antibodies! were! able! to! bind! specifically! to! CTLA<4.! ! To! do! this,! an! ELISA! was!
developed!whereby!a!plate!was!coated!with!CTLA<4!Ig.!!Increasing!concentrations!of!
each!antibody!were!then!incubated!on!the!Ig,!the!plates!were!washed!and!presence!
of!bound!antibody!was!detected!using!an!HRP!conjugated!secondary!antibody.!!The!
exception!to!this!is!tremelimumab,!which,!as!a!result!of!the!fact!that!both!it!and!the!
CTLA<4!Ig!are!humanised,!was!directly!conjugated!to!HRP.!!The!presence!of!HRP!was!
detected! by! TMB! substrate,! the! reaction!was! stopped! and! plates! read! at! 450nm.!!
The!optical!densities!(OD)!were!then!plotted!on!the!graphs!as!shown!in!figure!3.2.1.!!!
!
Importantly,! it! can! be! seen! that! all! of! the! antibodies!were! able! to! bind! to!
CTLA<4!and!that!they!interacted!with!the!extracellular!domain!of!the!protein.! !Four!
of!the!antibodies,!BNI3,!10A8,!26B!Whole!and!26B!ScFv!reached!maximal!binding!at!
around!0.01µg/ml,!11D4!at!0.1µg/ml!and!both! tremelimumab!and!11D4!F(ab)2!did!
not!reach!their!maximum!until!1µg/ml.!!!
!
!
!
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!
!
!
!!
Figure'3.2.1:' 'Anti8CTLA84"antibodies"bind"to"the"extracellular"domain"of"CTLA84"Ig" in"
an#ELISA.# #ELISA&plates&were&coated&with&0.5μg/ml%of%CTLA<4"Ig,"before"the"addition"of"
increasing) concentrations) of) each) antibody.& & The& presence& of& bound& anti<CTLA<4"
antibodies* was* detected* by* adding* a* secondary* anti<mouse& HRP& antibody.&&
Tremelimumab*was*directly* conjugated* to*an*HRP.* * TMB*substrate*was*added* to* react*
with% the% HRP,% the% reaction% was% stopped% and% plates% read% at% 450nm.$ $ Optical$ density$
reading(were(plotted(on(graphs(as(shown.( (The(data( is( representative(of(at( least( three(
independent'experiments.'' 
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These!variations!in!peak!binding!values!may!reflect!differing!affinities!of!each!
antibody! for! CTLA<4;! it! was! therefore! decided! to! obtain! data! on! affinities! and!
avidities!by!surface!Plasmon!resonance.! !For!this,!a!chip!was!coated!with!CTLA<4!Ig!
before! increasing!concentrations!of!each!antibody!were!passed!over!the!surface!of!
the!chip!for!thirty!minutes!to!measure!the!on!rate.!!The!flow!was!stopped!and!the!off!
rate!measured!for!a!further!thirty!minutes,!the!data!for!these!are!shown!in!part!A!of!
figures! 3.2.2! to! 3.2.9.! ! To! obtain! data! as! to! the! affinity! of! antibody! binding,!
calculated! as! the! KD! value,! the! maximal! response! unit! from! each! dilution! was!
plotted! as! a! graph! as! shown! in! part! B! of! figures! 3.2.2! to! 3.2.9.! ! ! Interestingly,!
although! tremelimumab!appears! to!have!one!of! the!poorest!binding! curves!of! the!
antibodies! in! the!ELISA,!according! to! the!BIAcore!data,! this!antibody! is! the!highest!
affinity!with!a!KD!value!of!just!1.051nM.!!It!is!also!the!antibody!that!appears!to!have!
the! steepest!off! rate! curve! suggesting! that! although! it! binds! very! strongly,! it! does!
also! fall!off!quickly.! ! This!may!explain!why! the!antibody!appeared! to!have!a! lower!
binding!capacity!for!CTLA<4!in!the!ELISA.!
!
The!10A8!and!BNI3!antibodies!had!a!largely!similar!affinity!with!KD!values!at!6.891!
and!6.908nM!respectively,!the!next!best!binder!was!11G1!with!a!KD!of!13.89.!!!!It!is!
interesting!to!note!that!the!26B!Whole!antibody!had!a!KD!value!that!is!comparable!
to!the!ScFv!version!of!the!antibody.!!However,!it!appeared!that!once!bound,!the!
whole!antibody!was!able!to!form!a!more!stable!complex!than!the!Fv!as!evidenced!by!
the!rate!at!which!the!antibodies!detached!from!CTLA<4!Ig!upon!stopping!the!flow.!!
Both!11D4!antibodies!had!very!poor!binding!curves!and,!surprisingly,!it!seems!that!
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the!whole!version!of!the!antibody!was!a!worse!binder!than!its!equivalent!F(ab)2!
fragment.!
!
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!
kD = 1.051nM!
Figure'3.2.2:' 'Kinetics'of'Tremelimumab'Binding' to'CTLA84" Ig." "Binding&kinetics&
were$ determined$ using$ surface$ plasmon$ resonance.$ $ CTLA<4" Ig" was" bound" to" a"
CM5$chip.$$Increasing$concentrations$of$Tremelimumab$were$then$passed$over$the$
surface(of( the(chip(and( the(amount(of(binding(detected.( (After(30(minutes,( the(
flow%was%stopped%and%the%off%rate%measured.%%A.! !Binding&plot&of&tremelimumab&
for$CTLA<4" Ig"at"the"various"concentrations." "B.! !The$maximum$response$unit$for$
each% concentration%was% plotted% in% a% graph% and% a% non<linear' regression' one' site'
binding&model&was&performed&in&prism&to&calculate&the&KD&value.!
A!
B!
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!
Figure' 3.2.3:' ' Kinetics' of' BNI3' Binding' to' CTLA84" Ig." Binding& kinetics& were&
determined( using( surface( plasmon( resonance.( ( CTLA<4" Ig" was" bound" to" a" CM5"
chip.&&Increasing&concentrations&of&BNI3&were&then&passed&over&the&surface&of&the&
chip$and$the$amount$of$binding$detected.$$A.!!Binding&plot&of&BNI3&for&CTLA<4"Ig"at"
the$ various$ concentrations.$ $ B.! ! The$ maximum$ response$ unit$ for$ each$
concentration)was)plotted)in)a)graph)and)a)non<linear'regression'one'site'binding'
model&was&performed&in&prism&to&calculate&the&KD&value.!
kD = 6.908nM 
A 
B 
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!
Figure' 3.2.4:' ' Kinetics' of' 10A8' Binding' to' CTLA84" Ig." Binding& kinetics& were&
determined( using( surface( plasmon( resonance.( ( CTLA<4" Ig" was" bound" to" a" CM5"
chip.&&Increasing&concentrations&of&10A8&were&then&passed&over&the&surface#of#the#
chip%and%the%amount%of%binding%detected.%%A.!!Binding&plot&of&10A8&for&CTLA<4"Ig"at"
the$ various$ concentrations.$ $ B.! ! The$ maximum$ response$ unit$ for$ each$
concentration)was)plotted)in)a)graph)and)a)non<linear'regression'one'site'binding'
model&was&performed'in'prism'to'calculate'the'KD'value.!
kD = 6.891nM 
A 
B 
! 71!
!
!
Figure' 3.2.5:' ' Kinetics' of' 11G1' Binding' to' CTLA84" Ig." Binding& kinetics& were&
determined( using( surface( plasmon( resonance.( ( CTLA<4" Ig" was" bound" to" a" CM5"
chip.&&Increasing&concentrations&of&11G1&were$then$passed$over$the$surface$of$the$
chip%and%the%amount%of%binding%detected.%%A.!!Binding&plot&of&11G1&for&CTLA<4"Ig"
at# the# various# concentrations.# # B.! ! The$ maximum$ response$ unit$ for$ each$
concentration)was)plotted)in)a)graph)and)a)non<linear'regression"one"site"binding"
model&was&performed&in&prism&to&calculate&the&KD&value.!
kD = 13.89nM 
A 
B 
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!
Figure'3.2.6:' 'Kinetics'of'26B'Whole'Binding'to'CTLA84"Ig."Binding&kinetics&were&
determined( using( surface( plasmon( resonance.( ( CTLA<4" Ig" was" bound" to" a" CM5"
chip.!!Increasing*concentrations*of*26B*Whole*were*then*passed*over*the*surface*
of#the#chip#and#the#amount#of#binding#detected.##A.!!Binding&plot&of&26B&Whole&for&
CTLA<4"Ig"at"the"various"concentrations.""B.!!The$maximum$response$unit$for$each$
concentration)was!plotted'in'a'graph'and'a'non<linear'regression'one'site'binding'
model&was&performed&in&prism&to&calculate&the&KD&value.!
kD = 2.607nM 
A 
B 
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Figure' 3.2.7:' ' Kinetics' of' 26B' ScFv' Binding' to' CTLA84" Ig."Binding& kinetics&were&
determined( using( surface( plasmon( resonance.( ( CTLA<4" Ig" was" bound" to" a" CM5"
chip.&&Increasing&concentrations&of&26B&ScFv&were&then&passed&over&the&surface&of&
the$ chip$and$ the$ amount$ of$ binding$ detected.$ $A.! !Binding& plot& of& 26B&ScFv& for&
CTLA<4"Ig"at"the"various"concentrations.""B.!!The$maximum#response#unit#for#each#
concentration)was)plotted)in)a)graph)and)a)non<linear'regression'one'site'binding'
model&was&performed&in&prism&to&calculate&the&KD&value.!
kD = 2.882nM 
A 
B 
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!
Figure'3.2.8:''Kinetics'of'11D4'Whole'Binding'to'CTLA84"Ig."Binding&kinetics&were&
determined( using( surface( plasmon( resonance.( ( CTLA<4" Ig" was" bound" to" a" CM5"
chip.&&Increasing&concentrations&of&11D4&Whole&were&then&passed&over&the&surface&
of#the#chip#and#the#amount#of#binding#detected.##A.!!Binding&plot&of&11D4&Whole&
for$CTLA<4!Ig#at#the#various#concentrations.# #B.! !The$maximum$response$unit$for$
each% concentration%was% plotted% in% a% graph% and% a% non<linear' regression' one' site'
binding&model&was&performed&in&prism&to&calculate&the&KD&value.!
kD = 325.6nM 
A 
B 
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Figure'3.2.9:''Kinetics"of"11D4"F(ab)2!Binding&to&CTLA84"Ig."Binding&kinetics&were&
determined( using( surface( plasmon( resonance.( ( CTLA<4" Ig" was" bound" to" a" CM5"
chip.&&Increasing&concentrations&of&11D4&F(ab)2!were$then$passed$over$the$surface$
of#the#chip#and#the#amount#of#binding#detected.&&A.! !Binding&plot&of&11D4&F(ab)2!
for$CTLA<4" Ig"at"the"various"concentrations." "B.! !The$maximum$response$unit$for$
each% concentration%was% plotted% in% a% graph% and% a% non<linear' regression' one' site'
binding&model&was&performed&in&prism&to&calculate&the&KD"value.!
kD = 57.48nM 
A 
B 
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Having!studied!the!binding!of!the!antibodies!to!CTLA<4!Ig,! it!was!decided!to!
check!that!they!were!able!to!bind!to!full! the!full<length!native!protein.! !To!do!this,!
CHO! cells! expressing! CTLA<4! were! used.! ! Initially,! expression! of! CTLA<4! was!
confirmed!by! incubating!the!cells!at!37°C!for!30!minutes!with!a!PE! labelled!CTLA<4!
antibody.!!!!!Figure!3.2.10!shows!that!the!cells!expressed!very!high!levels!of!CTLA<4.!!!
!
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Figure' 3.2.10' Phenotype' of' CHO8CTLA84" Cells.! ! CHO$ cells$
expressing) CTLA<4" were" labeled" with" CTLA<4" PE" at" 37°C" for" 30"
minutes( before( being( analysed( by( flow( cytometry.( ( The( data(
presented(is(representative$of$the$cell$line.!
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To! check! that! each! of! the! antibodies! could! specifically! recognise! the! full<
length!protein,!CTLA<4!CHO!cells!were! incubated!with!each!antibody!at!4°C! for!30!
minutes.!!The!antibodies!were!then!stained!with!an!anti<human!or!anti<mouse!FITC!
antibody! and! presence! of! bound! antibody! was! determined! using! flow! cytometry.!!
Figure!3.2.11!shows!the!results!of!these!experiments.! !This!figure!shows!that!all!of!
the! antibodies! could! indeed! recognise! full! length! CTLA<4.! ! Interestingly,! although!
both!11D4!molecules!had!very!poor!BIAcore!results,!the!fluorescent!profiles!of!these!
antibodies!upon!binding! full! length!CTLA<4!was! the!highest! suggesting! that!a! large!
amount!of!these!antibodies!could!bind!to!the!protein.!Both!10A8!and!26B!whole!also!
seemed!to!have!bright!peaks!of!binding.!!The!remaining!antibodies!had!very!uniform!
binding!patterns.!
!
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Figure' '3.2.11:' ' Anti8CTLA84" antibodies" bind" to" full" length" CTLA84" expressed" in"
CHO$ cells.$ $The$antibodies$were$ incubated$with$CHO$cells$expressing$CTLA<4"on#
ice$ for$30$minutes$to$stain$the$surface$protein.$$Cells$were$then$labelled$with$an$
anti<mouse&FITC&or&anti<human&FITC&(for&tremelimumab&only)&on&ice&for&a&further&
30#minutes.##The#staining#was#then#analysed#by#flow#cytometry.!
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Having! determined! the! binding! characteristics! of! the! antibodies,! it! was!
decided!to!test! if! the!antibodies!were!able!to!disrupt!CTLA<4!binding!to! its! ligands.!!!
In!order!to!carry!out!the!blocking!experiments!successfully!a!concentration!of!CTLA<4!
Ig!that!provided!sub<maximal!staining!was!desired!to!ensure!that!the!antibodies!and!
ligands!could!compete! for!CTLA<4! Ig!binding.! ! To! find!out! this!dose,!CTLA<4! Ig!was!
titrated!from!20μg/ml!to!0.0001μg/ml,!each!sample!was!subjected!to!flow!cytometry!
analysis! and! the!mean! fluorescence!was!plotted!on! a! graph! (figure! 3.2.12).! ! From!
these!data! it!was!determined! that!using! the!CTLA<4! Ig!at!a! fixed!dose!of!0.1μg/ml!
provided!sub!maximal!staining!for!both!CHO!cells!that!stably!express!either!CD80!or!
CD86!and!this!was!the!concentration!of!CTLA<4! Ig!used!for!all! subsequent!blocking!
experiments.!
!
!
!
!
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!
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Figure' 3.2.12:' ' Titration'of# CTLA84" Ig" to" achieve" sub"maximal" staining" of"
CHO$cell$tranfectants.$$A"sub<maximal&dose&of&CTLA<4"Ig"for"use"in"blocking"
experiments* was* determined* by* incubating* 150,000* CHO,* CHO<CD80% or%
CHO<CD86% cells% for% 30% minutes% with% various% concentrations% of% CTLA<4" Ig.""
The$cells$were$ stained$with$an$anti<human&Fc& specific&antibody&which&was&
directly)conjugated)to)a)FITC)fluorophore.) )Each)sample)was)then)analysed)
by#flow#cytometry#and#the#mean#flueoresence#plotted#on#a#graph.##The#data#
presented(is(representative(of#three#independent#experiments.!
!
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To! address! if! the! antibodies!were!blockers,! an! assay!was!developed!where!
various!dilutions!of! the!antibody!was! incubated!with!CTLA<4! Ig! that!had!been!pre<
labelled!with!a!PE! fluorophore.! !To! this,!CHO!cells!expressing!either!CD80!or!CD86!
were!added.!!The!detection!of!bound!Ig!was!carried!out!by!flow!cytometry!and!the!
results!are!shown!in!figure!3.2.13!and!3.2.14.!!These!data!show!that!10A8!and!11G1!
are! all! capable!of! blocking!CTLA<4!binding! to!both!CD80! and!CD86! and!do! so! at! a!
concentration! of! 1μg/ml.! ! Interestingly,! although! the! ELISA! data! suggested! that!
tremelimumab!seemed!to!have!around!100!fold!lower!binding!capacity!than!most!of!
the!other!antibodies,!this!antibody!turned!out!to!be!a!very!good!blocking!antibody!
and! could! also! completely! ablate! ligand! binding! at! 1μg/ml.! ! Importantly,! not! all!
antibodies! that! recognise! CTLA<4!make! good! blockers,! for! example,! although! 26B!
was!able!to!recognise!CTLA<4!Ig!in!the!ELISA!and!was!able!to!completely!block!CTLA<4!
interactions!with!CD86,!it!was!only!able!to!partially!inhibit!binding!to!CD80.!!Further!
to!this,!11D4!was!also!a!very!poor!blocking!antibody!as!it!could!only!inhibit!binding!
by!around!50%!for!both!ligands.!!These!data!highlight!the!importance!of!carrying!out!
a! thorough! characterisation! of! antibodies! for! use! in! functional! studies.! ! Since!
tremelimumab! appeared! to! be! one! of! the! best! blocking! antibodies,! this! was! the!
antibody!chosen!for!use!in!functional!experiments.!
!
!
!
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Figure' 3.2.13:' ' Tremelimumab'blocks' CTLA84"binding" to" ligands" expressed"on"CHO"
cells.& & CHO$ Cells$ expressing$ either$ CD80$ or$ CD86$were$ incubated$with$0.1μg/ml% of%
CTLA<4"Ig,"which"had"been"directly"conjugated"to"a"FITC"fluorophore,"in"the"presence"
of#increasing#concentrations#of#anti<CTLA<4.#A.!Flow%cytometry%plots%showing%intensity%
of#CTLA<4"Ig"binding"to"ligand.""B.!!Percentage)blocking)is)calculated)based)on)the)MFI)
of#CTLA<4"Ig"staining"in"the"presence"of"decreasing"concentrations"of"anti<CTLA<4.##The#
data$presented$are$representative$of$at$least$three$independent$experiments.$$ 
! 84!
!
!
!
Figure' 3.2.14:$ $ Anti8CTLA84"
antibodies*blocking*CTLA84"binding"
to# its# ligands# with# differing#
efficiencies.( ( CHO$ Cells$ expressing$
either& CD80& or& CD86& were&
incubated*with*0.1μg/ml%of%CTLA<4"
Ig,$which$was$directly$conjugated$to$
a"FITC"fluorophore,"in"the"presence"
or# absence# of# various# anti<CTLA<4"
antibodies* at* the* indicated*
concentrations.+ + Percentage+
blocking) are) calculated( based( on(
the$MFI$of$CTLA<4"Ig"staining"in"the"
presence' of' decreasing'
concentrations*of*anti<CTLA<4.#!
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To! determine! if! blocking! efficiency! could! be! predicted! using! the! KD,! it!was!
decided! to! plot! the! KD! values! against! the! percentage! blocking! obtained! using!
0.1µg/ml!of!each!antibody!(figure!3.2.15).!!A!non<linear!regression!was!fitted!to!the!
graph!and!the!R2!value!calculated.!!This!data!shows!that!the!blocking!of!both!CD80!
and! CD86! followed! a! similar! trend! at! this! concentration! of! antibody.! ! Further,! it!
appears!that!the!blocking!potential!of!each!antibody!cannot!be!readily!predicted!by!
the!KD!value!associated!with!the!antibody.!
!
!
!
!
!
!
!
!
!
! 86!
!
!
!
0.1 1 10 100 1000
0
20
40
60
80
100
CD80
kD
Pe
rc
en
ta
ge
 B
lo
ck
in
g
0.1 1 10 100 1000
0
20
40
60
80
100
CD86
kD
Pe
rc
en
ta
ge
 B
lo
ck
in
g
Figure'3.2.15:''Does'KD'Value'Predict'Blocking'Capability'of'Antibody:''The$KD$
values' for' each'of' the!antibodies*derived* from* the*BIAcore* experiments*were*
plotted'against'the'percentage'blocking'achieved'using'a'concentration'of'anti<
CTLA<4" antibody" of" 0.1μg/ml.& & The& graphs& were& fitted& with& a& non<linear'
regression(and(the(R
2
!value&calculated.&&!
R
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3.3!Discussion!
!
Antibodies! against! CTLA<4! provide! both! a! useful! tool! in! studying! the!
importance!of! ligand!binding!to!T<cell!activation!as!well!as!presenting!a!potentially!
powerful!target!in!the!treatment!of!tumours.!!With!this!in!mind!it!was!decided!to!try!
to!characterise!a!panel!of!antibodies!that!were!available!within!the!laboratory.!!!
!
Very! little! was! known! about! any! of! these! antibodies,! other! than! claimed!
specificity,!so!to!begin!the!characterisation!it!was!important!for!determine!that!the!
antibodies!were!able! to! recognise!CTLA<4.! ! The!ELISA!data! confirmed! that! they! all!
had! the! ability! to! bind! the! extra<cellular! domain! of! the! protein! but! that! 11D4!
required!one!hundred!fold!more!antibody!to!achieve!what!was!perceived!as!maximal!
binding.! ! Further! to! this,! tremelimumab! appeared! to! reach! its! highest! level! of!
absorbance! at! 10μg/ml,! thus! requiring! one! thousand! fold!more! antibody! than! the!
others.! ! The! fact! that! even! at! this! concentration! it! cannot! be! guaranteed! that!
tremelimumab! has! managed! to! saturate! binding! suggests! that! this! is! a! fairly! low!
affinity!antibody.!!!
!
However,! an! alternative! explanation! for! the! apparent! poor! binding! of!
Tremelimumb!in!the!ELISA!experiments!may!be!that!there!is!saturation!of!the!signal!
on! the! plate! reader! and! that! we! are! simply! observing! that! the! other! antibodies!
saturate!this!signal!earlier.!!!!!A!further!difficulty!with!the!ELISA!data!is!the!fact!that!
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Tremelimumab! had! to! be! directly! conjugated! to! HRP,! whereas! all! of! the! other!
antibodies!were!detected!by!probing!with! a! secondary!HRP! antibody.! ! This!makes!
direct! comparison! of! the! antibodies! problematic.! ! Whilst! the! ELISA! was! initially!
intended! for! use! as! a! system! to! reveal! the! binding! the! characteristics! of! the!
antibodies! for!CTLA<4,! these! issues!meant!an!alternative!means!of!verification!was!
required.! ! The! BIAcore! analysis! enabled! a! more! sensitive! approach! to! determine!
binding!characteristics!of!the!antibodies.!!Further!as!a!result!of!the!fact!that!binding!
could! be! detected! in! the! absence! of! a! secondary! reagent,! it! meant! that! direct!
comparisons!of!the!antibodies!could!be!carried!out.!!
!
In!contrast!to!what!was!implied!by!the!ELISA!data,!it!was!actually!found!that!
Tremelimumab!had! the! lowest! kD!value!when!analysed!by!BIAcore.! ! The!antibody!
appeared!to!have!a!very!fast!on!rate!and,!once!the!flow!stopped,!a!large!amount!of!
the!antibody! fell!off,!before!stabilisation!of! the!curve.! !This!binding!profile!may!go!
some! way! to! explaining! the! seemingly! poor! binding! characteristics! in! the! ELISA!
experiments.!
!
As! could! be! observed! from! the! comparison! of! blocking! capability!with! KDs!
derived! from!BIAcore,! it!was! interesting! to!note! that! that!not!all!of! the!antibodies!
had! such! good! blocking! potential! as! would! be! expected! based! on! the! binding!
profiles.!!!For!example,!BNI3!and!10A8!had!very!similar!KD!values!with!6.908nM!and!
6.891nM! respectively,! but! their! blocking! potential! at! a! concentration! of! 0.1µg/ml!
! 89!
was!around!75%! for!BNI3!and!65%! for!10A8.!A!possible! reason! for! the!variance! in!
blocking! capability! of! antibodies! with! similar! KD! values! could! be! a! result! of! the!
epitope! that! the! antibodies! recognise.! ! It! may! be! that! the! epitope! recognised! by!
BNI3!is!more!conducive!to!blocking!CTLA<4:ligand!interactions!than!that!of!10A8.!!
!
It!would!have!been!useful!to!carry!out!some!direct!competition!experiments!
between! the! antibodies! to! confirm! the! affinity! data! obtained! from! the! BIAcore.!!
However,! this!was!not! performed!as! there!were! insufficient! quantities! of! some!of!
the!antibodies!to!carry!out!a!comprehensive!competition!study.!!A!further!issue!with!
competition!studies! is!that!the!epitopes!for!most!of!the!antibodies!were!unknown,!
which! would! possibly! have! made! interpretation! of! any! competition! data! more!
difficult.!!!
!
It!is!interesting!to!note!that!some!antibodies!had!varying!blocking!potentials!
depending!on!which!ligand!they!were!attempting!to!disrupt!CTLA<4!binding!to.!!One!
example!of! this! is! 26B.! !While! this! antibody! seems!able! to! completely!block!CD86!
binding!it!can!only!inhibit!CD80!binding!by!up!to!75%.!!The!antibody!having!a!higher!
affinity!for!CTLA<4!than!CD86!but!a!lower!affinity!for!CTLA<4!than!CD80!presumably!
causes!this!effect.!!The!selective!nature!of!this!antibody!makes!it!potentially!useful!in!
studying! the! importance!of! the! individual! ligands! in!CTLA<4!mediated! suppression.!!
The! poor! blocking! status! of! 26B! was! perhaps! not! entirely! surprising! given! its!
apparent!binding!site.!The!26B!antibody!is!one!of!the!only!antibodies!tested!where!
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the!binding!site!has!been!determined!(Figure!3..3.1).!!Mutational!analysis!carried!out!
determined! that! 26B! ScFv! bound! to! the!M11! epitope! 65SICT68! [11],! a! site! located!
away! from! the! ligand!binding!MYPPY!motif.! ! ! ! It! could!be! that! binding! to! this! site!
causes!a!conformational!change!in!the!structure!of!the!ligand<binding!site!and!that!
this!prevents!ligand!engagement.!!
!
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Figure'3.3.1:%% %Crystal%structure%of%CTLA84" ligand"binding"domain.!!The$left$hand$
image&shows&the&ligand&binding&portion&of&CTLA<4.##The#MYPPYY#loop#which#allows#
binding&to&the&CTLA<4"ligands"is"indicated.""The"diagram"also"indicates"the"region"
where%mutational%studies%have%placed%26B%binding.%%This%site%is%located%away%from%
the$ ligand$ binding$ site.$ $ The$ right$ hand$ image$ is$ the$ same$ except$ it$ has$ been$
rotated' by' 30°.' ' Image' adapted' from' the' Research' Collaboratory' for' Structural'
Bioinformatics,(RCSB),protein,data,bank;#file#ID#1I8L.pdb.!
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Some!interesting!observations!could!be!made!when!looking!at!the!ability!of!
the!antibodies!to!bind!CTLA<4!expressed! in!CHO!cell! lines.! !From!the!surface!stains!
for!both!11D4!antibodies!and!10A8,! it!appeared!that!only!a!proportion!of! the!cells!
were! being! stained! and! that! those! cells! that! did! become! stained! had! very! high!
fluorescent!profiles.!!A!simple!explanation!for!these!data!would!be!that!the!antibody!
is!aggregating!and!this! is!causing!the!bright!fluorescence.! !Alternatively,! it!could!be!
that!these!antibodies!are!only!able!to!bind!to!a!specific!subset!of!CTLA<4!molecules.!!
It!is!known!that!increased!glycosylation!of!CTLA<4!is!required!for!surface!expression!
of!the!protein![12]!as!well!as!for!the!stabilisation!of!the!CTLA<4!homodimer![13,!14].!!
It! has! also! been! shown! that! phosphorylation! of! the! tail! of! CTLA<4! is! required! for!
inhibition!of! its! interaction!with!clathrin!adapter!molecule!AP<2![15,!16]!and!hence!
increased!surface!expression.!!It!may!be!that!some!of!these!modifications!interrupt!
antibody!binding!to!the!protein!resulting!in!the!strange!staining!patterns!observed!
!
Overall! this! chapter! highlighted! the! importance! of! fully! characterising!
antibodies!before!using!them!in!functional!studies.!!Just!because!an!antibody!is!able!
to!bind!to!the!extra<cellular!region!of!CTLA<4,!does!not!necessarily!mean!that!it!will!
be!a!good!blocking!antibody.!!Upon!full!assessment!of!the!antibodies,!it!was!decided!
to! use! tremelimumab! in! studying! the! function! of! CTLA<4,! since! it! was! one! of! the!
most!potent!blocking!antibodies.!!
!
!
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Chapter!4:!
Assessing!CTLA84!Function!
!
!
!
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4.1!Introduction!
The!mechanism! by! which! CTLA<4! functions! to! control! T<cell! responses! has!
been!subject!of!debate.!!Numerous!modes!of!action!have!been!proposed!for!CTLA<4!
since! it!was!first!discovered,!despite!this,!exactly!how!this!protein!modulates!T<cell!
responses! remains!unknown.! ! The!broad!aim!of! this!project!was! to!determine! the!
context! of! CTLA<4! function! by! testing! the! predictions! of! various!models! that! have!
been!suggested.!!One!of!the!most!widely!embraced!mechanisms!of!action!for!CTLA<4!
is! that! it! delivers! a! negative! signal! into! the! T<cell! upon! ligand! engagement.! ! This!
model! was! first! suggested! after! the! discovery! that! cross<linking! CTLA<4! with!
antibodies!results!in!reduced!IL<2!production!and!proliferation![1].!!Subsequently,!it!
has! been! shown! that! CTLA<4</<! mice! expressing! a! form! of! CTLA<4! lacking! the!
intracellular! domain! fails! to! entirely! rescue! the! fatal! phenotype! of! these!mice! [2].!!
This!suggests!that!it!is!important!for!the!protein!to!interact!with!the!inside!of!the!T<
cell!in!order!to!function!completely.!!A!number!of!laboratories!have!shown!evidence!
that!CTLA<4!can!interact!with!a!number!of!signalling!proteins!including!PI3K!and!SHP<
2!suggesting!CTLA<4!may!function!by!signalling!into!the!T<cell.!
!
Having! characterised! a! series! of! antibodies! in! the! previous! chapter,! it! was!
decided! to! use! these! as! tools! to! study! the! function! of! CTLA<4! with! a! focus! on!
determining!if!the!protein!is!able!to!deliver!a!negative!signal!when!stimulated!with!
natural!ligands.!!Accordingly,!blocking!the!interaction!between!CTLA<4!and!its!ligands!
should!reveal!settings!in!which!CTLA<4!is!active!by!enhancing!T<cell!responses.!
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4.2!Results!
4.2.1!Activating!T8cells!with!CHO!cells!expressing!CTLA84!ligands!
!
The! theory! about! the! negative! signal! has! arisen! from! experiments! using!
antibodies! to! cross<link! CTLA<4! and! observing! a! subsequent! down! regulation! in!
proliferation!and!IL<2!production.!!However,!to!our!knowledge,!this!mechanism!has!
not! been! shown! to! occur! upon! engagement! with! CD80! and! CD86! ligands.! ! ! To!
determine! whether! CTLA<4! was! inhibitory! in! a! ligand! driven! model! of! T<cell!
activation,!CHO!cells!expressing!either!CD80!or!CD86!on!their!surface!were!used!to!
provide!co<stimulation.!!Our!laboratory!previously!created!stable!CHO!cells!lines!that!
express!high!levels!of!the!B7!molecules!(figure!4.2.1).!!To!carry!out!these!functional!
experiments,! responder! CD25<! T<cells! were! isolated! from! peripheral! blood!
mononuclear! cells! (PBMCs),! the! initial! step! in! this! process! involved! negative!
selection!of! CD4+! T<cells!which,! as! is! shown! in! figure! 4.2.2,! resulted! in! a! purity! of!
around! 87%! of! CD3+CD4+! T<cells.! ! These! cells! were! then! subjected! to! a! further!
negative!selection!step!to!isolate!CD25<!T<cells,!which!yielded!a!purity!of!greater!than!
90%!CD25<!T<cells.!!Purities!of!cells!were!assessed!before!every!experiment!and!the!
data!presented!in!figure!4.2.2!are!representative!of!a!typical!yield!of!purified!cells.!
!
!
!
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CHO! CHO<CD80! CHO<CD86!
Figure' 4.2.1:' ' Phenotype' of' CHO' cell' transfectants.' ' CHO$ cells,$ either$
untransfected+ or+ transfected+ with+ CD80+ or+ CD86,+ were+ stained+ with+ CD86+
FITC% and% CD80% PE% on% ice% for% 30% minutes% before% being% analysed% by% flow"
cytometery( ( Gates( were( drawn( using( the( CD80( and( CD86( staining( on( an(
untransfected+CHO+cell.+!
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Figure'4.2.2' :' 'Purity'of'T8cells% isolated% from%PBMCs.% %T"cells"were"isolated"from"
PBMCs& using& a& two& step& process.& & Step& 1& involved& the& selection& of&CD4
+
! T<cells,&
whilst' step' 2' saw' the' selection' of' CD25
<
! T<cells.& & At& each& stage& of& the& isolation&
process,(samples(of(the(T(cell(cultures(were(surface(stained(for(CD3,(CD4(and(CD25(
before& being& fixed,& permeabilised& and& stained& for& FoxP3.& Purities& of& T<cells%were$
determined( before( each( experiment.( ( The( data( presented( is( representative( of( a(
 typical(yield.(
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It!was!first! important!to!assess!whether!or!not!the!CHO!cells!would!provide!
adequate! co<stimulation.! ! To!do! this,! CD25<! T<cells!were! labelled!with!CFSE!before!
being! stimulated! with! CD3! in! the! presence! of! untransfected,! CD80! or! CD86!
expressing!CHO!cells.!!On!days!2,!3,!4!and!5!after!stimulation!the!T<cells!were!stained!
for!their!CD25!expression!and!both!this!and!the!proliferation!was!measured!by!flow!
cytometry! (figure! 4.2.3).! ! ! ! The! T<cells! stimulated!with! both! CHO<CD80! and! CHO<
CD86!cells!have!begun! to!up<regulate!expression!of!CD25!by!day!2.! !By!day!5,! the!
majority! of! these! cells! are! expressing! this! protein.! ! Despite! this! up<regulation! of!
CD25! by! day! 2,! those! cells! stimulated! with! CHO<CD86! cells! don’t! show! signs! of!
proliferation! until! day! 3.! ! The! CHO<CD80! cells! appear! to! stimulate! the! T<cells! at! a!
slower!rate!as! these!T<cells!begin! to!proliferate!by!day!4,!however,! the!purpose!of!
the!experiment!was!not!to!test!the!relative!effects!of!each!ligand!and!differences!in!
expression! may! account! for! these! effects.! ! Nonetheless,! in! the! case! of! both! cell!
types,!the!majority!of!T<cells!are!proliferating!by!day!5.!Importantly,!it!appears!that!
those! T<cells! stimulated! in! the!presence!of! untransfected!CHOs!neither! proliferate!
nor!up<regulate!CD25,!highlighting!that!this!model!requires!the!presence!of!the!co<
stimulatory!ligands!and!that!CD3!is!not!enough!to!drive!activation.!!Taken!together,!
these!data!indicate!that!the!CHO!cells!do!provide!a!suitable!model!for!co<stimulation!
for!which!to!study!CTLA<4!function.!!!
!
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Figure' 4.2.3:' ' CHO' cells' expressing' CD80' or' CD86' can' provide' T8cell$ co8
stimulation.+ +CFSE% labelled%CD25
<!
T<cells%were%stimulated%with%10μg/ml%of%CD3% in%
the$ presence$ of$ gluteraldehyde* fixed* CHO,* CHO<CD80% or% CHO<CD86% expressing%
cells%at%a%ratio%of%one%CHO%cell%to%three%T<cells.&&At&day&2,&3,&4&and&5&the&cells&were&
stained(for(the(presence(of(surface(CD25(by(incubating(the(on(ice(for(30(minutes.((
Both%CD25%and% the%amount%of%proliferation+ in+ the+cultures+was+analysed+by+ flow+
cytometry.))The)data)presented)is#representative#of#five#independent##experiments.! 
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To! determine! if! CTLA<4! is! able! to! deliver! a! negative! signal! in! this! setting,!
CD25<!T<cells!were!labelled!with!CFSE!and!stimulated!with!CHO,!CHO<CD80!or!CHO<
CD86! cells! together! with! CD3.! ! This! was! done! in! the! presence! or! absence! of! the!
blocking! antibody! tremelimumab.! ! After! five! days! of! stimulation! the! cells! were!
analysed! by! flow! cytometry! and! the! data! are! shown! in! figure! 4.2.4.! ! Again! we!
observed! that! the! T<cell! proliferation! was! co<stimulation! dependent! as! there! was!
very!little!proliferation!when!the!untransfected!cells!are!present!compared!to!when!
the!CD80!and!CD86!cells!provide!the!co<stimulation.!!Surprisingly,!we!observed!that!
blocking! CTLA<4! in! this! assay! has! no! effect! on! T<cell! proliferation,! a! finding! not!
obviously!consistent!with!this!molecule!delivering!a!cell!intrinsic!negative!signal.!!To!
ensure! that! the! T<cells!were! expressing! CTLA<4! at! this! time! point! the! T<cells!were!
fixed,!permeabilised!and!stained!for!the!protein!at!day!five!(figure!4.2.5).!!From!this,!
we!see!that!all!of!the!proliferating!cells!are!expressing!CTLA<4.!!The!fact!that!blocking!
CTLA<4! is! having! no! effect! is! therefore! not! a! result! of! an! absence! of! CTLA<4!
expression.!!Thus!in!this!model!we!observe!ligand!dependent!T<cell!stimulation!and!
up<regulation! of! CTLA<4! yet! despite! both! ligand! and! receptor! being! expressed! no!
obvious!inhibitory!function!of!CTLA<4!is!revealed.!
!
!
!
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Figure' 4.2.4:' ' Blocking' CTLA84" has" no" effect" on" the" proliferation" of" T8cells% co8
stimulated* with* CHO* cell* transfectants.* * * CFSE$ labelled$ CD25
<
! T<cells% were%
stimulated* with* 10μg/ml% of% CD3% and% gluteraldehyde% fixed% untransfected% CHO,%
CHO<CD80%or%CHO<CD86%expressing%cells%at%a%ratio%of%one%CHO%cell%to%three%T<cells.&&&
The$ cultures$ were$ incubated$ in$ the$ presence$ or$ absence$ of$ a$ blocking% CTLA<4"
antibody)(Tremelimumab,)50μg/ml).''After'five'days'the'level'of'proliferation'was'
determined( by( flow( cytometry.( ( The( data( presented( is( representative( of( five(
independent'experiments.!
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Figure'4.2.5:' 'CD25
8
!T8Cells%co8stimulated*with*CHO*cell* transfectants*express*
CTLA84.##CFSE%labelled%CD25
<
!T<cells%were%stimulated%with%CD3%(10μg/ml)&in&the&
presence' of' gluteraldehyde' fixed' untransfected' CHO,' CHO<CD80%or% CHO<CD86%
expressing)cells,$at$a$ratio$of$one$CHO$cell$ to$three$T<cells.& & The&cultures&were&
incubated*in*the*presence*or*absence*tremelimumab*(50μg/ml)&to&block&CTLA<4.##
After& five&days& the&cells&were& fixed& in&3%&PFA&and&permeabilised& in&a&5%&PBS<
Saponin'solution'and'stained'for!total%CTLA<4"expression"before"being"analysed"
by#flow#cytometry.##The#data#presented#are#representative#of#five#independent#
experiments. 
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The! lack! of! antibody! effects! could! possibly! be! explained! by! the! fact! that! a!
very! high! numbers! of! CHO! cells! were! used! to! provide! co<stimulation.! ! It! was!
therefore! decided! to! assess! if! a! negative! signal! could! be! revealed! by! reducing!
numbers!of!CHO!cells!used!to!stimulate!T<cells!thereby!weakening!the!co<stimulation!
via!CD28.! !As!can!be!seen!from!figure!4.2.6,! titrating!out!the!number!of!CHO!cells,!
only!revealed!in!effect!in!the!cultures!stimulated!with!CHO<86!cells!at!a!1:500!ratio,!
no!other!samples!revealed!any!evidence!of!a!negative!signal.!
!
It! has! been! previously! shown! by! other! laboratories! that! cross<linking!
antibodies! against! CTLA<4! results! in! reduced! IL<2! production.! ! It! was! therefore!
decided!to!see!if!blocking!CTLA<4!using!non!cross<linked!antibody!model!would!affect!
IL<2! expression! in! our! CHO! system.! ! To! do! this,! CD25<! T<cells! were! stimulated! as!
described.! ! After! 5! days! of! stimulation! the! samples!were! re<stimulated!with! PMA,!
Ionomycin! and! Brefeldin! A! for! four! hours! to! induce! cytokine! production,! the! cells!
were!then!fixed!permeabilised!and!stained!for!the!presence!of!IL<2,!data!is!shown!in!
figure! 4.2.7.! ! ! These! data! show! that! both! CD80! and! CD86! can! stimulate! IL<2!
production! in! T<cells! however! it! does! appear! that! stimulating!with!CD86! results! in!
more!IL<2!producing!cells!than!stimulating!with!CD80.!!Importantly!however,!Instead!
of! enhancing! IL<2! production,!we! observed! that! blocking! CTLA<4! results! in! a! slight!
decrease! in! overall! IL<2! expression,! a! finding! that! is! counter! to! previous!
observations.!!To!investigate!if!CTLA<4!can!influence!other!cytokine!production,!the!
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expression!of!IFNγ,!IL<17!and!IL<21!were!also!studied!(figure!4.2.8).!!Again,!both!CHO<
CD80!and!CHO<CD86!cells!stimulate!the!production!of!IFNγ,!IL<17!and!IL<21!to!varying!
degrees.!!Thus!in!this!model!of!T<cell!stimulation!we!consistently!found!that!blocking!
CTLA<4!had!little!effect!on!cytokine!production.!!
!
!
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Figure'4.2.6:''Titrating'the!number'of'co8stimulatory+CHO+cells+does+not+reveal+a+
negative(signal.( (CFSE%labelled%CD25
<
!T<cells%were%stimulated%with%CD3%(10μg/ml)&
and$ reducing$ numbers$ of$ gluteraldehyde$ fixed$ CHO$ cell$ transfectants$ in$ the$
presence'or'absence'of' the'blocking'CTLA<4"antibody"Tremelimumab" (50μg/ml).''
Proliferation+ was+ determined+ by+ flow+ cytometery+ after+ five+ days.% % The% data%
presented(is(representative(of(five(independent(experiments.!
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Figure'4.2.7:''Blocking'CTLA!4"does"not"enhance"IL!2"production"in"a"CHO"
cell$transfectant$driven$assay$of$T!cell$proliferation.$$CFSE%labelled!CD25
!
!
T!cells% were% stimulated% with% CD3% (10μg/ml)& in& the& presence& of!
gluteraldehyde+fixed&CHO&cells&expressing&either&CD80&or&CD86&at&a&ratio&
of# one# CHO# cell# for# every# three# T!cells.& & After& 5& days,& cultures&were& re!
stimulated* with* PMA* (50ng/ml),* Ionomycin* (1μM)# and! Brefeldin) A)
(5μg/ml)& for& four&hours,& the&cultures&were& then& fixed&with&PFA! (3%)%and!
permeabilised+in+a+5%+PBS!Saponin'solution'before'being'stained'for'IL!2"
production.+ The+ data+ presented+ is+ representative+ of+ five+ independent+
experiments.++ 
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Figure# 4.2.8:# # Blocking# CTLA84" has" differential" effects" on" the" production" of"
cytokines.+CFSE% labelled!CD25
<
!T<cells%were%stimulated%with%CD3% (10μg/ml)& in&the&
presence' of' gluteraldehyde' fixed' CHO' cells' expressing' either' CD80' or' CD86' at' a'
ratio& of& three& T<cells% to# every# one# CHO# cell.# # After# 5# days,# cultures# were# re<
stimulated*with*PMA*(50ng/ml),*Ionomycin*(1μM)#and#Brefeldin#A#(5μg/ml)&for&four&
hours&before&being&stained&for&IL<17,$IL<21#or#IFNγ!production.++The+data+presented+
is#representative#of#five#independent"experiments."""" 
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Since!CTLA<4!does!not!become!up<regulated!until!after!the!T<cell!is!activated,!
it!could!be!argued!that!the!lack!of!antibody!affects!may!be!a!result!of!the!fact!that!
the!target!protein!is!not!there!at!the!beginning!of!the!experiment,!it!was!therefore!
decided! to! see! if! blocking!CTLA<4!would!have!any!effect!on!T<cell! blasts.! ! For! this,!
CD25<!T<cells!were!stimulated!with!CD3/28!dynabeads!for!five!days.!!The!beads!were!
removed,! the! cells! rested! overnight! before! being! CFSE! labelled! and! re<stimulated!
with! CD3! in! the! presence! of! CHO,! CHO<80! and! CHO<86! cells.! ! The! responder!
population!were!allowed!to!divide!for!a! further! five!days!before!being!analysed!by!
flow!cytometry.!!The!data!shown!in!figure!4.2.9!represents!the!MFI!of!each!sample!
such!that!the!further!the!cells!have!divided,!the!lower!the!MFI.!!Again!from!this!it!can!
be!seen!that!CHO!cells!trigger!very!little!proliferation!of!the!blasts!but!the!CHO<CD80!
and!CHO<CD86!cells!allow!the!blasts!to!proliferate!indicating!that!the!blasts!require!
co<stimulation!to!divide.! !Again,!we! find!that!blocking!CTLA<4!had!no!effect!on!the!
amount!of!proliferation!the!T<cells!undergo.!!This!is!despite!the!fact!that!at!the!point!
of!re<stimulation,!all!of!the!cells!are!expressing!CTLA<4.!!It!was!next!decided!to!see!if!
any!other!antibodies!could!modulate!T<cell!proliferation!in!this!assay.!!For!this,!CFSE!
labelled!CD25<!T<cells!were!stimulated!with!CD3!and!the!various!types!of!CHO!cells!in!
the!presence!of!anti<CTLA<4,!CTLA<4!Ig!and!a!blocking!CD28!antibody!(figure!4.2.10).!!
Again,! we! find! that! blocking! with! anti<CTLA<4! has! no! effect! on! proliferation;!
however,! if!we!add!CTLA<4!Ig!or!CD28!antibodies!we!find!that!T<cell!proliferation!is!
completely! ablated! highlighting! that! blocking! this! co<stimulatory! pathway! does!
result! in! functional!effects.! !Taken!together,!all!of! these!data!are! inconsistent!with!
the!concept!that!CTLA<4!delivers!a!cell!intrinsic!negative!signal.!!!!!!!!!
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Figure'4.2.9:' 'Blocking'CTLA84"upon"re8stimulation*of*T8cell$blasts$with$CHO$
cell$ transfectants$ does$ not$ affect$ T8cell$ proliferation.$ CD25
<
! T<cells% were%
stimulated*with* CD3/28* dynabeads* for* five* days.* * The* beads*were* removed*
and$ the$ cells# were# rested# overnight# in# RPMI# media.# # The# cells# were# then#
labelled& with& CFSE& and& were& stimulated& for& a& further& five& days& with&
gluteraldehyde+ fixed+ CHO+ cell+ transfectants+ in+ the+ presence+ or+ absence+ of" a"
blocking) CTLA<4" antibody" (Tremelimumab;" 50μg/ml).' ' Proliferation' was'
determined( by( flow( cytometry,( the( mean( fluorescence( intensity( values(
calculated(and(plotted( in(the(graph(as(shown.((Statistical(analysis(showed(no(
significant)difference)between)controls$and$test$samples$when$using$a$Kruskal<
Wallis& test& with& a&Dunn’s& post& test.& The& data& presented& is& representative& of&
three%independent%experiments.!
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Figure'4.2.10:''Anti8CD28%and%CTLA84"Ig"are"able"to"modulate"T8cell$proliferation$
where%anti8CTLA84!cannot.' 'CFSE% labelled!CD25
<!
T<cells%were%stimulated%with%CD3%
(10μg/ml)&in&the&presence&of&gluteraldehyde&fixed&CHO&cells&expressing&either&CD80&
or# CD86# at# a# ratio# of# one# CHO# cell# to# 10# T<cells% (Control).% % Anti<CTLA<4"
(Tremelimumab;, 50μg/ml),' CTLA<4" Ig" (10μg/ml)& or& anti<CD28% (10μg/ml)! were$
added$ to$ the$ cultures$ and$ the$ amount$ of$ proliferation$ was$ determined$ by$ flow$
cytomtery(after(5(days.((The(data(presented(is(representative(of(three(independent(
experiments. 
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4.2.2!Does!Blocking!CTLA84!Affect!Proliferation!When!Using!Dendritic!Cells!as!APC?!
!
The! next! stage! in! the! process! was! to! move! away! from! using! CHO!
transfectants! and! determine! the! effect! of! blocking! CTLA<4! in! a! slightly! more!
physiological! setting,! for! this,! dendritic! cells! were! used! to! provide! co<stimulation.!!
The!dendritic! cells!were!derived! from!monocytes! that!were! cultured!with! IL<4!and!
GM<CSF.!!After!6!days!of!culture,!some!of!the!DCs!were!matured!by!adding!LPS.!!On!
day!7!the!DCs!were!phenotyped!by!staining!for!CD80!and!CD86,!the!data!is!shown!in!
figure!4.2.11.! !The!DCs!were!initially!gated!on!CD11c!expression,! it! is!shown!in!this!
figure!that!upon!maturation,!the!DCs!up<regulate!their!expression!of!both!CD80!and!
CD86.!!To!ensure!the!DCs!were!able!to!provide!effective!T<cells!co<stimulation,!CD25<!
responder!cells!were!labelled!with!CFSE!and!stimulated!for!five!days!in!the!presence!
of!CD3!and!either!immature!or!mature!DCs!(figure!4.2.12!–!black!line).!!This!indicates!
that! the! DCs! can! stimulate! T<cells! to! divide.! ! It! appears! that! this! division! is! co<
stimulation! dependent! since! the! overall! amount! of! proliferation! can!be! limited!by!
reducing! the! number! of! DCs! in! the! assay.! ! To! confirm! that! the! proliferation! is!
dependent! on!B7! co<stimulation,! it!was! decided! to! block! CD80! and!CD86! in! these!
assays! (figure! 4.2.12! –! red! line).! ! By! blocking! B7! ligands! it! is! clear! that! T<cell!
proliferation! is! almost! completely! ablated! indicating! that! this! model! of! T<cell!
activation!is!ligand!dependent.!!!
!
!
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Figure'4.2.11:%%Phenotype%of%dendritic%cells.!!Monocytes)were)cultured)for)7)days)
in# the#presence#of# IL<4" (500U/ml)" and" (GM<CSF$800U/ml).$ $On$day$6$ cells$were$
either&left&untreated&or&matured&overnight&with&1μg/ml%of%LPS.%%Cell%were%stained%
on# ice# for# 30#minutes#with# CD80# and# CD86,#DCs#were# gated# on# CD11c# positive#
cells.&&Phenotypes&were&tested&before&every&experiment&and&the&data&presented&is&
representative*of*a*typical*culture. 
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Figure'4.2.12:''T8Cell$ responses$are$dependent$on$co8stimulation.++CD25
<
!
T<cells%were%isolated%and%stimulated%with%10μg/ml%of%CD3%in%the%presence%
of# mature# or# immature# DCs.# # Cultures# were# left# untreated# or# were#
incubated* for* five* days*with* blocking* antibodies* to* CD80* and* CD86* at* a*
concentration)of)10μg/ml%each.%%T<cell$proliferation'was'determine'by'flow'
cytometry 
! !
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To! assess! the! affect! of! blocking! CTLA<4! in! a! DC! based! assay,! T<cells!were! labelled!
with!CFSE!and!were!stimulated!with!CD3!and!reducing!numbers!of!DCs.! !As!can!be!
seen!from!figure!4.2.13,!when!high!numbers!of!DCs!are!present,!blocking!CTLA<4!has!
little!effect!on!T<cell!proliferation.! ! Interestingly,!however,!as!the!number!of!DCs! is!
reduced,! blocking! CTLA<4! dramatically! enhances! proliferation.! ! Again,! the!
proliferating! cells! are! all! expressing!CTLA<4! (figure! 4.2.14).! ! To! find!out! if! blocking!
CTLA<4!in!the!DC!assay!affects!IL<2!production,!the!T<cells!were!analysed!for!their!IL<2!
expression.!!Figure!4.2.15!shows!that!there!is!very!little!difference!between!blocked!
and!control!samples!when!high!numbers!of!DCs!are!used,!where!there!are!fewer!DCs!
however,!there!is!a!large!increase!in!IL<2!production!in!the!blocked!samples.!!These!
data! suggest! that! CTLA<4!may! be!more! effective!where! it! can! compete! effectively!
with!CD28!for!B7!engagement.!!!
!
Again,!it!was!decided!to!look!at!the!affect!blocking!CTLA<4!had!on!IFNγ,!IL<17!
and!IL<21:!!figure!4.2.16.!!At!the!1/3!DC:T<cell!ratio,!blocking!CTLA<4!seems!to!cause!
an!overall!decrease!in!both!IFNγ!and!IL<17!expression!whereas!there!is!apparently!no!
effect!on!IL<21.!!At!the!lower!ratio!of!1/25,!it!seems!that!blocking!CTLA<4!results!in!a!
modest!increase!in!both!IFNγ!and!IL<17!but!it!appears!that!the!treatment!results!in!a!
decrease! in! IL<21! production.! ! CTLA<4! therefore! seems! to! have! a! more! profound!
effect!on!IL<2!production!than!other!cytokines.!!!
!
!
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Figure' 4.2.13:' ' Blocking' CTLA84" in" a" DC" based" assay" enhances" T8cell$ proliferation$
when! co8stimulation* is* limiting.* * CFSE% labelled! CD25
<
! T<cells% were% stimulated% with%
10μg/ml%of%CD3%and%the%indicated%ratio%of%immature%monocyte<derived&dendritic&cells&
in# the# presence# or# absence# of# the# blocking# CTLA<4" antibody" (Tremelimumab;"
50μg/ml).''After'5'days,&proliferation&of&T<cells%was%analysed%by%flow%cytometry.!!!!The$
data$presented$is$representative$of$at$least$five$independent$experiments. 
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Figure'4.2.14:''Proliferating'cells'express'CTLA84.##CFSE%labelled%CD25
<
!T<cells%were%
stimulated*with*CD3* (10μg/ml)&and& immature&DCs& in& the&presence&or&absence&of&
the$ blocking$ CTLA<4" antibody" (Tremelimumab;" 50μg/ml).' ' After' 5' days,' cultures'
were$fixed$(3%$PFA)$and$permeabilised$(5%$PBS<Saponin)(to(stain(for(the(presence(
of#total#CTLA<4,#cultures#were#analysed#by#flow$cytometry.$ $The$data$presented$is$
representative*of*at*least*five*independent*experiments. 
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Figure'4.2.15:' 'Blocking'CTLA84"enhances"IL82"production"where"the"number"of!
DCs$used$to$provide$co8stimulation*is* limited.* *CFSE%labelled!CD25<!T<cells%were%
stimulated*with*CD3* (10μg/ml)&and& the& indicated& ratios&of& immature&DCs& in& the&
presence'of'Tremelimumab'(50μg/ml).''After'5'days,'cultures'were're<stimulated*
with% PMA% (50ng/ml),# Ionomycin# (1μM)# and#Brefeldin# A# (5μg/ml)& for& four& hours&
before&being&fixed,&permeabilised&and&stained&for&IL<2"production.""Cultures"were"
analysed( by( flow( cytometery.( ( The( data( presented( is( representative( of( five(
independent'experiments.''''' 
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Figure'4.2.16:''Blocking'CTLA84"has"differential"effects"on"T8cell$cytokine#production.#
CFSE%labelled!CD25
<
!T<cells%were%stimulated%with%CD3%(10μg/ml)&in&the&presence&of&the&
indicated(ratios(of(immature(DCs(and(Tremelimumab!at#50μg/ml.&&After&5&days,&cultures&
were$re<stimulated*with*PMA*(50ng/ml),*Ionomycin*(1μM)#and#Brefeldin#A#(5μg/ml)&for&
four% hours% before% being% fixed,% permeabilised% and% stained% for% IL<17,$ IL<21# or# IFNγ!
production.+++Cells+were+analysed+by+FACS,+the+data+presented+is+representative+of+three+
independent'experiments.'' 
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To! study! the! effect! of! blocking! CTLA<4! upon! re<stimulation,! CD25<! T<cells!
were!stimulated!with!CD3/28!beads!for!five!days,!the!beads!removed!and!the!T<cells!
rested!over!night!before!being! labelled!with!CFSE!and! re<stimulated!with!CD3!and!
increasing! numbers! of! DCs.! ! After! five! days! of! re<stimulation,! the! amount! of!
proliferation!was!determined!by!flow!cytometry!the!data!is!shown!in!figure!4.2.17.!!
As!with!the!experiments!carried!out!with!CHO!cells,!these!data!are!expressed!as!MFI!
such!that!the!more!cell!division!that!occurs,!the!lower!the!MFI.!!These!results!mirror!
the!primary!response!data!in!that!reducing!the!number!of!DCs!present,!reduces!the!
amount! of! proliferation! that! the! T<cells! undergo.! ! Importantly,! blocking! CTLA<4! is!
again!only!effective!where!fewer!DCs!are!present!further!arguing!against!the!delivery!
of!a!negative!signal.!
!
Since! T<cell! proliferation! appears! to! be! entirely! dependent! on! B7! co<
stimulation!and!CTLA<4!appears!to!be!more!effective!under!conditions!where!it!can!
out! compete! CD28! for! ligand,! it! was! decided! to! assess! if! the! addition! of! a! CD28!
agonist!would! overcome! the! effects! of! blocking! CTLA<4.! ! To! do! this,! CFSE! labelled!
CD25<!T<cells!were!stimulated!with!CD3!and!DCs!as!described!previously.! !This!was!
done! in! the! presence! of! anti<CTLA<4,! dynabeads! coupled! to! an! agonistic! CD28!
antibody!or!a!combination!of!both!(figure!4.2.18)! !Again!we!see!that!blocking!with!
CTLA<4!(red!line)!alone!only!affects!the!proliferation!of!T<cells!when!there!are!fewer!
DCs!present.! ! As! expected,! addition!of! the!CD28! agonist! enhances!proliferation! at!
this! ratio!of!DCs! (green! line).! ! ! Surprisingly,! however,! addition!of!both!anti<CTLA<4!
and!the!CD28!agonists!together!appear!to!have!an!additive!effect.!!!
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Figure'4.2.17:''Blocking'CTLA84"enhances"the"proliferation"of"T8cell$blasts$co8
stimulated#with#DCs.##CFSE!labelled!CD25
<!
T<cells%were%stimulated%with%CD3/28%
dynabeads(for(five(days.((The(beads(were(removed(and(the(cells(were(rested(
overnight*in*RPMI*media.**The*cells*were*then*labelled*with*CFSE*(2.5μM)#and#
were$ stimulated$ for$ a$ further$ five$ days$ with$ CD3$ (10μg/ml),' DCs' at' the#
indicated( ratios( in( the(presence(or( absence( of( the(blocking( CTLA<4" antibody"
(Tremelimumab;,50μg/ml).' 'Proliferation'was'determined'by' flow'cytometry,'
the$mean$fluouresence$intensity$values$calculated$and$plotted$in$the$graph$as$
shown.' ' The' data' presented" is" representative" of" " three" independent"
experiments.+ + Statistical+ analysis+ was+ carried+ out+ using+ a+ Kruskal<Wallis& test&
with%a%Dunn’s%post%test.%%ns#=#not#significant,#***#p<0.001. 
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Figure'4.2.18:' 'Does'addition&of&a&CD28&agonist&overcome&the&effect&of&blocking&
CTLA84.# # CFSE% labelled! CD25
<!
T<cells% were% stimulated% with% CD3% (10μg/ml)& in& the&
presence'of'gluteraldehyde'fixed'CHO'cells'expressing'either'CD80'or'CD86'at'the'
indicated(ratios.( (Anti<CTLA<4"(Tremelimumab;"50μg/ml),'CD28'agonist'(clone'9.3;'
10μg/ml)&or&a&combination&of&both&were&added!to#the#cultures#and#the#amount#of#
proliferation+was+determined+by+flow+cytometry+after+5+days.++The+data+presented+
is#representative#of#three#independent#experiments. 
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4.3!Discussion!
!
The!theory!that!CTLA<4!delivers!an! inhibitory!signal! into!the!T<cell!has!been!
widely! embraced! however,! all! of! the! supporting! data! has! come! from!experiments!
using! antibodies! against! CTLA<4! [1,! 3].! ! However,! there! are! numerous! problems!
associated!with!the!use!of!cross<linked!antibodies,! it!was!therefore!decided!to!look!
for!evidence!of!a!negative!signal!using!natural!CTLA<4! ligands.! !To!do!this,!a!model!
system! using! CHO! cells! that! express! either! CD80! or! CD86! on! their! surface! was!
employed.! !The!use!of!CHO!cells!to!provide!co<stimulation!offers!a!useful!model!to!
test! for!a!negative!signal!since!the!cells!express!relatively! large!amounts!of! ligands!
this!reduces!the!likelihood!of!competition!affecting!the!results.!!Further!to!this,!the!
CHO!cells! are!unable! to!produce! signals! that!would!enhance!T<cell!proliferation!or!
indeed! receive! signals,! therefore! presenting! a! clean! system! to! study! the! effect! of!
blocking!CTLA<4!on!T<cell!activation.! !The!data!presented!suggest! that!CTLA<4!does!
not! inhibit! T<cell! proliferation!by!delivering!a! ligand!dependent! inhibitory! signal! as!
there!is!no!effect!of!blocking!CTLA<4!on!proliferation!responses.!!Only!when!the!CHO!
cells!are!titrated!to!very!low!levels!do!we!see!any!effect!of!blocking!CTLA<4.!!In!the!
samples!stimulated!with!CHO<86!cells!where!there!was!only!one!CHO!cell! to!every!
500!T<cells,!we!do!start!to!see!enhance!proliferation!of!the!T<cells.!!However,!the!fact!
that!the!number!of!co<stimulatory!cells!had!to!be!titrated!so!low!before!an!effect!of!
blocking!CTLA<4!was!revealed!further!argues!against!the!delivery!of!a!negative!signal.!!
Instead,! it! is! likely! that! blocking! CTLA<4! at! very! low! levels! of! co<stimulation! is!
inhibiting!the!competition!of!this!protein!and!CD28!for!ligand!engagement.!
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It!may! be! suggested! that! the! lack! of! effect! of! blocking! CTLA<4! in! CHO! cell!
assays!is!because!the!antibody!does!not!allow!functional!effects.!!However,!the!since!
the!same!antibody!seems!able!to!cause!considerable!enhancement!of!proliferation!
in!DC!based! assays! suggests! otherwise.! !Moreover! the! antibodies! used!have!been!
extensively!characterised!in!chapter!3!ruling!out!trivial!criticisms!of!non<blocking!or!
low!affinity.!!!The!data!presented!here!does!not!rule!out!the!possibility!that!CTLA<4!
can!signal!without!the!need!for!engagement!of!B7.!!It!has!been!shown!in!mice!that!a!
ligand! independent! splice! variant! of! CTLA<4! (liCTLA<4)! can! be! expressed! and! is!
associated!with!a!number!of!autoimmune!diseases!such!as!type!I!diabetes![4].!!This!
liCTLA<4!was!subsequently!shown!to!be!able! to! inhibit!T<cell!proliferation!and! IFNγ!
production!to!the!same!extent!as!full!length!CTLA<4![5].!!!However,!recent!studies!by!
Wicker!et#al!have!shown!that!Li<CTLA<4!is!unable!to!rescue!the!fatal!CTLA<4!deficient!
phenotype,!suggesting!the!role!of!this!isoform!is!at!best!limited![2].!!Further!to!this,!
it! has! been! shown! that! full! length! CTLA<4! could! inhibit! proliferation! and! IL<2!
production! in! the! absence! of! ligand! [6]! suggesting! that! a! negative! signal! could! be!
ligand!independent.!!!
!
To! test! the!effect!of!blocking!CTLA<4! in!a!more!physiological! setting,! it!was!
decided! to! use! dendritic! cells! as! antigen! presenting! cells.! ! Both! mature! and!
immature!dendritic!cells!were!used.!!It!was!perhaps!surprising!to!note!that!immature!
dendritic!cells!provided!just!as!effective!co<stimulation!as!mature!cells.!!It!would!be!
expected! that!mature!DCs!would!be! capable!of!driving!greater!proliferation! in! the!
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responder!population!due!to! the! fact! that! they!express!higher! levels!of!both!CD80!
and!CD86!on!their!surface!(as!shown!in!figure!4.2.11).! !The!equivalent! levels!of!co<
stimulation! may! be! explained! by! the! fact! that! the! addition! of! the! T<cells! to! the!
cultures! results! in! the! DCs! maturing! and! hence! driving! further! proliferation.!!
Activated!T<cells!express!CD40!Ligand!(CD40L)![7]!which!binds!to!CD40!expressed!on!
DCs.! It! has! been! shown! that! CD40<CD40L! interactions! can! result! in!DC!maturation!
categorised! by! enhanced! CD80! and! CD86! expression! [8]! and!may! account! for! the!
equivalent! levels! of! proliferation! observed.! ! In! the! experiments! carried! out! using!
DCs,! it! is! interesting! to! note! that! whilst! the! antibody! has! very! little! effect! on!
proliferation!or!IL<2!production!when!there!are!many!DCs!present,!there!are!striking!
effects!when! there! are! fewer!DCs.! ! This! further! supports! the! concept! that! CTLA<4!
does! not! deliver! a! ligand! dependent! T<cell! intrinsic! negative! signal! as! it! would! be!
expected!that! if!a!negative!signal!was!delivered,!having!more! ligand!present!might!
produce!a!stronger!signal.!!One!of!the!most!basic!models!for!CTLA<4!function!is!that!
it! is!able! to!out<compete!with!CD28!for!B7! ligand,!binding!due!to! its!higher!avidity!
and!affinity!for!the!protein!thus!reducing!the!activation!signal!that!would!otherwise!
be!delivered!into!the!cell![9<12].!!The!fact!that!CTLA<4!is!more!effective!in!a!setting!
where! the! amount! of! ligand! is! limiting! suggests! the! possibility! that! CTLA<4! could!
function!by!some!form!of!competition!with!CD28.! !Although!it! is!probable!that!this!
mechanism!will! have! some! influence!on! T<cell! responses,! if! this!mechanism!was! a!
major!factor!it!would!be!expected!that!pronounced!effects!of!blocking!CTLA<4!would!
be! observed! upon! reducing! the! number! of! transfected! CHO! cells! used! as! co<
stimulators!and!not!just!when!the!number!of!DCs!were!reduced.!
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An!important!feature!of!CTLA<4!biology!is!that!the!protein!is!only!expressed!
in! resting! T<cells! once! these! cells! become! activated.! ! CTLA<4! can! be! detected! on!
activated! T<cells! as! early! as! 24<48! hours! post! stimulation! [1,! 13<15].! ! It! could!
therefore!be!argued!that!the!absence!of!CTLA<4!effects!in!the!CHO!cell!experiments!
may!be!a!result!of!the!delayed!expression!of!the!protein!on!the!surface!of!the!T<cells.!!
It! has! certainly! been! shown! that! primary! responses! in! CTLA<4</<! CD8! T<cells! are!
comparable!to!those!of!CTLA<4+/+!cells,!whereas,!re<stimulated!CTLA<4</<!CD8!T<cells!
are! hyper<responsive! when! compared! to! the! WT<cells! [16].! ! There! are! however,!
numerous!experiments! in! chimeric! settings! that! show! that!CTLA<4!deficient! T<cells!
are!normal!in!the!presence!of!other!CTLA<4!expressing!cells.! !This!strongly!suggests!
that!a!cell!intrinsic!role!for!CTLA<4!function!is!unlikely!to!be!important!in#vivo![17<20].!!
The!fact!that!blocking!CTLA<4!was!able!to!enhance!T<cells!responses!when!DCs!were!
used!to!stimulate!in!both!primary!and!re<stimulated!responses!argues!that!CTLA<4!is!
effective! in! both! settings.! It! therefore! follows! that! the! lack! of! effects! when! using!
CHO! cells! to! re<stimulate! is! further! evidence! against! CTLA<4! acting! as! an! intrinsic!
negative!signal.!!!
!
When!CTLA<4!was! initially!associated!with!a!negative! signal,! this! conclusion!
was! reached! as! a! result! of! experiments! that! showed! cross<linking! CTLA<4! with!
antibody!resulted! in!decreased! IL<2!production![1].! !The!data!presented!here!show!
that!blocking!CTLA<4!also!resulted! in! increased! IL<2!production,!which! is!consistent!
with!these!early!studies!into!CTLA<4!function.!!This!enhancement!of!IL<2!production!
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is! more! pronounced! when! fewer! DCs! are! present! which! reflects! the! proliferation!
data!presented!and!implies!that!CTLA<4!is!more!effective!when!the!APC!is!limiting.!!!!
!
It!was!decided!to!assess! the!effect!of!blocking!CTLA<4!on!the!production!of!
other! pro<inflammatory! cytokines.! ! ! The!data!presented!here! show!an!example!of!
the!results!from!such!experiments;!however,!the!data!was!highly!variable!making!it!
difficult!to!draw!concrete!conclusions!from!these!experiments.!!The!inconsistency!in!
the!data!could!be!a!result!of!donor!variability!and!may!suggest!that!there!are!factors!
other!than!CTLA<4!that!are!required!for!regulating!the!production!of!these!cytokines.!!!
!
Taken!together,!the!data!presented!here!are!inconsistent!with!the!idea!that!
CTLA<4!is!able!to!deliver!a!ligand<dependent,!cell!intrinsic!negative!signal.!!Instead,!it!
appears! that! the! protein! functions! by! some! means! of! competition! with! CD28! by!
virtue!of!the!fact!that!blocking!CTLA<4!is!more!effective!when!the!numbers!of!APCs!
are!limited.!!!
!
!
!
!
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Chapter!5:!
CTLA84!Acts!as!an!Extrinsic!Regulator!of!T8cell!
Activation!
!
!
!
!
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5.1!Introduction!
!
In!the!previous!chapter!we!found!no!evidence!that!CTLA<4!was!able!to!deliver!
a!ligand!dependent!negative!signal.!!Blocking!CTLA<4!did!enhance!the!proliferation!of!
T<cells! in!a!DC!based!assay!but!only!when!the!numbers!of!DCs!were! limiting.! !One!
interpretation!of!these!data!is!that!CTLA<4!could!act!extrinsically!to!regulate!the!DC!
and! that! this! regulation! is!most! effective!when! there!are! lower! amounts!of! ligand!
available.!!The!aim!of!this!chapter!was!to!test!further!the!settings!where!CTLA<4!can!
effectively! regulate! the! proliferation! of! responder! cells! and! to! try! to! assess! the!
mechanisms!that!may!account!for!this!function.!!!
!
!
!
!
!
!
!
!
!
!
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5.2!Results!
5.2.1! Can! CTLA84! expressing! Cells! Regulate! the! Proliferation! of! a! Responder!
Population?!
!
The! existence! regulatory! T<cells,! a! subset! of! T<cell! that! constitutively!
expresses! CTLA<4,! has! long! been! known.! ! These! cells! are! thought! to! regulate!
responder! populations! by! various! mechanisms.! ! ! It! was! decided! to! assess! the!
function!of!CTLA<4!in!regulatory!T<cell!responses.!!Our!laboratory!previously!isolated!
regulatory!T<cells! from!PBMCs! initially!by!CD4!negative!selection! followed!by!CD25!
positive! selection.! ! Figure! 5.2.1.1! shows! yields! of! each! cell! type! at! the! difference!
stages! of! purification.! ! This! shows! that! only! around! 30%! of! the! CD25+! T<cells! are!
Tregs! based! on! them! expressing! both! CD25! and! FoxP3.! ! In! order! to! attempt! to!
understand!how!CTLA<4!works!in!Tregs,!it!was!important!to!try!to!improve!the!yield!
of!these!cells.!!!It!has!been!recently!shown!that!selecting!both!CD127!low,!CD49d!low!
yields! a!pure!population!of! “untouched”!Tregs! [1].! ! It!was! therefore! attempted! to!
improve! the!yield!of!Treg!by! first!negatively! selecting!CD4+CD127low!cells!using! the!
“stemcell”!isolation!kit.!!Figure!5.2.1.2!shows!that!this!kit!resulted!in!good!purity!of!
CD3+CD4+!cells!and!that!about!99%!of!these!cells!expressed!almost!no!CD127.!!This!
method!of!isolation!alone!resulted!in!only!around!16%!of!cells!expressing!both!CD25!
and!FoxP3.!!At!this!stage!of!selection,!around!45%!of!the!cells!expressed!CD49d.!!To!
isolate! the! CD49d! negative! cells,! the! CD4+CD127low! cells! were! incubated! with! a!
CD49d!FITC! labelled!antibody!before!being! labelled!with!anti<FITC!magnetic!beads.!!
The!labelled!cells!were!then!isolated!from!the!samples!using!a!magnet.!!This!second!
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round!of!selection!resulted!in!almost!a!60%!purity!of!Tregs!based!on!CD25!and!FoxP3!
expression,!double!the!purity!of!the!previous!method!of!Treg!isolation.!!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
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Figure'5.2.1.1:''Purity'of'Tregs'isolated'by'CD25'positive'selection.((CD4
+
!T<cells%were%
isolated) from)PBMCs)before)being) incubated)with)CD25) selection)beads.) ) The) cells)
were$then$passed$through$a$column.$$Negative$cells$were$collected$before$detaching$
the$positive$cells$from$the$column.$$The$isolated$cells$were$stained$for$surface$CD25,$
fixed,'permeabilised'and'stained'for'FoxP3'and'protein'expression'was'determined'by'
flow% cytometry.% % Purities% were% determined% before% every% experiment% and% the% data%
presented(is(representative(of(a(typical(yield. 
! 132!
!
Figure'5.2.1.2:' 'Negative'selection'of'regulatory'T8cells%by%a%combination%of%CD49d%
and$CD127$negative$selection$improves$the$yield$of$Tregs.$$PBMCs&were&treated&with&
CD4
+
CD127
<
!negative'selection'cocktail,'positive'cells'were'removed'from'the'sample'
by#magnet.##These#cells#were#either#stained#for#purity#or#subjected#to#further#negative#
selection)by)CD49d.))All)purified)cells)were)stained)on)the)surface)for)CD4)and)CD49d)
before&being#fixed,#permeabilised#and#stained#for#FoxP3.##Expression#levels#of#protein#
were$determined$by$flow$cytometery.$$The$data$presented$is$representative$of$three$
independent'experiments.''''!!!! 
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To! assess! the! role! of! CTLA<4! on! Treg! function,! CFSE! labelled! CD25<! T<cells!
were!stimulated!with!CD3!and!DCs.!!Samples!were!treated!with!anti<CTLA<4,!Tregs!or!
a! combination! of! both! (Figure! 5.2.1.3).! ! Surprisingly,! instead! of! suppressing!
responder!cell!proliferation,!it!appeared!that!addition!of!the!Tregs!actually!enhanced!
T<cell! proliferation.! Further,! it! was! found! that! blocking! CTLA<4! in! the! absence! of!
Tregs! enhanced!proliferation,! but! had!no! effect! on! T<cell! proliferation!when! Tregs!
were!present.!!!
!
These!results!may!reflect!the!fact!that!the!isolated!Tregs!were!still!not!pure!
enough! for! effective! suppression! and! that! contaminating! activated! T<cells!
contributed!to!proliferation.!!!To!address!this!issue,!it!was!also!decided!to!use!jurkats!
as! a! suppressor! population! as! wild! type! (WT)! jurkats! don’t! express! CTLA<4.! ! Our!
laboratory!was! able! to! transduce! some!of! these! cells! so! that! they!became!CTLA<4!
positive! using! a! retroviral! approach.! ! Expression! of! CTLA<4! was! confirmed! by!
labelling!the!cells!with!a!CTLA<4!antibody!at!37°C.!!Figure!5.2.1.4!shows!that!the!WT!
jurkats!were!negative! for!CTLA<4!expression!whereas! the!CTLA<4! jurkats!expressed!
the!protein.!!Further,!since!this!labelling!was!carried!out!a!37°C,!it!appears!that!the!
CTLA<4! in! these! cells! is! recycling! effectively! between! the! membrane! and! the!
cytoplasm.!!!
!
!
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Figure' 5.2.1.3:' Addition' of' Treg' cells' enhances' proliferation' of' responder' CD25
8
!T8
cells.&&Responder)CD25
<
!T<cells%were%labelled%with%CFSE%and%were%stimulated%with%CD3"
(10μg/ml)& and& immature& DCs& at& the& ratios& indicated.& & Tregs& (1:3),& blocking& CTLA<4"
antibody) (Tremelimumab;)50μg/ml)& or& a& combination& of& both&were& added.& & After& 5&
days%of%culture,%the%proliferation%of%the%responder%population%was%determined%by%flow%
cytometry.$$The$data$presented$is$representative$of$two$independent$experiments.$$ 
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Figure' 5.2.1.4:' ' Jurkat' cell' lines' express' CTLA84.# # Jurkat' cells' were'
incubated* with* a* PE* labelled* anti<CTLA<4" antibody" (BNI3)" at" 37°C" for"
thirty& minutes& to& stain# the# recycling# pool# of# the# protein.# # Protein#
expression)was)then)determined)by)flow)cytometry. 
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To!find!out!if!CTLA<4!expressing!cells!were!able!to!suppress!the!proliferation!
of! responder! cells,! CFSE! labelled! T<cells!were! stimulated!with! CD3! and!DCs! in! the!
presence!of!either!WT!or!CTLA<4!jurkats.! !As!can!be!seen!from!figure!5.2.1.5!when!
there! were! high! numbers! of! DCs! present,! CTLA<4+! jurkat! cells! had! little! effect! on!
proliferation! when! compared! to! cells! cultured! in! the! presence! of! WT! jurkats.!!
However,!as! the!numbers!of!DCs!were!reduced,! it! can!be!seen!that!CTLA<4! jurkats!
were! able! to! suppress! the! proliferation! of! the! CFSE<labelled! responder! T<cell!
population.! ! ! These! data! suggest! that! CTLA<4! expressing! cells! are! capable! of!
suppressing! the!proliferation!of! surrounding!cells,! consistent!with!CTLA<4!acting!as!
an!external! regulator!of!T<cell! function.! ! ! !Furthermore!the!ability!of! jurkat!cells! to!
suppress!is!dependent!on!the!number!of!APCs!present!suggesting!that!CTLA<4+!jurkat!
cells!are!affecting!the!APC!rather!than!the!responder!T<cells.!
!
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Figure' 5.2.1.5:' ' CTLA84" expressing" jurkats" can" suppress" responder" cell"
proliferation., , Responder) CD25
<
!T<cells%were% labelled%with% CFSE% and% stimulated%
with% % CD3" (10μg/ml)& and& DCs& at& the& indicated& ratios.& & This& was& done& in& the&
presence'of'WT'or'CTLA<4"expressing"jurkat"cells"at"a"ratio"of"one"jurkat"to"three"
T<cells.&&The&amount&of&proliferation&of&the&responder&population&was&determined&
after&5&days&by& flow&cytometry.' 'The'data'presented'are' representative'of' three'
independent'experiments. 
! 138!
5.2.2!Determining!CTLA84!Effector!Function!
!
The!data!presented! so! far! are! consistent!with!CTLA<4! acting! as! an! external!
effector!molecule! capable! of! affecting!APCs.! ! To! address!which!mechanisms! could!
account!for!the!observations!made,!it!was!decided!to!look!at!models!where!CTLA<4!
acts!extrinsically!to!influence!the!DC.! !The!first!mechanism!to!be!looked!at!was!the!
role!of!IDO!in!these!assays.!!It!has!been!suggested!that!CTLA<4!is!able!to!back!signal!
into! the! dendritic! cell! upon! ligand! binding,! this! back! signalling! results! in! up<
regulation!of!the!enzyme!IDO.!!IDO!is!required!for!the!breakdown!of!tryptophan,!an!
essential!amino!acid!required!for!T<cell!proliferation,!thereby!reducing!the!capacity!
for!T<cells!to!divide![2,!3].!!!To!test!if!IDO!accounts!for!the!enhanced!proliferation!and!
IL<2!production!seen!in!dendritic!cell!assays!upon!blocking!CTLA<4!it!was!decided!to!
use!1<methyl!tryptophan!(1<MT),!a!widely!used!inhibitor!of!IDO!function.!!Addition!of!
1<MT! to! our! samples! results! in! increased! T<cell! proliferation! modestly! only! when!
using!both!mature!and!immature!DCs!at!very!high!numbers!(5:1!ratio,!figure!5.2.2.1).!!
However,!as!the!numbers!of!DCs!in!the!assay!were!reduced!the!effect!of!1<MT!is!lost.!!
In!fact,!at!very!low!numbers!of!DCs!(1:50!ratio)!it!seems!that!the!1<MT!became!toxic!
to!the!cells.!!The!fact!that!the!effects!of!CTLA<4!blocking!antibodies!are!only!seen!at!
low!DC!numbers!and! the!1<MT!effects!are!only! seen!at!high!DC!numbers! suggests!
that! IDO! does! not! account! for! the! increase! proliferation! of! our! DC! experiments!
above.!!To!confirm!this!it!was!decided!to!carry!out!a!blocking!experiment!at!the!5:1!
DC! to! T<cell! ratio.! ! As! can! be! seen! from! figure! 5.2.2.2,! blocking! CTLA<4! at! this!DC!
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ratio! had! no! effect! on! proliferation.! ! This! argues! against! the! fact! that! CTLA<4! is!
exerting!its!function!via!IDO!in!these!assays.!
!
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Figure'5.2.2.1:' ' Enhanced'proliferation'after'CTLA84"blockade" is"not"a" result"of" IDO.!!
CFSE% labelled% CD25
<
! T<cells% were% stimulated% with% CD3% (10μg/ml)& in& the& presence& of&
either! immature( or(mature( DCs( at( the( indicated( ratos.( ( Cultures(were( left( untreated(
(control))or)treated)with)the)IDO)inhibitor)1<methyl'tryptophan'(500μM).$$Proliferation$
of#responder#cells#was#determined#by#flow#cytometry#after#5#days.##The#data#presented#
are$representative*of*three*independent*experiments. 
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Figure' 5.2.2.2:' ' Effect' of' blocking' CTLA84" does" not" correlate" with" the" effect" of" 18MT#
inhibition.( ( CFSE% labelled% CD25
<
! T<cells% were% incubated% with% CD3% (10μg/ml)& in& the&
presence'of'mature'or' immature'DCs'at'a"ratio"of"5"DCs"for"every"T"cell." "Cells"were"left"
untreated(or(were(treated(with(anti<CTLA<4"(Tremelimumab;"50μg/ml)&or&1<MT#(500μM).$$
Cultures( were( analysed( by( flow( cytometry( after( 5( days.( ( The( data( presented( is(
representative*of*three*independent*experiments. 
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During! the! course! of! my! thesis! work,! data! from! our! laboratory! began! to!
indicate!that!one!role!for!CTLA<4!is!to!acquire!CD86!from!DCs![4].!!To!test!if!this!could!
account!for!the!observations!made!in!DC!assays!and!in!the!suppression!of!responder!
cells! by!CTLA<4!expressing! jurkat! cells! it!was!decided! to! test! if! CTLA<4+! jurkat! cells!
could! indeed! acquire! CD86.! ! To! do! this,! CHO! cells! expressing! CD86! GFP! were!
incubated!with!either!WT!or!CTLA<4!jurkats!for!six!hours.!!To!allow!easy!separation!of!
the!different!cell!types,!the!CHO!cells!were!first! labelled!with!a!far!red!dye!(Figure.!!
The!amount!of!GFP!present! in! the! jurkat!was! then!determined!by! flow!cytometry.!!
Figure! 5.2.2.3! shows! that! the! WT! jurkats! express! very! little! GFP! whereas! those!
jurkats! expressing!CTLA<4! appear! to!have! acquired! a! considerable! amount!of!GFP.!!
These!data!suggest!that!CD86!acquisition!can!occur!in!a!CTLA<4!dependent!manner!
in!jurkat!cells!and!could!therefore!act!to!suppress!T<cell!co<stimulation.!
!
!
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Figure'5.2.2.3:''Jurkats'can'acquire'CD86'GFP'from$CHO$cells.$$WT##or#CTLA<4"
jurkats(were(incubated(with(CHO(cells(expressing(GFP(tagged(CD86(for(6(hours(
at#37°C.###!!Presence'of'GFP'tagged'protein'in'the'jukat'cells'was'determined'by'
flow% cytometry.% % The% data% presented% is% representative% of% four% independent%
experiments. 
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The!next!step!was!to!determine!if!CD80!or!CD86!acquisition!by!CTLA<4!could!
account!for!the!functional!effects!observed!in!the!DC!assay.!!To!do!this,!CFSE!labelled!
CD25<! T<cells! were! stimulated! with! CD3! and! reducing! numbers! of! DCs! in! the!
presence!or!absence!of!anti<CTLA<4.! !After! five!days,! the!cultures!were!stained! for!
CD11c,! CD80! and! CD86! to! assess! the! levels! of! these! proteins! on! the! DC.! ! These!
markers!and!the!T<cell!proliferation!were!then!analysed!by!flow!cytometry.! !As!can!
be!seen!from!figure!5.2.2.4,!the!DCs!were!expressing!both!CD80!and!CD86!and!that!
the!overall! levels! of! B7! ligands! increased!when! the!DCs! are! incubated!with! T<cells!
and! that! the! increase! is! less!marked!when!DC!numbers!are! reduced.! ! Importantly,!
where!high!numbers!of!DCs!were!present!(1/3)!blocking!CTLA<4!had!little!effect!on!
the! down! regulation! of! B7! ligands.! !Whilst! in! contrast! we! observed! that! blocking!
CTLA<4!results!in!a!marked!increase!in!B7!expression!on!the!DC.!!These!data!highlight!
that!modulation!of! the!DCs!by!CTLA<4!could!account! for! the!enhance!proliferation!
observed!when!CTLA<4!is!blocked.!
!
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Figure'5.2.2.4:''Blocking'CTLA84"results"in"the"down"regulation"of"CD80"and"CD86"
on#DCs.##CFSE%labelled%CD25
<!
T<cells%were%incubated%with%CD3$(10μg/ml)&and&DCs&at&
the$ indicated$ ratios$ in$ the$ presence$ or$ absence$ of$ blocking$ antibody$
(Tremelimumab;,50μg/ml)& for& five&days.& &At&day& five,& the&cultures&were&stained&for&
surface( CD80( and( CD86( and( protein( levels( analysed( by( flow( cytometry.( ( The(
statistical'analysis'was'performed'using'a'Two<way$Annova$followed$by$a$Bonferroni$
post% test.% % ns# =# not# significant,# *# p<0.05,# ***# p<0.001.# # The$ data$ presented$ is$
representative*of*five*independent*experiments.** 
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Since!it!appears!that!CTLA<4!is!able!to!acquire!CD80!and!CD86!from!the!APC,!
it!was!decided!to!assess!if!CD86!is!degraded!upon!entry!into!the!T<cell.! !To!do!this,!
CHO<CD86!GFP! cells!were! incubated! for! six! hours!with!either!WT!or!CTLA<4! jurkat!
cells.! ! This! was! done! in! the! presence! or! absence! of! NH4Cl,! a! known! inhibitor! of!
lysosomal! degradation.! ! Figure! 5.2.2.5! shows! again! the!when! the! CHO! cells! were!
incubated! with! the! WT! jurkats! that! there! was! no! acquisition! of! the! GFP! signal,!
further,! incubating!these!cells!with!NH4Cl!had!no!effect.! !However,!when!the!CHO<
CD86! cells! are! incubated!with! CTLA<4! jurkats,! around! a! third! of! the! cells! acquired!
GFP.!!!!Interestingly,!when!this!sample!is!incubated!with!NH4Cl,!the!overall!number!of!
CTLA<4! jurkat! cells! that! have! GFP! increases! two! fold! to! around! 60%.! ! These! data!
suggest!that!CD86!is!degraded!in!lysosomes!after!it!enters!the!CTLA<4!expressing!cell.!!
To!confirm!these!data,!it!was!decided!to!carry!out!a!similar!experiment!but!this!time!
assessing! overall! protein! concentration!within! cells! by!western! blot! analysis.! ! This!
was! done! by!mixing! untransfected! CHO! cells!with! CHO<CD86! cells! or!mixing! CHO<
CTLA<4! cells! with! CHO<CD86! cells,! both! of! which! were! done! in! the! presence! or!
absence! of!NH4Cl! (Figure! 5.2.2.6).! ! After! six! hours! of! incubation! the! all! cells!were!
collected,!protein!was!extracted!and!the!overall!amount!of!CD86!in!the!samples!was!
determined!by!western!blot.! !As!can!be!seen,! in!the!CHO!+!CHO<CD86!sample,! the!
amount! of! protein! in! the! cells! treated! with! NH4Cl! is! increased! relative! to! the!
untreated!cells.! !Where!CHO<CD86!cells!are! incubated!with!CHO<CTLA<4!cells! it!can!
be! seen! that! there! is! an!overall!decrease! in! the!amount!of!CD86! in! these! samples!
when!compared!to!controls,!this!decrease!in!protein!is!recoverable!with!the!addition!
of!NH4Cl.! !These!data!are!consistent!with!the! idea!that!CTLA<4!expressing!cells!can!
acquire!CD86!and!that!the!CD86!is!degraded!in!lysosomes.!
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Figure' 5.2.2.5:' ' Acquired' CD86' is' degraded' in' the' jurkat.'WT#or# CTLA<4" jurkats"
were$ incubated$ with$ CHO$ cells$ expressing$ GFP$ tagged$ CD86$ in$ the$ presence$ or$
absence'of'NH4Cl#(CONCENTRATION)#for#6#hours#at#37°C.##Presence#of#GFP#tagged#
protein(in(the!jurkat'cells'was'determined'by'flow'cytometry.! 
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Figure'5.2.2.6:''CD86'is'degraded'after'acquisition'by'CTLA84.##CHO<CD86%cells%were%
incubated*for*6*hours*alone,*with*CHO,*CHO<CTLA<4"or"CHO<CTLA<4Δ23#cells# in#the#
presence'or'absence'of'NH4Cl# (CONCENTRATION).# #A." "The"protein"was"extracted% ,%
separated(by(SDS<PAGE%gel%electrophoresis%before%being%transferred%to%a%membrane.%%
The$membrane$was$then$blocked$and$probed$with$a$primary$antibody$against$CD86$
(C<19;$1:1,000)$or$Actin$(AC<40;$1:2,500)$and$a$secondary$HRP$antibody$(1:2,500).$$B.""
The# intensity# of# bands# was# determined# by# plotting# each# sample# as# OD# against#
distance)and)calculating)the)area)under)the)curve.))The)ratio)of)sample)to)actin)was)
then%calculated%and%plotted%in%the%graph%as%shown.%% 
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As! a! further! control,! CHO<CD86! cells! were! incubated! with! CHO<CTLA<4Δ23!
cells!(Figure!5.2.2.6).!!The!CTLA<4Δ23!is!a!mutant!form!of!CTLA<4!that!is!missing!the!
final! 23! amino! acids! of! the! tail.! ! This! mutant! has! increased! surface! expression!
relative! to!WT! CTLA<4! and! has! been! shown! to! be! less! effective! at! acquiring! CD86!
from!neighbouring!cells!(OS!Qureshi,!unpublished!observations).!!We!found!that!the!
overall! levels! of! CD86! in! these! cells! is! equivalent! to! the! control!well! (CHO!+!CHO<
CD86)!indicating!that!the!CD86!has!to!be!internalised!into!the!CTLA<4!expressing!cell!
in! order! for! it! to! be! degraded.! ! To! find! out! if! CTLA<4! is! also! degraded! upon!
acquisition! of! CD86,! CHO<CTLA<4! cells! were! incubated! with! either! untransfected!
CHO’s! or! CHO<CD86! cells.! ! After! six! hours,! the!protein!was! extracted! and!western!
blot!analysis!was!carried!out!to! look!at!CTLA<4!(Figure!5.2.2.7).! !From!these!data! it!
appears!that!CTLA<4!is!also!specifically!degraded!after!acquiring!CD86.!!Interestingly,!
however,! it! seems! that! CTLA<4! may! be! less! effectively! degraded! when! incubated!
with! CD80! expressing! cells.! ! Whilst! preliminary! these! data! provide! interesting!
insights! into!the!possible!differential! fate!of!CTLA<4!when!bound!by! its!two!natural!
ligands.!!!
!
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Figure'5.2.2.7:''CTLA84"is"also"degraded"after%acquiring%CD86.%CHO<CTLA<4"cells"
were$incubated$for$6$hours$alone,$with$CHO,$CHO<CD86%or%CHO<CD80!cells%in%the%
presence'or'absence'of'NH4Cl#(CONCENTRATION).##A.##The$protein$was$extracted$
," separated" by" SDS<PAGE% gel% electrophoresis% before% being% transferred$ to$ a$
membrane.( ( The( membrane( was( then( blocked( and( probed( with( a( primary(
antibody) against) CTLA<4" (C<19;$ 1:2,500)$ or$ Actin$ (AC<40;$ 1:2,500)$ and$ a$
secondary*HRP*antibody*(1:2,500).!B."The"intensity"of"bands"was"determined"by"
plotting(each(sample(as(OD(against'distance'and'calculating'the'area'under'the'
curve.''The'ratio'of'sample'to'actin'was'then'calculated'and'plotted'in'the'graph'
as#shown.## 
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5.3!Discussion!
!
Regulatory!T<cells!are!a!distinctive!subset!of!T<cells!that!are!thought!to!play!
an! important! role! in! immune! tolerance,! with! data! suggesting! that! these! cells! are!
defective!in!patients!with!various!autoimmune!diseases![5<7].!!It!would!be!expected!
that!addition!of!Treg!cells!to!cultures!would!result! in!the!suppression!of!responder!
cell!proliferation.! ! It!was!therefore!surprising!to!find!that!addition!of!these!cells,! in!
fact,!enhanced!the!proliferation!of!the!responder!population.!!The!most!likely!reason!
for!this!is!down!to!the!fact!that!the!suppressor!cell!population!constituted!only!60%!
CD25+FoxP3+! cells.! ! The! contamination! of! the! suppressor! population! with! a! large!
number! of! effector! cells! may! have! resulted! in! the! production! of! additional! pro<
inflammatory! cytokines! and! that! are! driving! the! responder! to! undergo! further!
proliferation.!!More!recent!data!from!the!laboratory!have!now!shown!that!with!pure!
Treg,!CTLA<4!based!suppression!can!be!seen!as!predicted!(DMS!personal!comments).!
!
Isolation!of!a!pure!population!of!regulatory!T<cells!from!PBMCs!proved!to!be!
a! difficult! task,! probably! as! a! result! of! the! fact! that! these! cells! exist! in! very! small!
number!within!peripheral!blood.!!To!therefore!study!if!CTLA<4!expressing!cells!were!
able! to! regulate! the! expression! of! a! responder! population,! it! was! decided! to! use!
jurkat! cells! that! had! been! transduced! to! express! CTLA<4.! ! This! provided! a! useful!
model! for!studying!the!ability!of!CTLA<4!to!control! the!proliferation!of!surrounding!
cells!since!WT! jurkats!could!be!used!as!a!control.! !These!experiments!showed!that!
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the! presence! of! CTLA<4! expressing! cells! resulted! in! the! inhibition! of! a! responder!
population.!!The!idea!that!CTLA<4!can!regulate!its!external!environment!is!not!new.!!
Indeed,!it!has!been!shown!that!both!CD4!and!CD8!T<cell!responses!to!viral!proteins!
are!unaffected!by!the!absence!of!cell<intrinsic!expression!of!CTLA<4!and!instead!that!
these!responses!can!be!controlled!by!the!presence!of!other!CTLA<4!expressing!cells!
[8].!!Further,!it!has!previously!shown!that!CTLA<4!knockout!mice!reconstituted!with!
WT!bone!marrow!are!rescued!from!disease![9]!suggesting!that!the!presence!of!CTLA<
4! expressing! cells! can! control! the! proliferation! of! other! non<expressing! cells.!!
However,! these! data! go! further! and! show! that! suppression! by! CTLA<4! does! not!
require!a!specialised!Treg!cell!and!that!it!can!be!carried!out!by!any!CTLA<4!expressing!
cell.! ! This! strongly! suggests! that! CTLA<4! is! itself! sufficient! to!mediate! suppression!
without!the!need!for!additional!specialised!machinery.!!!
!
It! is! interesting! to! note! that! the! use! of! a! CTLA<4! expressing! “regulatory”!
population! of! cells! was!most! effective! when! the! number! of! DCs! in! cultures! were!
limited.! ! These! data! reflect! the! concept! presented! in! the! previous! chapter!where!
blocking!CTLA<4!with!antibodies!was!most!effective!when!there!were! fewer!DCs! in!
the! culture! and! that! CD80! and! CD86! down! regulation! is!most!marked! in! cultures!
stimulated! with! fewer! DCs.! ! These! data! are! consistent! with! the! idea! that! CTLA<4!
could!be!out!competing!CD28!for!ligand!engagement!in!a!cell!extrinsic!manner.! !By!
depleting!ligand!levels!on!APC!CTLA<4!can!diminish!CD28!co<stimulation.!!It!was!also!
interesting! to! find! that!CD86!appeared! to!be!more! readily!depleted! than!CD80.! ! It!
would!perhaps!be!expected!that!CD80!would!be!the!first!ligand!removed!considering!
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that!the!CTLA<4:CD80!interaction!is!stronger!than!the!CTLA<4:CD86!interaction.!!This!
finding!may!be! in!part!due!to! the! fact! that!CTLA<4!has!been!shown!to! form! lattice!
structures!with! CD80! [10]!which!may! anchor! both! proteins! at! the! cell! surface.! ! In!
contrast,!CD86!is!thought!not!to!form!dimers![11]!which!may!make!this!protein!more!
susceptible! to! removal! from! the! surface! of! the! APC.! ! Taken! together,! these! data!
further! suggest! that!CTLA<4! is! acting! as! competition! for!CD28! resulting! in! reduced!
positive!signalling.!!!!
!
One!of!the!possible!explanations!for!the!lack!of!functional!effects!using!CHO!
cells! but! not! DCs! may! be! down! to! the! dendritic! cells! being! signalled! via! CTLA<4!
ligands!to!produce!factors!that!inhibit!T<cell!proliferation.!!One!of!the!most!obvious!
candidates!for!this!was!via!the!production!of!IDO!as!previously!reported.!!However,!it!
was!found!that!inhibiting!IDO!only!affected!proliferation!in!T<cells!when!there!were!
very!high!numbers!of!DCs.! !Such!high!numbers!of!DCs!may!be!required! in!order!to!
produce!enough!IDO!to!deplete!the!tryptophan!in!the!serum!rich!environment!that!
the!experiments!were!carried!out!in.!!It!could!be!expected!that!the!1<MT!is!toxic!to!
the!cells!and!certainly! it! appears! that!when! there!are!very! few!DCs! in! the!culture,!
that! treating! with! 1<MT! results! in! a! vast! decrease! in! proliferation! compared! to!
untreated! cells.! ! However,! where! there! are! more! DCs,! the! levels! of! proliferation!
between!treated!and!untreated!cells!are!largely!equivalent!suggesting!that!toxicity!of!
the!1<MT!is!not!a!major!factor!in!this!experiment.!!It!is!thought!that!IDO!can!exist!as!
both!an!inactive!and!active!form!and!that!activation!of!IDO!occurs!via!IFNγ![12,!13].!!
It!may! therefore! be! the! case! that! in! those! cultures! with! fewer! DCs,! fewer! T<cells!
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become! activated! lowering! the! total! amount! of! IFNγ! in! these! cultures.! ! It! is!
interesting! to! note! that! in! our! experience,! all! mature! DCs! express! IDO! following!
stimulation,!yet!can!effectively!stimulate!T<cell!responses.!!Accordingly!this!suggests!
that!there!must!be!some!specific!context!to! IDO!regulation.! !The!fact!that!blocking!
CTLA<4!at!such!high!numbers!of!DCs!had!no!effect!on!proliferation!suggests!that!IDO!
does! not! account! for! the! functional! effects! seen! in! our! assays.! ! The! relationship!
between! CTLA<4! and! IDO! still! remains! enigmatic! with! little! reproduction! of! the!
original!literature.!!Whilst!the!situation!remains!unclear!our!data!suggest!that!there!
are!clear!functions!of!CTLA<4!that!do!not!relate!to!IDO.!!!
!
The!data!presented!here!and!elsewhere![4]!show!that!one!function!of!CTLA<4!
is!to!acquire! ligands!from!APC.! !We!assessed!the!fate!of!the!acquired! ligands!upon!
entry! to! the! T<cell,! it! was! found! that! specifically! blocking! degradation! results! in!
increased!presence!of!CD86!GFP!within!CTLA<4!cells.!!This!implies!that!the!protein!is!
indeed! degraded! upon! acquisition.! ! Interestingly,! it! appears! that! both! CTLA<4! and!
CD86! are! degraded! once! acquisition! occurs.! ! These! findings! may! provide! an!
explanation!as!to!why!CTLA<4!is!recycled!between!the!cytoplasm!and!the!cell!surface!
and!why!the!protein!to!be!targeted!to!lysosomes!for!degradation![14<17].!!!However,!
this!data! is!still!very!preliminary!and!requires! further!work!to!fully!corroborate!the!
findings.!
!!
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Overall,!the!data!presented!in!this!chapter!are!consistent!with!the!idea!that!
CTLA<4!is!able!to!regulate!the!proliferation!of!surrounding!cells!by!modulating!APCs.!!
Indeed,! previous! data! has! shown! that! regulatory! T<cells! are! able! to!modulate! the!
expression! of! the! B7! lignads! on! DCs! [18].! ! Further,! our! laboratory! has! recently!
published!data!showing!that!CTLA<4!can!specifically!down<regulate!the!expression!of!
CD80!and!CD86![4].!!
!
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!
!
!
!
!
!
! 157!
6.1!Final!Discussion!
!
There! is! little! doubt! that! CTLA<4! acts! as! a! negative! regulator! of! T<cell!
activation,! however,! the! mechanism,! or! indeed! mechanisms,! employed! by! the!
protein!have!been!subject!to!much!debate.!!The!aim!of!this!project!was!therefore!to!
use!well!validated!reagents!to!try!and!test!the!various!suggested!models!of!CTLA<4!
mediated! suppression! in! order! to! establish! how! this! protein! exerts! its! inhibitory!
function.!!!!
!
The! aim! of! chapter! three! was! to! characterise! a! range! of! anti<CTLA<4!
antibodies! that! our! laboratory! had! in! order! to! assess! their! suitability! for! tools! in!
studying!the!role!of!CTLA<4.! !Although! it!appeared!that!all!of!the!antibodies!tested!
were! able! to! bind! to! the! extra<cellular! domain! of! their! target! protein,! it! was!
interesting!to!note!that!this!did!not!necessarily!predict!that!they!would!be!capable!of!
blocking!CTLA<4!interactions.!!These!data!highlight!the!importance!of!carrying!out!a!
comprehensive!study!on!the!antibodies!prior!to!carrying!out!functional!experiments!
using! them.! ! The! importance! of! a! full! characterisation! was! particularly! evident! in!
experiments!where!no!functional!effects!were!observed!upon!blocking!CTLA<4!in!T<
cells!stimulated!with!B7!expressing!CHO!cells.!!If!the!blocking!antibodies!hadn’t!been!
fully!tested!then!it!could!be!concluded!that!CTLA<4!wasn’t!functioning!in!this!setting.!!
However,! the! fact! that! it!was!known!that! the!antibodies!were!capable!of!blocking,!
together! with! the! subsequent! data! using! DCs! as! co<stimulators! where! large!
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functional!effects!were!revealed,!suggests!that!CTLA<4!just!does!not!function!in!this!
assay!despite!its!high!levels!of!expression.!!!
!
The!reason!for!a!lack!of!functional!effects!when!blocking!CTLA<4!in!the!CHO!
cell!assays,!even!when!the!numbers!of!CHO!cells!present!were!very! low!is! itself!an!
interesting! result.! ! It! supports! the!possibility! that!CTLA<4,!despite!popular!belief,! is!
unable! to! deliver! a! negative! signal! into! the! T<cells.! ! If! it! were! able! to! deliver! a!
negative!signal,!it!would!be!expected!that!having!more!ligand!available!would!result!
in!a!stronger!negative!signal.!!It!cannot!be!said!that!the!lack!of!a!negative!signal!is!a!
result!of! the!process!of! fixation!as! these!same! ligands!are!capable!of!driving!T<cell!
proliferation! in! the! first! place! and! the! fact! that! this! proliferation! is! dependent! on!
B7:CD28!interactions!suggest!that,!despite!fixation,!the!ligands!are!still!functional.!!It!
is! therefore! reasonable! to! conclude! that! if! a! negative! signal! were! important! in!
restricting!T<cell!proliferation!that!this!signal!would!also!be!deliverable!in!this!setting!
and!therefore!observable!in!the!CHO!experiments.!!!
!
The!fact!that!there!was!no!effect!of!blocking!proliferation!in!a!CHO!cell!assay!
but! were! sizeable! effects! under! other! conditions! using! DCs! as! APC,! points! to! the!
possibility! that! CTLA<4!may! be! capable! of! acting! on! the! DC.! ! It! could! be! that! the!
process!of!fixation!inhibits!the!removal!of! ligands!from!the!surface!of!the!CHO!cell,!
which! is!why!no!effects!of!blocking!CTLA<4!could!be!observed.! ! In!order!to!address!
this!issue,!CHO!cells!were!irradiated!or!treated!with!mitomycin!C!before!being!used!
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to! provide! co<stimulation! for! the! responder! T<cell! population.! ! It! was! found,!
however,! that! the!T<cells! did!not!undergo!proliferation!when!mitomycin!C! treated!
CHO! cells! were! used.! ! The! reason! for! this! is! currently! under! investigation.! ! One!
possible!explanation!could!be!due!to!the!fact!that!CHO!cells!do!not!express!adhesion!
molecules!on!their!surface.!!One!of!the!major!adhesion!molecules!is!LFA<1,!which!has!
been! shown! to! be! required! for! IS! formation! [1].! ! LFA<1! is! thought! to! aid! the!
formation!of!the!pSMACs!and!hence!assisting!with!TCR!signalling![2].!!It!could!be!that!
the!process!of!fixation!holds!the!activation!molecules!in!place,!allowing!optimal!TCR!
signalling.! ! In! contrast,! the! live! cells! may! be! too! fluid! which,! in! the! absence! of!
adhesion!molecules,!results!in!inadequate!activation!signals!resulting!in!impaired!T<
cell!responses.!!!
!
It! was! then! decided! to! assess! if! the! removal! of! ligands! from!DCs! could! be!
inhibited!by!fixing!the!APCSs!prior!to!their!use!as!co<stimulators.!!Again,!however,!it!
was! found! that! fixed!DCs!were!unable! to!provide!co<stimulation! for! the!T<cells.! ! It!
would!be!interesting!in!future!to!find!a!method!of!blocking!the!removal!of!ligand!on!
the!DC!and!testing!if!blocking!CTLA<4!still!had!a!functional!outcome.!!Despite!these!
limitations! the! simple! negative! signal! model! is! not! supported! by! the! above! data,!
suggesting! either! very! specific! requirements! for! this! function! or! that! intrinsic!
inhibition!is!not!a!major!mechanism.!!!
!
!
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The!data!presented!in!this!thesis!provide!a!little!more!clarity!as!to!how!CTLA<
4!is!able!to!modulate!T<cell!responses,!a!summary!of!which!is!shown!in!figure!6.1.!!It!
would! appear! that! CTLA<4! and! CD28! work! to! maintain! the! fine! balance! required!
between! producing! a! sufficiently! robust! immune! response! to! overcome! infection,!
whilst! maintaining! tolerance! to! self! antigens! and! thus! preventing! autoimmunity.!!
There!are!several!key!features!of!the!biology!of!both!CD28!and!CTLA<4!that!seem!to!
enable!this!fine!balance!to!be!met.!!Firstly,!is!the!timing!of!protein!expression.!!It!has!
been! found! that! CD28! expressed! on! all! resting! T<cells! [3]! and! is! therefore!
immediately!available!for!engagement!when!an!antigen!is!encountered.!!Conversely,!
it! is! only! once! the! TCR! engages! with! antigen! together! with! co<stimulatory! signals!
from! CD28! engagement! that! high! levels! of! CTLA<4! expression! are! induced! [4].!!
Further,!it!has!been!demonstrated!that!CTLA<4!has!a!very!high!turnover!rate!with!a!
half<life!of!roughly!2<4!hours![5].! !The!timing!differences!of!the!expression!patterns!
would! allow! T<cells! to! initiate! a! response! on! encountering! an! infectious! agent!
without!the!response!being!drowned!out!by!CTLA<4!suppression.!!!
!
!
!
!
!
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Figure' 6.1:' ' Summary' Diagram' of' CTLA84" Mediated" Suppression.! ! T<cells% are%
activated(after(stimulation(of(the(TCR#together#with#CD28#mediated#co<stimulation.++
Activation) of) the) T<cells% results% in% induced% IL<2" production," proliferation" and"
induction(of(CTLA<4"expression.""CTLA<4" is"then"transported"to"the"surface"where" it"
out$competes$CD28$for$binding$to$CD80$and$CD86.$$Upon$engagement$of$CTLA<4"to"
its$ligands,$both$molecules$are$internalised$into$the$T<cell$resulting$in$reduced$levels$
!of#ligand#on#the#surface#of#the#DCs.#####
! 162!
The!second!critical!feature!of!these!proteins!biology!is!location!of!expression.!!
CD28!is!found!at!relatively!high!levels!localised!at!the!surface!of!the!T<cell!where!it!is!
readily!available!to!engage!with! its! ligands!thus!driving!the!early!T<cell! response!to!
infection! unimpeded.! ! Conversely,! CTLA<4! is! found! largely! in! intracellular! vesicles!
with!only!a!very!small!amount!of!the!protein!being!found!at!the!surface!at!any!given!
time! [5,!6].! !Once! the!T<cell! is! activated,!CTLA<4! is! trafficked! to! the! immunological!
synapse! [7]! before! being! re<internalised! back! into! the! T<cell.! ! This! limited! surface!
expression!would!be!expected!to!reduce!the!opportunity!for!CTLA<4!to!engage!with!
its!ligands!preventing!T<cell!responses!from!being!prematurely!suppressed.!!!
!
!A! third! important! difference! in! the! biology! of! CD28! and! CTLA<4! that!
contributes! to! function! is! that! CTLA<4! is! able! to! bind! to! its! ligands! with! greater!
avidity!and!affinity!than!CD28!thus!enabling!CTLA<4!to!out<compete!CD28!for!ligand!
binding! [8,! 9].! ! This! feature! allows! CTLA<4! to! act! as! an! efficient! antagonist! to! a!
protein! that! is!expressed!earlier!and!more!abundantly!on!the!surface!of! the!T<cell.!!!
The!data!presented! in!chapter!5!showing!that!CTLA<4! is!able! to!down!regulate! the!
expression! of! CD80! and! CD86! on! the! APC! fits! well! with! a! competition!model! for!
suppression!by!CTLA<4.!!Firstly,!the!T<cell!is!activated!by!engagement!of!the!TCR!and!
co<stimulation!by!CD28.!!This!results!in!expression!of!CTLA<4!which!is!transported!to!
the!IS!where! it!competes!with!CD28!for! ligand!binding.! !Upon!engagement,!CTLA<4!
and!bound! ligand!are!re<internalised!and!targeted!to!the! lysosome!for!degradation!
[10]!thus!reducing!the!availability!of!B7!on!the!APC!and!hence!the!capacity!for!CD28!
to!provide!further!co<stimulation.! ! ! It! is! interesting!to!note!that! in!preliminary!data!
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studying!the!fate!of!CTLA<4!after!the!removal!of! ligand!suggests!that!the!protein! is!
only!degraded!after!engaging!with!CD86!but!not!with!CD80.!!It!does!appear!that!the!
CTLA<4!is!capable!of!removing!both!ligands!so!these!data!could!therefore!imply!that!
once! internalised,! the! protein! may! be! processed! differently! in! lysosomes.!!
Alternatively,! it! has! been! shown! that! CTLA<4! and! CD80! can! form! lattice! like!
structures!on!the!surface!of!the!T<cell![11].!!The!formation!of!such!lattices!may!make!
it!more!difficult!for!CD80!to!be!removed!from!the!surface!of!the!APC!and,!consistent!
with!this! idea,!the!data!presented! in!figure!5.2.3.4!does!suggest!that!CD86! is!more!
readily!down<regulated!than!CD80.!!!!!
!
The!data!showing!that!CTLA<4!expressing!jurkat!T<cells!were!able!to!suppress!
a! responder! population! suggests! that! CTLA<4!may! work! in! the! same! way! in! both!
helper! and! regulatory! T<cells.! ! It! has! been! shown! that! Tregs! constitutively! express!
CTLA<4![12],!which!may!go!some!way!to!explaining!their!highly!suppressive!nature.!!
Having!CTLA<4!available!from!the!first!engagement!may!prevent!or!limit!the!delivery!
of!the!initial!co<stimulatory!signal!from!CD28!thus!increasing!the!threshold!for!T<cell!
activation.!!There!have!also!been!some!data!suggesting!that!CTLA<4!may!be!able!to!
reduce!the!contact!time!between!the!T<cell!and!the!APC![13]!and!that!lower!levels!of!
ligand!are!detected! in!the!presence!of!CTLA<4!positive!cells! [14,!15],!both!of!which!
may! be! a! result! of! CTLA<4! depleting! B7! ligands! from! the! DC.! ! The! idea! of! CTLA<4!
removing! ligands! from! the! APC! provides! a! mechanism! for! CTLA<4! that! would! be!
functional!in!both!settings.!!!!!
!
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The! transfer! of! proteins! between! cells! has! been! observed! in! a! number! of!
situations! and! appears! to! be! particularly! prevalent! between! cells! of! the! immune!
system![16<19].!!The!exact!molecular!mechanisms!driving!the!inter<cellular!trafficking!
of!proteins!remain!largely!unknown.!!!!Two!potential!mechanisms!of!protein!transfer!
have! been! identified;! these! are! trogocytosis! and! nanotube! formation! [20].!!
Nanotubes!are!long!membrane!projections!that!connect!T<cells!enabling!the!transfer!
of! information! [21].! ! There! is! evidence! to! suggest! that! specific! proteins! can! be!
directed! to! nanotubes! [20]! raising! the! possibility! that! this! could! play! a! role! in! the!
transfer! of! ligands!between! the!DC!and! the! T<cell.! ! An! alternative! to!nanotubes! is!
trogocytosis,! which! is! an! active! process! of! protein! transfer! that! requires! cell<cell!
contact.! ! It! would! therefore! be! expected! that! upon! transport! to! the! immune!
synapse,!that!CTLA<4!could!be!in!a!position!to!induce!trogocytosis!to!occur.!!Further,!
as! a! process,! trogocytosis! is! thought! to! occur! rapidly! [22,! 23],!which! could! enable!
CTLA<4! to! modulate! T<cell! responses! quickly! and! effectively.! ! Both! nanotube!
formation! and! trogocytosis! require! further! study! to! determine! how! they! enable!
protein!transfer.!!Additional!work!is!also!necessary!to!establish!the!mechanisms!that!
CTLA<4!uses!to!remove!ligands!from!the!DCs.!
!
!
Further!work!would!begin!by!trying!to!determine!if!the!“ripping”!of!CD86!from!the!
surface!of!T<cells!is!a!major!mechanism!for!CTLA<4!function.!!It!would!be!interesting!to!try!to!
reveal! CTLA<4! function! using! the! CHO! cell! transfectants! as! stimulatory! cells! by! finding! a!
model!where!non<fixed!CHO!cells!were!able!to!drive!T<cell!proliferation.! !This!may!become!
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possible!by! including! factors! such!as! adhesion!molecules! in! the!CHO!cell! thereby!enabling!
the!T!cell!to!engage!more!tightly!with!the!CHO!cell.!!
!
In! parallel! to! this,! it! would! be! useful! to! develop! a! DC! driven! system! where! it! is!
possible! to! inhibit! the! transfer!of! co<stimulatory!molecules.! ! This! could! take! the! form!of!a!
fixed! DC! that! is! capable! of! driving! proliferation.! ! To! do! this,! it!may! be! necessary! to! over!
express! co<stimulatory!molecules! on! the! surface! to! overcome! the! fact! that! fixed! DCs! not!
able!to!drive!T<cell!proliferation.!Alternatively,!it!may!be!possible!to!develop!a!DC!that!has!its!
CD86!anchored!to!the!membrane!possibly!by!tethering!the!B7!ligands!to!integral!membrane!
proteins.!!If!the!use!of!the!modified!DCs!resulted!in!the!loss!of!CTLA<4!effects!when!APCs!are!
titrated,! it! would! go! some! way! towards! showing! that! the! transfer! of! co<stimulatory!
molecules!is!an!important!mechanism!of!CTLA<4!function.!!!
!
Another!avenue!for!investigation!would!be!to!assess!the!role!of!CTLA<4!on!Treg!cells.!!
The! jurkat! experiments! presented! in! this! thesis! suggest! that! any! CTLA<4! expressing! cell! is!
capable!of!suppression.! ! It!would!be!useful!to!try!to! isolate!a!pure!population!of!Treg!cells!
and! to! assess! their! ability! to! suppress! responder! T<cell! function! when! compared! to! non<
regulatory!cells.! ! It!may!be! that! regulatory!T<cells!are!more!effective!suppressors!and! that!
anti<CTLA<4! effects! may! be! observed! at! an! earlier! time! point! when! compared! to! non<
regulatory!cells.!!However,!this!could!be!driven!by!other!means!of!suppression.!
!
It! would! also! be! interesting! to! conduct! further! investigation! of! the! preliminary!
western!blot!data!suggesting!that!CD86!is!degraded!upon!acquisition!by!CTLA<4.! !From!the!
preliminary!data!it!appears!that!CD86!is!degraded!where!CTLA<4!is!not,!this!could!either!be!
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because! the! proteins! are! becoming! detached! inside! the! T<cell! or! that! new! CTLA<4! is!
generated!more!rapidly!than!CD86.!!It!is!known!that!CTLA<4!is!trafficked!towards!lysosomes!
so!it!could!be!that!once!in!here,!the!pH!of!the!lysosome!causes!CTLA<4!to!detach!from!CD86!
enabling!the!CTLA<4!to!be!redirected!to!the!surface!of!the!T<cell!whilst!the!CD86!is!degraded.!!
!
It!was!also!interesting!to!note!from!the!preliminary!data!that!levels!of!CD86!declined!
where! CD80!didn’t.! ! Further! investigation!would! try! to! elucidate! if! this!was! important! for!
maintaining! the! immune! response! active! during! the! course! of! an! infection.! ! It! would! be!
interesting!to!make!a!single!CD80!molecule!that!was!incapable!of!dimerization!to!determine!
if!this!made!it!possible!for!CTLA<4!to!remove!this!protein!also.!!
!
Overall,! there! still! remain! a! number! of! unknowns! surrounding! exactly! how!
CTLA<4! modulates! T<cell! activation.! ! Understanding! how! this! protein! works! could!
have! important! therapeutic! implications.! ! ! There! are! a! number! of! autoimmune!
diseases! that!are!associated!with!defective!CTLA<4! [24<28],! further;! it!appears! that!
blocking!CTLA<4!function!could!improve!the!prognosis!in!certain!cancer!patients![29,!
30].!!Utilising!the!negative!regulatory!function!of!CTLA<4!has!already!proven!to!have!
some!success!in!the!treatment!of!RA![31].!!It!appears!that!one!of!the!biggest!issues!
with! the! use! of! blocking! CTLA<4! antibodies! as! a! treatment! is! a! lack! of! specificity.!!
Blocking!CTLA<4!can!result!in!the!inhibition!of!all!T<cell!responses,!which!can!increase!
susceptibility! to! infection! and! also! result! in! a! breakdown! of! peripheral! tolerance!
causing!the!development!of!autoimmune!conditions.! !Adverse!reactions!as!a!result!
of! indiscriminate!blocking!of!CTLA<4!on!all!expressing!cells!appear!to!correlate!with!
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the!effectiveness!of!the!treatment!against!cancer![30].!!If!all!CTLA<4!expressing!cells!
are! capable! of! suppressing! then! it! is! not! surprising! that! blocking! the! proteins!
function! results! in! a! breakdown! of! tolerance! and! inducement! of! autoimmune!
conditions.! ! It! may! be! more! appropriate! to! try! to! target! the! blocking! antibody!
therapies! to! antigen! specific! T<cells! in! order! to! reduce! the! incidence! of! adverse!
reactions!to!the!treatment.!!!!!!
!
Understanding!processes!up!or!downstream!of!CTLA<4!function!may!also!be!
important! in! developing! therapeutics.! ! It! may! be! possible! to! isolate! areas! of! the!
pathway!that!will!allow!specific!targeting!towards!CTLA<4.!!!
!
!
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